CN102869768B - Produce fatty acid and the microbial project of derivative of fatty acid - Google Patents
Produce fatty acid and the microbial project of derivative of fatty acid Download PDFInfo
- Publication number
- CN102869768B CN102869768B CN201180022036.4A CN201180022036A CN102869768B CN 102869768 B CN102869768 B CN 102869768B CN 201180022036 A CN201180022036 A CN 201180022036A CN 102869768 B CN102869768 B CN 102869768B
- Authority
- CN
- China
- Prior art keywords
- cell
- bio
- oil
- fuel
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000014113 dietary fatty acids Nutrition 0.000 title claims description 160
- 239000000194 fatty acid Substances 0.000 title claims description 160
- 150000004665 fatty acids Chemical class 0.000 title claims description 157
- 230000000813 microbial Effects 0.000 title description 10
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 123
- 150000007523 nucleic acids Chemical class 0.000 claims description 123
- 108020004707 nucleic acids Proteins 0.000 claims description 123
- 241000235015 Yarrowia lipolytica Species 0.000 claims description 101
- 150000001720 carbohydrates Chemical class 0.000 claims description 90
- 235000014633 carbohydrates Nutrition 0.000 claims description 90
- DCXXMTOCNZCJGO-UHFFFAOYSA-N Stearin Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 claims description 84
- 238000000034 method Methods 0.000 claims description 80
- 230000014509 gene expression Effects 0.000 claims description 79
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 73
- 235000000346 sugar Nutrition 0.000 claims description 70
- 239000000463 material Substances 0.000 claims description 53
- 239000002028 Biomass Substances 0.000 claims description 46
- 238000000926 separation method Methods 0.000 claims description 43
- 230000001629 suppression Effects 0.000 claims description 42
- 102000004190 Enzymes Human genes 0.000 claims description 39
- 108090000790 Enzymes Proteins 0.000 claims description 39
- 239000002253 acid Substances 0.000 claims description 38
- WQZGKKKJIJFFOK-GASJEMHNSA-N D-Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 34
- 239000008103 glucose Substances 0.000 claims description 30
- 230000002538 fungal Effects 0.000 claims description 26
- 230000001105 regulatory Effects 0.000 claims description 26
- 230000001131 transforming Effects 0.000 claims description 26
- 108010022240 delta-8 fatty acid desaturase Proteins 0.000 claims description 25
- 150000008163 sugars Chemical class 0.000 claims description 23
- 239000000835 fiber Substances 0.000 claims description 21
- 229920001850 Nucleic acid sequence Polymers 0.000 claims description 19
- 239000001913 cellulose Substances 0.000 claims description 18
- 229920002678 cellulose Polymers 0.000 claims description 18
- 239000005516 coenzyme A Substances 0.000 claims description 17
- 238000010353 genetic engineering Methods 0.000 claims description 17
- 230000001939 inductive effect Effects 0.000 claims description 17
- 229940093530 Coenzyme A Drugs 0.000 claims description 16
- 229920002488 Hemicellulose Polymers 0.000 claims description 16
- SIARJEKBADXQJG-LFZQUHGESA-N Stearoyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CCCCCCCCCCCCCCCCC)O[C@H]1N1C2=NC=NC(N)=C2N=C1 SIARJEKBADXQJG-LFZQUHGESA-N 0.000 claims description 16
- 241000196324 Embryophyta Species 0.000 claims description 12
- 230000000735 allogeneic Effects 0.000 claims description 12
- 241000195493 Cryptophyta Species 0.000 claims description 11
- 230000005017 genetic modification Effects 0.000 claims description 11
- 235000013617 genetically modified food Nutrition 0.000 claims description 11
- 230000001954 sterilising Effects 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 229920000160 (ribonucleotides)n+m Polymers 0.000 claims description 9
- 229920002472 Starch Polymers 0.000 claims description 7
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 7
- 238000006460 hydrolysis reaction Methods 0.000 claims description 7
- 150000002772 monosaccharides Chemical group 0.000 claims description 7
- 239000008107 starch Substances 0.000 claims description 7
- 235000019698 starch Nutrition 0.000 claims description 7
- 241000233866 Fungi Species 0.000 claims description 5
- 125000002252 acyl group Chemical group 0.000 claims description 5
- 239000003814 drug Substances 0.000 claims description 5
- 230000003301 hydrolyzing Effects 0.000 claims description 5
- 241000228245 Aspergillus niger Species 0.000 claims description 4
- 241000235072 Saccharomyces bayanus Species 0.000 claims description 4
- 241000235347 Schizosaccharomyces pombe Species 0.000 claims description 4
- 241000499912 Trichoderma reesei Species 0.000 claims description 4
- 230000003115 biocidal Effects 0.000 claims description 4
- 230000001413 cellular Effects 0.000 claims description 4
- 238000005215 recombination Methods 0.000 claims description 4
- 239000004382 Amylase Substances 0.000 claims description 3
- 108010065511 Amylases Proteins 0.000 claims description 3
- 102000013142 Amylases Human genes 0.000 claims description 3
- 241001138401 Kluyveromyces lactis Species 0.000 claims description 3
- 241000320412 Ogataea angusta Species 0.000 claims description 3
- 241000223253 Rhodotorula glutinis Species 0.000 claims description 3
- 241000235070 Saccharomyces Species 0.000 claims description 3
- 241000235060 Scheffersomyces stipitis Species 0.000 claims description 3
- 235000019418 amylase Nutrition 0.000 claims description 3
- 229940079593 drugs Drugs 0.000 claims description 3
- 238000003379 elimination reaction Methods 0.000 claims description 3
- 241001149952 Amylomyces rouxii Species 0.000 claims description 2
- 206010003486 Aspergillus infection Diseases 0.000 claims description 2
- 241000228136 Aspergillus shirousami Species 0.000 claims description 2
- 241000223233 Cutaneotrichosporon cutaneum Species 0.000 claims description 2
- 102000004157 Hydrolases Human genes 0.000 claims description 2
- 108090000604 Hydrolases Proteins 0.000 claims description 2
- 241000235058 Komagataella pastoris Species 0.000 claims description 2
- 241001489207 Lipomyces lipofer Species 0.000 claims description 2
- 241000907999 Mortierella alpina Species 0.000 claims description 2
- 240000007594 Oryza sativa Species 0.000 claims description 2
- 235000007164 Oryza sativa Nutrition 0.000 claims description 2
- 241000235061 Pichia sp. Species 0.000 claims description 2
- 241001123650 Schwanniomyces occidentalis Species 0.000 claims description 2
- 241000223230 Trichosporon Species 0.000 claims description 2
- 241000306282 Umbelopsis isabellina Species 0.000 claims description 2
- 241000235033 Zygosaccharomyces rouxii Species 0.000 claims description 2
- 230000001028 anti-proliferant Effects 0.000 claims description 2
- 201000002909 aspergillosis Diseases 0.000 claims description 2
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium monoxide Chemical compound [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 claims description 2
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims description 2
- 235000013372 meat Nutrition 0.000 claims description 2
- 238000002203 pretreatment Methods 0.000 claims description 2
- 235000009566 rice Nutrition 0.000 claims description 2
- 230000001461 cytolytic Effects 0.000 claims 3
- 230000035772 mutation Effects 0.000 claims 2
- 230000002452 interceptive Effects 0.000 claims 1
- 239000002551 biofuel Substances 0.000 abstract description 266
- 244000005700 microbiome Species 0.000 abstract description 223
- OZAIFHULBGXAKX-UHFFFAOYSA-N precursor Substances N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 abstract description 128
- 229910052799 carbon Inorganic materials 0.000 abstract description 79
- OKTJSMMVPCPJKN-UHFFFAOYSA-N carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract description 78
- 230000037356 lipid metabolism Effects 0.000 abstract description 10
- 210000004027 cells Anatomy 0.000 description 202
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 115
- 150000002632 lipids Chemical class 0.000 description 111
- 239000003921 oil Substances 0.000 description 78
- 235000019198 oils Nutrition 0.000 description 77
- 239000000047 product Substances 0.000 description 60
- 102100015696 DGCR2 Human genes 0.000 description 56
- 230000015572 biosynthetic process Effects 0.000 description 56
- 230000000694 effects Effects 0.000 description 56
- 230000002194 synthesizing Effects 0.000 description 54
- 238000003786 synthesis reaction Methods 0.000 description 53
- 235000019197 fats Nutrition 0.000 description 49
- 230000012010 growth Effects 0.000 description 46
- 102000001554 Hemoglobins Human genes 0.000 description 34
- 108010054147 Hemoglobins Proteins 0.000 description 34
- -1 SCD Proteins 0.000 description 34
- 238000004519 manufacturing process Methods 0.000 description 32
- 238000006243 chemical reaction Methods 0.000 description 31
- 230000001965 increased Effects 0.000 description 31
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N Oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 30
- 229940088598 Enzyme Drugs 0.000 description 29
- 235000001727 glucose Nutrition 0.000 description 29
- 230000033228 biological regulation Effects 0.000 description 27
- 102000000452 Acetyl-CoA Carboxylase Human genes 0.000 description 26
- 108010016219 Acetyl-CoA Carboxylase Proteins 0.000 description 26
- 238000009825 accumulation Methods 0.000 description 25
- 102000014156 AMP-Activated Protein Kinases Human genes 0.000 description 24
- 108010011376 AMP-Activated Protein Kinases Proteins 0.000 description 24
- 235000011187 glycerol Nutrition 0.000 description 24
- 235000018102 proteins Nutrition 0.000 description 24
- 102000004169 proteins and genes Human genes 0.000 description 24
- 108090000623 proteins and genes Proteins 0.000 description 24
- 239000012071 phase Substances 0.000 description 23
- 108010052832 Cytochromes Proteins 0.000 description 22
- 102000018832 Cytochromes Human genes 0.000 description 22
- 102100005528 MAPK9 Human genes 0.000 description 22
- 108010087313 Mitogen-Activated Protein Kinase 9 Proteins 0.000 description 22
- 102100016914 SCD Human genes 0.000 description 22
- 108010053156 lipid transfer protein Proteins 0.000 description 22
- 239000000203 mixture Substances 0.000 description 22
- 239000000126 substance Substances 0.000 description 22
- 108010028096 Stearoyl-CoA Desaturase Proteins 0.000 description 21
- 239000000446 fuel Substances 0.000 description 21
- 239000002994 raw material Substances 0.000 description 21
- 102000018711 Facilitative Glucose Transport Proteins Human genes 0.000 description 20
- 101700086098 FAT2 Proteins 0.000 description 19
- 239000000969 carrier Substances 0.000 description 19
- 239000000758 substrate Substances 0.000 description 19
- 108010026217 EC 1.1.1.37 Proteins 0.000 description 17
- 102000013460 EC 1.1.1.37 Human genes 0.000 description 17
- 101700015998 FADD Proteins 0.000 description 17
- 108091006272 Glucose transporter family Proteins 0.000 description 17
- QIQXTHQIDYTFRH-UHFFFAOYSA-N Stearic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 17
- 101710009782 fadD11 Proteins 0.000 description 17
- 101710010463 fadD15 Proteins 0.000 description 17
- 101710010457 fadD17 Proteins 0.000 description 17
- 101710010449 fadD19 Proteins 0.000 description 17
- 101710009908 fadD21 Proteins 0.000 description 17
- 101710010378 fadD23 Proteins 0.000 description 17
- 101710009902 fadD25 Proteins 0.000 description 17
- 101700051677 fadK Proteins 0.000 description 17
- 230000004136 fatty acid synthesis Effects 0.000 description 17
- 239000001963 growth media Substances 0.000 description 17
- 101700037037 vraA Proteins 0.000 description 17
- 102000004146 ATP citrate synthases Human genes 0.000 description 16
- 108090000662 ATP citrate synthases Proteins 0.000 description 16
- 239000002585 base Substances 0.000 description 16
- 230000002068 genetic Effects 0.000 description 16
- 230000013190 lipid storage Effects 0.000 description 16
- 101710008102 FASN Proteins 0.000 description 15
- 102100008329 FASN Human genes 0.000 description 15
- 239000005642 Oleic acid Substances 0.000 description 15
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 15
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 15
- 108010053763 EC 6.4.1.1 Proteins 0.000 description 14
- 102100007000 PC Human genes 0.000 description 14
- 230000001580 bacterial Effects 0.000 description 14
- VLKZOEOYAKHREP-UHFFFAOYSA-N hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 14
- 230000001473 noxious Effects 0.000 description 14
- 101710015183 FAA1 Proteins 0.000 description 13
- 230000036740 Metabolism Effects 0.000 description 13
- 230000004060 metabolic process Effects 0.000 description 13
- 230000035786 metabolism Effects 0.000 description 13
- 235000003534 Saccharomyces carlsbergensis Nutrition 0.000 description 12
- 229940081969 Saccharomyces cerevisiae Drugs 0.000 description 12
- 150000001875 compounds Chemical class 0.000 description 12
- 230000035897 transcription Effects 0.000 description 12
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Chemical class CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 11
- 239000002773 nucleotide Substances 0.000 description 11
- 125000003729 nucleotide group Chemical group 0.000 description 11
- 238000001228 spectrum Methods 0.000 description 11
- 239000003225 biodiesel Substances 0.000 description 10
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 10
- 230000003204 osmotic Effects 0.000 description 10
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 10
- 230000028327 secretion Effects 0.000 description 10
- 102100008328 FAT2 Human genes 0.000 description 9
- 230000004129 fatty acid metabolism Effects 0.000 description 9
- 230000003834 intracellular Effects 0.000 description 9
- 241000894006 Bacteria Species 0.000 description 8
- 102100009281 CYB5A Human genes 0.000 description 8
- 235000021355 Stearic acid Nutrition 0.000 description 8
- 230000004913 activation Effects 0.000 description 8
- 230000002708 enhancing Effects 0.000 description 8
- 230000002255 enzymatic Effects 0.000 description 8
- 150000002148 esters Chemical group 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 229910052760 oxygen Inorganic materials 0.000 description 8
- 239000001301 oxygen Substances 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 239000008117 stearic acid Substances 0.000 description 8
- 101700035010 COASY Proteins 0.000 description 7
- 102100004201 COASY Human genes 0.000 description 7
- 108010007167 Cytochromes b5 Proteins 0.000 description 7
- XJLXINKUBYWONI-NNYOXOHSSA-N Nicotinamide adenine dinucleotide phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-NNYOXOHSSA-N 0.000 description 7
- 241001597008 Nomeidae Species 0.000 description 7
- IPCSVZSSVZVIGE-UHFFFAOYSA-N Palmitic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 7
- 238000000605 extraction Methods 0.000 description 7
- 235000019387 fatty acid methyl ester Nutrition 0.000 description 7
- 239000008079 hexane Substances 0.000 description 7
- 229910052738 indium Inorganic materials 0.000 description 7
- 230000002401 inhibitory effect Effects 0.000 description 7
- 230000004048 modification Effects 0.000 description 7
- 238000006011 modification reaction Methods 0.000 description 7
- 230000001603 reducing Effects 0.000 description 7
- 229920002676 Complementary DNA Polymers 0.000 description 6
- SRBFZHDQGSBBOR-SQOUGZDYSA-N Xylose Natural products O[C@@H]1CO[C@@H](O)[C@@H](O)[C@@H]1O SRBFZHDQGSBBOR-SQOUGZDYSA-N 0.000 description 6
- FRYDSOYOHWGSMD-UHFFFAOYSA-N [C].O Chemical compound [C].O FRYDSOYOHWGSMD-UHFFFAOYSA-N 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- 125000001931 aliphatic group Chemical group 0.000 description 6
- 150000001413 amino acids Chemical group 0.000 description 6
- 239000006227 byproduct Substances 0.000 description 6
- 238000006555 catalytic reaction Methods 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 238000000855 fermentation Methods 0.000 description 6
- 230000004151 fermentation Effects 0.000 description 6
- 239000002609 media Substances 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- MYMOFIZGZYHOMD-UHFFFAOYSA-N oxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-N phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 6
- 239000010902 straw Substances 0.000 description 6
- VOFUROIFQGPCGE-UHFFFAOYSA-N Nile red Chemical compound C1=CC=C2C3=NC4=CC=C(N(CC)CC)C=C4OC3=CC(=O)C2=C1 VOFUROIFQGPCGE-UHFFFAOYSA-N 0.000 description 5
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 5
- 241000209149 Zea Species 0.000 description 5
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 5
- 239000000654 additive Substances 0.000 description 5
- 230000000996 additive Effects 0.000 description 5
- 230000000844 anti-bacterial Effects 0.000 description 5
- 125000004432 carbon atoms Chemical group C* 0.000 description 5
- 239000002299 complementary DNA Substances 0.000 description 5
- 235000005822 corn Nutrition 0.000 description 5
- 235000005824 corn Nutrition 0.000 description 5
- 239000002803 fossil fuel Substances 0.000 description 5
- 230000001404 mediated Effects 0.000 description 5
- 230000002503 metabolic Effects 0.000 description 5
- 229920001239 microRNA Polymers 0.000 description 5
- 239000002679 microRNA Substances 0.000 description 5
- 235000021281 monounsaturated fatty acids Nutrition 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- 238000007254 oxidation reaction Methods 0.000 description 5
- 239000000049 pigment Substances 0.000 description 5
- 229920000642 polymer Polymers 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- WQZGKKKJIJFFOK-VFUOTHLCSA-N β-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 5
- HVYWMOMLDIMFJA-DPAQBDIFSA-N (3β)-Cholest-5-en-3-ol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- BVDRUCCQKHGCRX-UHFFFAOYSA-N 2,3-dihydroxypropyl formate Chemical compound OCC(O)COC=O BVDRUCCQKHGCRX-UHFFFAOYSA-N 0.000 description 4
- 241000195649 Chlorella <Chlorellales> Species 0.000 description 4
- BJHIKXHVCXFQLS-UYFOZJQFSA-N Fructose Natural products OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO BJHIKXHVCXFQLS-UYFOZJQFSA-N 0.000 description 4
- 241000282414 Homo sapiens Species 0.000 description 4
- 108020004999 Messenger RNA Proteins 0.000 description 4
- SECPZKHBENQXJG-FPLPWBNLSA-N Palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 4
- 231100000614 Poison Toxicity 0.000 description 4
- 230000025458 RNA interference Effects 0.000 description 4
- 210000000582 Semen Anatomy 0.000 description 4
- 108020004459 Small Interfering RNA Proteins 0.000 description 4
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 4
- 241000700605 Viruses Species 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 244000052616 bacterial pathogens Species 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 238000002485 combustion reaction Methods 0.000 description 4
- 229920003013 deoxyribonucleic acid Polymers 0.000 description 4
- 235000013601 eggs Nutrition 0.000 description 4
- 239000000727 fraction Substances 0.000 description 4
- 238000003306 harvesting Methods 0.000 description 4
- 238000002744 homologous recombination Methods 0.000 description 4
- 230000001665 lethal Effects 0.000 description 4
- 231100000518 lethal Toxicity 0.000 description 4
- 230000000670 limiting Effects 0.000 description 4
- 229920002106 messenger RNA Polymers 0.000 description 4
- 238000010369 molecular cloning Methods 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 230000037361 pathway Effects 0.000 description 4
- 239000010452 phosphate Substances 0.000 description 4
- 230000000630 rising Effects 0.000 description 4
- 230000002987 rna-interference Effects 0.000 description 4
- 239000002924 silencing RNA Substances 0.000 description 4
- 241000894007 species Species 0.000 description 4
- 210000001519 tissues Anatomy 0.000 description 4
- 230000002103 transcriptional Effects 0.000 description 4
- 238000001890 transfection Methods 0.000 description 4
- 238000011144 upstream manufacturing Methods 0.000 description 4
- CZPWVGJYEJSRLH-UHFFFAOYSA-N 289-95-2 Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 3
- ZSLZBFCDCINBPY-ZSJPKINUSA-N Acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 3
- 108010049418 Acyl Carrier Protein Proteins 0.000 description 3
- UDMBCSSLTHHNCD-KQYNXXCUSA-N Adenosine monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 3
- 229950006790 Adenosine phosphate Drugs 0.000 description 3
- 235000019737 Animal fat Nutrition 0.000 description 3
- 229940106157 CELLULASE Drugs 0.000 description 3
- 108010059892 Cellulase Proteins 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- 108010027279 Facilitative Glucose Transport Proteins Proteins 0.000 description 3
- 229940088597 Hormone Drugs 0.000 description 3
- 210000002824 Peroxisome Anatomy 0.000 description 3
- 210000002356 Skeleton Anatomy 0.000 description 3
- 102000004357 Transferases Human genes 0.000 description 3
- 108090000992 Transferases Proteins 0.000 description 3
- 229960003487 Xylose Drugs 0.000 description 3
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 238000010923 batch production Methods 0.000 description 3
- 238000004113 cell culture Methods 0.000 description 3
- 230000001276 controlling effect Effects 0.000 description 3
- 230000002349 favourable Effects 0.000 description 3
- 229940020899 hematological Enzymes Drugs 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 238000011031 large scale production Methods 0.000 description 3
- 239000007791 liquid phase Substances 0.000 description 3
- 150000004668 long chain fatty acids Chemical class 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 230000037353 metabolic pathway Effects 0.000 description 3
- 230000036961 partial Effects 0.000 description 3
- 235000011007 phosphoric acid Nutrition 0.000 description 3
- 229920001184 polypeptide Polymers 0.000 description 3
- 238000007781 pre-processing Methods 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 238000009790 rate-determining step (RDS) Methods 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 230000003612 virological Effects 0.000 description 3
- 210000004885 white matter Anatomy 0.000 description 3
- QRBLKGHRWFGINE-UGWAGOLRSA-N 2-[2-[2-[[2-[[4-[[2-[[6-amino-2-[3-amino-1-[(2,3-diamino-3-oxopropyl)amino]-3-oxopropyl]-5-methylpyrimidine-4-carbonyl]amino]-3-[(2R,3S,4S,5S,6S)-3-[(2S,3R,4R,5S)-4-carbamoyl-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)- Chemical compound N=1C(C=2SC=C(N=2)C(N)=O)CSC=1CCNC(=O)C(C(C)=O)NC(=O)C(C)C(O)C(C)NC(=O)C(C(O[C@H]1[C@@]([C@@H](O)[C@H](O)[C@H](CO)O1)(C)O[C@H]1[C@@H]([C@](O)([C@@H](O)C(CO)O1)C(N)=O)O)C=1NC=NC=1)NC(=O)C1=NC(C(CC(N)=O)NCC(N)C(N)=O)=NC(N)=C1C QRBLKGHRWFGINE-UGWAGOLRSA-N 0.000 description 2
- 101700080667 3SE1 Proteins 0.000 description 2
- 101700011277 3SE2 Proteins 0.000 description 2
- 101710027204 ACC1A Proteins 0.000 description 2
- 101700076614 ACS-1 Proteins 0.000 description 2
- 102100001249 ALB Human genes 0.000 description 2
- 229940100228 Acetyl Coenzyme A Drugs 0.000 description 2
- ZKHQWZAMYRWXGA-KQYNXXCUSA-N Adenosine triphosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-N 0.000 description 2
- 102000007592 Apolipoproteins Human genes 0.000 description 2
- 108010071619 Apolipoproteins Proteins 0.000 description 2
- 101710027503 Ava_3988 Proteins 0.000 description 2
- 101710002713 BCL2A1 Proteins 0.000 description 2
- 240000008371 Bacillus subtilis Species 0.000 description 2
- 229940075615 Bacillus subtilis Drugs 0.000 description 2
- 235000014469 Bacillus subtilis Nutrition 0.000 description 2
- 241000244203 Caenorhabditis elegans Species 0.000 description 2
- 229940041514 Candida albicans extract Drugs 0.000 description 2
- 229940107161 Cholesterol Drugs 0.000 description 2
- 210000004507 Chromosomes, Artificial Anatomy 0.000 description 2
- 210000004436 Chromosomes, Artificial, Bacterial Anatomy 0.000 description 2
- 210000000805 Cytoplasm Anatomy 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N D-sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 108020004461 Double-Stranded RNA Proteins 0.000 description 2
- 229960003722 Doxycycline Drugs 0.000 description 2
- 108010018763 EC 6.3.4.14 Proteins 0.000 description 2
- 210000002472 Endoplasmic Reticulum Anatomy 0.000 description 2
- 235000014966 Eragrostis abyssinica Nutrition 0.000 description 2
- 241000206602 Eukaryota Species 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- HYBBIBNJHNGZAN-UHFFFAOYSA-N Furfural Chemical compound O=CC1=CC=CO1 HYBBIBNJHNGZAN-UHFFFAOYSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 101710024478 HLCS Proteins 0.000 description 2
- 206010058490 Hyperoxia Diseases 0.000 description 2
- FDGQSTZJBFJUBT-UHFFFAOYSA-N Hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- GUBGYTABKSRVRQ-UUNJERMWSA-N Lactose Natural products O([C@@H]1[C@H](O)[C@H](O)[C@H](O)O[C@@H]1CO)[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1 GUBGYTABKSRVRQ-UUNJERMWSA-N 0.000 description 2
- 102000003960 Ligases Human genes 0.000 description 2
- 108090000364 Ligases Proteins 0.000 description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N Linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 2
- 229920000460 Mitochondrial DNA Polymers 0.000 description 2
- 235000021319 Palmitoleic acid Nutrition 0.000 description 2
- 108010035235 Phleomycins Proteins 0.000 description 2
- 241000589516 Pseudomonas Species 0.000 description 2
- 241000589776 Pseudomonas putida Species 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 102100007645 SLC2A1 Human genes 0.000 description 2
- 108091006276 SLC2A1 Proteins 0.000 description 2
- 101710026013 SPCC1281.06c Proteins 0.000 description 2
- 241000607142 Salmonella Species 0.000 description 2
- 206010039447 Salmonellosis Diseases 0.000 description 2
- 244000249201 Scenedesmus obliquus Species 0.000 description 2
- 235000007122 Scenedesmus obliquus Nutrition 0.000 description 2
- 241000187747 Streptomyces Species 0.000 description 2
- CZMRCDWAGMRECN-GDQSFJPYSA-N Sucrose Natural products O([C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1)[C@@]1(CO)[C@H](O)[C@@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-GDQSFJPYSA-N 0.000 description 2
- 210000004243 Sweat Anatomy 0.000 description 2
- NKANXQFJJICGDU-QPLCGJKRSA-N Tamoxifen Chemical compound C=1C=CC=CC=1C(/CC)=C(C=1C=CC(OCCN(C)C)=CC=1)/C1=CC=CC=C1 NKANXQFJJICGDU-QPLCGJKRSA-N 0.000 description 2
- 229960001603 Tamoxifen Drugs 0.000 description 2
- OFVLGDICTFRJMM-WESIUVDSSA-N Tetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O OFVLGDICTFRJMM-WESIUVDSSA-N 0.000 description 2
- 229960002180 Tetracycline Drugs 0.000 description 2
- 239000004098 Tetracycline Substances 0.000 description 2
- 229940035893 Uracil Drugs 0.000 description 2
- 241000607626 Vibrio cholerae Species 0.000 description 2
- 229920002522 Wood fibre Polymers 0.000 description 2
- 230000003213 activating Effects 0.000 description 2
- 238000009632 agar plate Methods 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 239000012075 bio-oil Substances 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 230000037348 biosynthesis Effects 0.000 description 2
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 108010085477 biotin carboxyl carrier protein Proteins 0.000 description 2
- 230000001488 breeding Effects 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 230000035569 catabolism Effects 0.000 description 2
- 230000022131 cell cycle Effects 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 239000005515 coenzyme Substances 0.000 description 2
- 238000004624 confocal microscopy Methods 0.000 description 2
- 230000001808 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- JBIWCJUYHHGXTC-AKNGSSGZSA-N doxycycline Chemical compound O=C1C2=C(O)C=CC=C2[C@H](C)[C@@H]2C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]1[C@H]2O JBIWCJUYHHGXTC-AKNGSSGZSA-N 0.000 description 2
- 238000004043 dyeing Methods 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 101700086902 fas1 Proteins 0.000 description 2
- 101700000357 fas2 Proteins 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 101700052622 gcdA Proteins 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 230000004190 glucose uptake Effects 0.000 description 2
- 239000002035 hexane extract Substances 0.000 description 2
- 239000002044 hexane fraction Substances 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 230000000222 hyperoxic Effects 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- 230000002045 lasting Effects 0.000 description 2
- LTYOQGRJFJAKNA-DVVLENMVSA-N malonyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CC(O)=O)O[C@H]1N1C2=NC=NC(N)=C2N=C1 LTYOQGRJFJAKNA-DVVLENMVSA-N 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 150000004702 methyl esters Chemical class 0.000 description 2
- 230000002438 mitochondrial Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000000051 modifying Effects 0.000 description 2
- 235000013379 molasses Nutrition 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N n-butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 239000002777 nucleoside Substances 0.000 description 2
- 150000003833 nucleoside derivatives Chemical class 0.000 description 2
- 150000007530 organic bases Chemical class 0.000 description 2
- 238000006366 phosphorylation reaction Methods 0.000 description 2
- 230000000865 phosphorylative Effects 0.000 description 2
- 230000000243 photosynthetic Effects 0.000 description 2
- 229920003258 poly(methylsilmethylene) Polymers 0.000 description 2
- 238000000575 proteomic Methods 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 230000002829 reduced Effects 0.000 description 2
- 230000000452 restraining Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 235000021003 saturated fats Nutrition 0.000 description 2
- 150000004671 saturated fatty acids Chemical class 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000007790 solid phase Substances 0.000 description 2
- 238000000638 solvent extraction Methods 0.000 description 2
- 150000003408 sphingolipids Chemical class 0.000 description 2
- 210000004215 spores Anatomy 0.000 description 2
- 125000003696 stearoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000001117 sulphuric acid Substances 0.000 description 2
- 235000011149 sulphuric acid Nutrition 0.000 description 2
- 230000001502 supplementation Effects 0.000 description 2
- 235000019364 tetracycline Nutrition 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- 241001430294 unidentified retrovirus Species 0.000 description 2
- 101710035147 ura3 Proteins 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N α-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 2
- GTRAYRSSCLGTSF-ZETCQYMHSA-N (2S)-2-amino-3-[3-(2-hydroxyethyl)imidazol-4-yl]propanoic acid Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1CCO GTRAYRSSCLGTSF-ZETCQYMHSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-L (S)-malate(2-) Chemical compound [O-]C(=O)[C@@H](O)CC([O-])=O BJEPYKJPYRNKOW-REOHCLBHSA-L 0.000 description 1
- MSSXOMSJDRHRMC-UHFFFAOYSA-N 2,6-Diaminopurine Chemical compound NC1=NC(N)=C2NC=NC2=N1 MSSXOMSJDRHRMC-UHFFFAOYSA-N 0.000 description 1
- MWBWWFOAEOYUST-UHFFFAOYSA-N 2-aminopurine Chemical compound NC1=NC=C2N=CNC2=N1 MWBWWFOAEOYUST-UHFFFAOYSA-N 0.000 description 1
- ALRHLSYJTWAHJZ-UHFFFAOYSA-N 3-Hydroxypropionic acid Chemical class OCCC(O)=O ALRHLSYJTWAHJZ-UHFFFAOYSA-N 0.000 description 1
- XTWYTFMLZFPYCI-KQYNXXCUSA-N 5'-adenylphosphoric acid Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XTWYTFMLZFPYCI-KQYNXXCUSA-N 0.000 description 1
- 229920001383 5S-rRNA precursor Polymers 0.000 description 1
- 101700021063 ACAC Proteins 0.000 description 1
- 101700056202 ACACA Proteins 0.000 description 1
- 102100011408 ACACA Human genes 0.000 description 1
- 101700081524 ACACB Proteins 0.000 description 1
- 102100011407 ACACB Human genes 0.000 description 1
- 101700008458 ACC1 Proteins 0.000 description 1
- 101700045148 ACC2 Proteins 0.000 description 1
- 102100016913 ACO1 Human genes 0.000 description 1
- 101700008728 ACP1 Proteins 0.000 description 1
- 101710027066 ALB Proteins 0.000 description 1
- 241000157880 Acrasis Species 0.000 description 1
- 229960000643 Adenine Drugs 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Natural products NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 241000432074 Adeno-associated virus Species 0.000 description 1
- 210000000577 Adipose Tissue Anatomy 0.000 description 1
- 241000588986 Alcaligenes Species 0.000 description 1
- 241000588810 Alcaligenes sp. Species 0.000 description 1
- 241000609240 Ambelania acida Species 0.000 description 1
- HTIQEAQVCYTUBX-UHFFFAOYSA-N Amlodipine Chemical compound CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1Cl HTIQEAQVCYTUBX-UHFFFAOYSA-N 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N Ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229920000945 Amylopectin Polymers 0.000 description 1
- WMGFVAGNIYUEEP-WUYNJSITSA-N Amylopectin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](OC[C@@H]2[C@H]([C@H](O)[C@@H](O)[C@@H](O[C@@H]3[C@H](O[C@H](O)[C@H](O)[C@H]3O)CO)O2)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@H]1O WMGFVAGNIYUEEP-WUYNJSITSA-N 0.000 description 1
- 108010083590 Apoproteins Proteins 0.000 description 1
- 102000006410 Apoproteins Human genes 0.000 description 1
- 229940114079 Arachidonic Acid Drugs 0.000 description 1
- YZXBAPSDXZZRGB-DOFZRALJSA-N Arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 1
- 241000620196 Arthrospira maxima Species 0.000 description 1
- 235000016425 Arthrospira platensis Nutrition 0.000 description 1
- 240000002900 Arthrospira platensis Species 0.000 description 1
- 229920000195 Bacterial small RNA Polymers 0.000 description 1
- 210000004369 Blood Anatomy 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000282817 Bovidae Species 0.000 description 1
- 101710016919 CELA3A Proteins 0.000 description 1
- 101700055109 CYB5A Proteins 0.000 description 1
- 241000218236 Cannabis Species 0.000 description 1
- 210000001736 Capillaries Anatomy 0.000 description 1
- 229960004424 Carbon Dioxide Drugs 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 210000000170 Cell Membrane Anatomy 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 240000009108 Chlorella vulgaris Species 0.000 description 1
- 235000007089 Chlorella vulgaris Nutrition 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 229920002839 Cis-regulatory element Polymers 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 240000002268 Citrus limon Species 0.000 description 1
- 108010075028 Cytochromes b Proteins 0.000 description 1
- 229940104302 Cytosine Drugs 0.000 description 1
- OPTASPLRGRRNAP-UHFFFAOYSA-N Cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N Dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229960003957 Dexamethasone Drugs 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 241000195632 Dunaliella tertiolecta Species 0.000 description 1
- 101710025058 EAS4 Proteins 0.000 description 1
- 108010009924 EC 4.2.1.3 Proteins 0.000 description 1
- 108010011449 EC 6.2.1.3 Proteins 0.000 description 1
- 229940022766 EGTA Drugs 0.000 description 1
- 229960005135 Eicosapentaenoic Acid Drugs 0.000 description 1
- JAZBEHYOTPTENJ-JLNKQSITSA-N Eicosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 1
- 210000002889 Endothelial Cells Anatomy 0.000 description 1
- 241000362749 Ettlia oleoabundans Species 0.000 description 1
- 210000002744 Extracellular Matrix Anatomy 0.000 description 1
- 108009000552 Fatty Acid Biosynthesis Proteins 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- 240000004282 Grewia occidentalis Species 0.000 description 1
- UYTPUPDQBNUYGX-UHFFFAOYSA-N Guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 1
- 101700060674 HFA1 Proteins 0.000 description 1
- 108091005861 Hemoglobin F Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 102000001974 Hyaluronidase Human genes 0.000 description 1
- 108010074224 Hyaluronoglucosaminidase Proteins 0.000 description 1
- NOEGNKMFWQHSLB-UHFFFAOYSA-N Hydroxymethylfurfural Chemical compound OCC1=CC=C(C=O)O1 NOEGNKMFWQHSLB-UHFFFAOYSA-N 0.000 description 1
- 101700042226 INHA Proteins 0.000 description 1
- 102100016057 ISYNA1 Human genes 0.000 description 1
- 101710004164 ISYNA1 Proteins 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 235000014663 Kluyveromyces fragilis Nutrition 0.000 description 1
- 244000285963 Kluyveromyces fragilis Species 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- 229960004488 Linolenic Acid Drugs 0.000 description 1
- 229940040461 Lipase Drugs 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 102100011046 MT-CYB Human genes 0.000 description 1
- 210000003470 Mitochondria Anatomy 0.000 description 1
- 108020005196 Mitochondrial DNA Proteins 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 210000002027 Muscle, Skeletal Anatomy 0.000 description 1
- 241000186359 Mycobacterium Species 0.000 description 1
- 101700080605 NUC1 Proteins 0.000 description 1
- 241000224474 Nannochloropsis Species 0.000 description 1
- 241000244206 Nematoda Species 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- KNGQILZSJUUYIK-VIFPVBQESA-N OCC(C)(C)[C@@H](OP(O)(O)=O)C(=O)NCCC(=O)NCCS Chemical group OCC(C)(C)[C@@H](OP(O)(O)=O)C(=O)NCCC(=O)NCCS KNGQILZSJUUYIK-VIFPVBQESA-N 0.000 description 1
- 101710009401 OLE1 Proteins 0.000 description 1
- 229920000272 Oligonucleotide Polymers 0.000 description 1
- 210000003463 Organelles Anatomy 0.000 description 1
- 101700023545 PPT2 Proteins 0.000 description 1
- 241000194105 Paenibacillus polymyxa Species 0.000 description 1
- 229920002224 Peptide nucleic acid Polymers 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- JDMUPRLRUUMCTL-VIFPVBQESA-N Phosphopantetheine Chemical group OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS JDMUPRLRUUMCTL-VIFPVBQESA-N 0.000 description 1
- 241000235648 Pichia Species 0.000 description 1
- HXEACLLIILLPRG-UHFFFAOYSA-N Pipecolic acid Chemical class OC(=O)C1CCCCN1 HXEACLLIILLPRG-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920001470 Polyketone Polymers 0.000 description 1
- MWWATHDPGQKSAR-UHFFFAOYSA-N Propyne Chemical compound CC#C MWWATHDPGQKSAR-UHFFFAOYSA-N 0.000 description 1
- 241000589540 Pseudomonas fluorescens Species 0.000 description 1
- 241000589774 Pseudomonas sp. Species 0.000 description 1
- 229940076788 Pyruvate Drugs 0.000 description 1
- 108020000793 RHO Proteins 0.000 description 1
- 101700034422 RINO1 Proteins 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 229920001785 Response element Polymers 0.000 description 1
- 241000316848 Rhodococcus <scale insect> Species 0.000 description 1
- 101700061430 SAT19 Proteins 0.000 description 1
- 101710026007 SCD Proteins 0.000 description 1
- 102100010113 SLC27A2 Human genes 0.000 description 1
- 108060007621 SMA2 Proteins 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 230000037165 Serum Concentration Effects 0.000 description 1
- 102000013275 Somatomedins Human genes 0.000 description 1
- 108010026080 Somatomedins Proteins 0.000 description 1
- 229940082787 Spirulina Drugs 0.000 description 1
- 102000009822 Sterol Regulatory Element Binding Proteins Human genes 0.000 description 1
- 108010020396 Sterol Regulatory Element Binding Proteins Proteins 0.000 description 1
- 241001655322 Streptomycetales Species 0.000 description 1
- 101700081234 TTR Proteins 0.000 description 1
- 210000001541 Thymus Gland Anatomy 0.000 description 1
- 235000015450 Tilia cordata Nutrition 0.000 description 1
- 240000007313 Tilia cordata Species 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 231100000765 Toxin Toxicity 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H Tricalcium phosphate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 229940118696 Vibrio cholerae Drugs 0.000 description 1
- 241000863000 Vitreoscilla Species 0.000 description 1
- 241000863024 Vitreoscilla stercoraria Species 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K [O-]P([O-])([O-])=O Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- DLFVBJFMPXGRIB-UHFFFAOYSA-N acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- 230000002378 acidificating Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000000240 adjuvant Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 229940050528 albumin Drugs 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 125000005600 alkyl phosphonate group Chemical group 0.000 description 1
- 102000004139 alpha-Amylases Human genes 0.000 description 1
- 108090000637 alpha-Amylases Proteins 0.000 description 1
- 229940024171 alpha-amylase Drugs 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000003078 antioxidant Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 229910052586 apatite Inorganic materials 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 150000001480 arabinoses Chemical class 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 150000001491 aromatic compounds Chemical class 0.000 description 1
- 239000010905 bagasse Substances 0.000 description 1
- 102000024070 binding proteins Human genes 0.000 description 1
- 108091007650 binding proteins Proteins 0.000 description 1
- 238000010170 biological method Methods 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 230000000903 blocking Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 238000011030 bottleneck Methods 0.000 description 1
- KQNZDYYTLMIZCT-KQPMLPITSA-N brefeldin A Chemical compound O[C@@H]1\C=C\C(=O)O[C@@H](C)CCC\C=C\[C@@H]2C[C@H](O)C[C@H]21 KQNZDYYTLMIZCT-KQPMLPITSA-N 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
- 229910002090 carbon oxide Inorganic materials 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 125000001721 carboxyacetyl group Chemical group 0.000 description 1
- 238000006473 carboxylation reaction Methods 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 230000003197 catalytic Effects 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 125000003636 chemical group Chemical group 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 230000000295 complement Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000010924 continuous production Methods 0.000 description 1
- 235000020940 control diet Nutrition 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 230000001472 cytotoxic Effects 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 238000006114 decarboxylation reaction Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000001419 dependent Effects 0.000 description 1
- 238000009795 derivation Methods 0.000 description 1
- 150000001982 diacylglycerols Chemical class 0.000 description 1
- 239000002283 diesel fuel Substances 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 1
- NAGJZTKCGNOGPW-UHFFFAOYSA-K dioxido-sulfanylidene-sulfido-$l^{5}-phosphane Chemical compound [O-]P([O-])([S-])=S NAGJZTKCGNOGPW-UHFFFAOYSA-K 0.000 description 1
- 201000009910 diseases by infectious agent Diseases 0.000 description 1
- 108010007093 dispase Proteins 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 101700025820 eas Proteins 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N edta Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 230000005518 electrochemistry Effects 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000019439 energy homeostasis Effects 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000002532 enzyme inhibitor Substances 0.000 description 1
- QUSNBJAOOMFDIB-UHFFFAOYSA-N ethyl amine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 1
- DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 238000005755 formation reaction Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 238000003208 gene overexpression Methods 0.000 description 1
- 239000003448 gibberellin Substances 0.000 description 1
- IXORZMNAPKEEDV-OBDJNFEBSA-N gibberellin A3 Chemical class C([C@@]1(O)C(=C)C[C@@]2(C1)[C@H]1C(O)=O)C[C@H]2[C@]2(C=C[C@@H]3O)[C@H]1[C@]3(C)C(=O)O2 IXORZMNAPKEEDV-OBDJNFEBSA-N 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 150000002327 glycerophospholipids Chemical class 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 239000005431 greenhouse gas Substances 0.000 description 1
- 230000012447 hatching Effects 0.000 description 1
- 229940059442 hemicellulase Drugs 0.000 description 1
- 108010002430 hemicellulase Proteins 0.000 description 1
- 150000002402 hexoses Chemical class 0.000 description 1
- 230000000493 homozygosity Effects 0.000 description 1
- 230000003054 hormonal Effects 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 229960002773 hyaluronidase Drugs 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 239000000413 hydrolysate Substances 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000001976 improved Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 238000009655 industrial fermentation Methods 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000009114 investigational therapy Methods 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl β-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- TWNIBLMWSKIRAT-VFUOTHLCSA-N levoglucosan Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@H]2CO[C@@H]1O2 TWNIBLMWSKIRAT-VFUOTHLCSA-N 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- 229960004232 linoleic acid Drugs 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 102000004882 lipase Human genes 0.000 description 1
- 108090001060 lipase Proteins 0.000 description 1
- 230000004132 lipogenesis Effects 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 238000011068 load Methods 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- CAAULPUQFIIOTL-UHFFFAOYSA-N methyl dihydrogen phosphate Chemical compound COP(O)(O)=O CAAULPUQFIIOTL-UHFFFAOYSA-N 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 101700008750 mlcG Proteins 0.000 description 1
- 101700022361 mokE Proteins 0.000 description 1
- 230000003990 molecular pathway Effects 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 101700006494 nucA Proteins 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 150000002889 oleic acids Chemical class 0.000 description 1
- 125000002811 oleoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 125000000962 organic group Chemical group 0.000 description 1
- 230000003534 oscillatory Effects 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- 230000033116 oxidation-reduction process Effects 0.000 description 1
- 125000001236 palmitoleoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- ZNXZGRMVNNHPCA-VIFPVBQESA-N pantetheine Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS ZNXZGRMVNNHPCA-VIFPVBQESA-N 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 230000001717 pathogenic Effects 0.000 description 1
- 150000002972 pentoses Chemical class 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- PTMHPRAIXMAOOB-UHFFFAOYSA-L phosphoramidate Chemical compound NP([O-])([O-])=O PTMHPRAIXMAOOB-UHFFFAOYSA-L 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 230000001402 polyadenylating Effects 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000023 polynucleotide Polymers 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 230000001124 posttranscriptional Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 210000001236 prokaryotic cell Anatomy 0.000 description 1
- 230000002062 proliferating Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propanol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 150000003212 purines Chemical class 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- 239000003638 reducing agent Substances 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 108091006075 regulatory enzymes Proteins 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 150000003291 riboses Chemical group 0.000 description 1
- 229920002973 ribosomal RNA Polymers 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 101700010221 sak Proteins 0.000 description 1
- 239000010865 sewage Substances 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229910052814 silicon oxide Inorganic materials 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000003270 steroid hormone Substances 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 230000004083 survival Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 150000003512 tertiary amines Chemical group 0.000 description 1
- RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 102000003995 transcription factors Human genes 0.000 description 1
- 108090000464 transcription factors Proteins 0.000 description 1
- 238000010361 transduction Methods 0.000 description 1
- 230000026683 transduction Effects 0.000 description 1
- 238000005809 transesterification reaction Methods 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 230000001960 triggered Effects 0.000 description 1
- 230000008601 triglyceride homeostasis Effects 0.000 description 1
- 238000005429 turbidity Methods 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N urethane group Chemical group NC(=O)OCC JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 150000004669 very long chain fatty acids Chemical class 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 239000002025 wood fiber Substances 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Abstract
Some aspects of the present invention relate to use engineered microorganism that carbon source is converted into bio-fuel or the method for bio-fuel precursor.Some aspects of the present invention relate to finding the key regulator of lipid metabolism in microorganism.Some aspects of the present invention relate to produce bio-fuel or the engineered microorganism of bio-fuel precursor.
Description
Related application
According to 35U.S.C. § 119 (e), this application claims the U.S. Provisional Patent Application submitted on March 2nd, 2010
U.S.S.N.61/309, the priority of 782, entire contents is incorporated herein by.
Technical field
The present invention relates to using engineered cell or microorganism that carbohydrate source is converted into biology at least in part
Fuel or the field of bio-fuel precursor (such as fatty acid or derivative of fatty acid, such as triacylglycerol).
Federal government subsidizes research
The research (at least partly) in terms of some of invention disclosed herein is caused to be subsidized 69106899 supports by Ministry of Energy.
U.S. government has certain rights in the invention.
Background technology
The bio-fuel of sustainable production is the succedaneum of Fossil fuel, and can aid in and alleviate can be easily obtained
The consumption of fossil fuel reserves, avoids the pollution relevant to Fossil fuel and greenhouse gas emission simultaneously, thus with continuable
Mode meets the growing demand to the energy afforded.But, some shortcomings of existing production method hamper extensively
General enforcement bio-fuel produces, and the plant and the cereal crops that such as produce bio-fuel compete the land area having agronomical value,
Or use the industrial material of the most limited supply as carbon source.
Summary of the invention
The sustainability of Fossil fuel and the concern day by day increased of recyclability are made to develop separate sources many
Plant substituting bio-fuel, including the lipid synthesized from Renewable resource by microorganism (such as antibacterial or yeast).Can be used as biology
The lipid of fuel or bio-fuel precursor includes such as fatty acid and derivant (such as, triacylglycerol) thereof.
The bio-fuel of Microbe synthesis or the economic feasibility of bio-fuel precursor depend on use have include multiple
The applicable microorganism of the phenotype of the combination of advantageous feature, described advantageous feature such as allow to be efficiently converted into carbon bio-fuel or
The metabolism of bio-fuel precursor, high biomass formation rate, bio-fuel or the high yield of bio-fuel precursor, bio-fuel or
The intracellular accumulation of high level of bio-fuel precursor or secretion, to raw material (carbon source and related substances) with synthesized product is (such as,
Fatty acid or triacylglycerol) well tolerable and bio-fuel or the stability of bio-fuel precursor (such as dense in low-carbon-source
Under degree).Conversion yield (grams of oil produced by every gram of substrate (such as glucose)) is particularly important.It is generally employed to produce biology
The microorganism of fuel or bio-fuel precursor does not meets the required table enough allowing to produce the most economically bio-fuel
Type.
Some aspects of the present invention relate to transforming in microorganism desirable characteristics to produce bio-fuel or bio-fuel before
Body.Although from nineteen thirties and nineteen forties, having studied the lipid in microorganism and fatty acid
Metabolism (see, e.g. Woodbine, M.1959, Microbial fat:Microorganisms as potential fat
Producers.Prog.Ind.Microbiol.1:181), but, although at genetically modified microorganism or optimize production process
Condition aspect has made many effort, and in microorganism, transformation produces the progress in terms of relevant expectation phenotype still to bio-fuel
The least.Up to the present, genetic modification work is concentrated mainly on operation fatty acid synthesis circuit upstream or gene target therein
Mark and optimization are fermented or condition of culture (such as, by supplementing growth medium with fatty acid).
One major obstacle of genetically modified microorganism is the absence of in target microorganism (such as oil-producing (oleaginous) yeast
In) genomic information of Key Metabolic path regulatory factor and annotation.Therefore, in the microorganism for producing bio-fuel still
So lack and control carbohydrate to the Function Identification of the key regulator of lipid Transfer and annotation.
Some aspects of the present invention relate to being accredited as giving birth to oleaginous yeast Yarrowia lipolytica (Y.lipolytica)
Produce bio-fuel or the microorganism of bio-fuel precursor.Some aspects of the present invention relate to finding fatty acid metabolism in microorganism
Key regulator.Some aspects of the present invention relate to finding that stearyl-coenzyme A desaturase (SCD) is as carbon water in microorganism
Compound is to the key regulator of lipid Transfer.Some aspects of the present invention relate to the pass of fatty acid metabolism in encoding microbial
The nucleic acid of the separation of key regulatory factor.Some aspects of the present invention provide the key of the fatty acid metabolism of coding oleaginous microorganism
The nucleic acid of the separation of regulatory factor (such as, SCD gene outcome).
Some aspects of the present invention relate to operating the activity (such as, passing through genetic manipulation) of fatty acid metabolism regulatory factor and come
Transformation is for producing the microorganism of bio-fuel.Some aspects of the present invention relate to transforming for producing bio-fuel or biological combustion
The microorganism of the separation of material precursor.Some aspects of the present invention relate to for carbohydrate source is converted into bio-fuel or life
The microorganism of the separation that thing fuel precursor is optimized, such as, comprises the oleaginous microorganism of the SCD gene outcome of activity increase.
Some aspects of the present invention relate to transformation for producing bio-fuel or the culture of microorganism of bio-fuel precursor.The present invention's
Some aspects are directed to use with transforming and carbohydrate source are converted into fatty acid or fat for producing the microorganism of bio-fuel
The method of acid derivative.Some aspects of the present invention are directed to use with transformation for producing the microorganism of bio-fuel by carbon hydrate
Thing is converted into the bioreactor of fatty acid or derivative of fatty acid.Some aspects of the present invention provide the engineered micro-life of use
Carbohydrate source is converted into bio-fuel or the method for bio-fuel precursor by thing at least in part.
Some aspects of the present invention relate to separate oil-producing cell, its comprise raising selected from hemoglobin, cytochrome,
GLUT, malate dehydrogenase (malic enzyme), ACC, SCD, FAA1, ACS, ACS2, FAT1, FAT2, PCS60, ACLY, FAS, acyl
The genetic modification of the expression of the one or more of genes of base CoA synthase, pyruvate carboxylase and AMPK gene, and/or
Reduce selected from JNK2 and the genetic modification of the expression of the gene of Δ-12 desaturase.In some embodiments, the oil-producing of separation
Cell comprises nucleic acid construct, and described nucleic acid construct comprises: (a) is included under the control of suitable homology or allogeneic promoter
The expression cassette of the nucleic acid of encoding gene product;B () is included in the interference controlling lower coding targeted gene product of allogeneic promoter
The expression cassette of the nucleic acid of RNA;And/or (c) inserts the nucleic acid construct of cellular genome, described construct comprises raising or reduces
The nucleotide sequence of gene product expression.In some embodiments, allogeneic promoter is induction type or constitutive promoter.One
In a little embodiments, the natural regulation of the natural gene of nucleic acid construct suppression or destruction (disrupt) encoding gene product, lead
Cause the process LAN of natural gene.In some embodiments, nucleic acid construct suppression or the expression of elimination natural gene.At some
In embodiment, a part for the regulatory region or regulatory region that lack, destroy, suddenly change and/or replace regulator gene expression it is situated between
Lead suppression or the destruction of the natural regulation of natural gene, or by lacking, destroy, suddenly change and/or replace the coding of natural gene
Regulatory region or a part for regulatory region that sequence or regulation natural gene are expressed mediate suppression or the elimination that natural gene is expressed.
In some embodiments, by composing type or inducible expression targeting JNK2 and/or Δ-12 delta 8 desaturase genes product and suppression
The nucleic acid of described gene expression mediates JNK2 and/or the reduction of Δ-12 delta 8 desaturase genes expression.In some embodiments
In, the nucleic acid of targeting JNK2 and/or Δ-12 delta 8 desaturase genes transcript is by the expression of RNAi approach suppression transcript.?
In some embodiments, the nucleic acid of targeting JNK2 and/or Δ-12 desaturase transcript is siRNA, shRNA or micro
RNA.In some embodiments, by knocking out wild type gene in microorganism (such as, by nucleic acid construct (such as targeting
Property carrier) with genome JNK2 or the homologous recombination of Δ-12 delta 8 desaturase genes seat) thus destroy wild type gene expression come
Reduce JNK2 and/or the expression of Δ-12 desaturase.In some embodiments, nucleic acid construct is inserted the gene of cell
In group.In some embodiments, the raising of gene product expression or reduce give cell carbohydrate source is converted into
The advantageous phenotypes of fatty acid, fatty acid derived and/or TAG.In some embodiments, advantageous phenotypes is the fatty acid changed
Spectrum, the triacylglycerol spectrum changed, the fatty acid increased and/or triacylglycerol synthetic ratio, the conversion yield of increase, cell increase
Triacylglycerol accumulation and strengthen the tolerance to osmotic pressure, the multiplication rate of increase, the cell volume of increase and/or cell pair
Concentration be lethal and/or suppress its same type cell the propagation without modified cells material strengthen tolerance.At some
In embodiment, with same cell type without compared with modified cells, the fatty acid profile of the change of cell or the trigalloyl of change
Glycerol stave reveals the ratio of C18 fatty acid and C16 fatty acid and increases at least 2 times.In some embodiments, with identical carefully
Comparing without modified cells of born of the same parents' type, the fatty acid profile of the change of cell or the triacylglycerol stave of change reveal C18 fat
Acid increases at least 2.5 times with the ratio of C16 fatty acid.In some embodiments, the most modified with same cell type
Cell is compared, and the fatty acid profile of the change of cell or the triacylglycerol stave of change reveal the ratio of C18 fatty acid and C16 fatty acid
Rate increases at least 5 times.In some embodiments, with same cell type without compared with modified cells, the change of cell
Fatty acid profile or the triacylglycerol stave of change reveal the ratio of C18 fatty acid and C16 fatty acid and increase at least 6.5 times.
In some embodiments, cell is survived under the conditions of to the osmotic pressure lethal without modified cells.In some embodiments,
Cell osmotic pressure level by tolerated without modified cells the 200% of top level under conditions of survive.Implement at some
In scheme, cell osmotic pressure level by tolerated without modified cells the 300% of top level under conditions of survive.One
In a little embodiments, cell osmotic pressure level by tolerated without modified cells the 400% of top level under conditions of deposit
Live.In some embodiments, with same cell type without compared with modified cells, cell proliferation rate increases at least 5
Again, at least 10 times, at least 20 times, at least 25 times or at least 30 times.In some embodiments, with same cell type without
Modified cells is compared, and the volume of cell increases at least 2 times.In some embodiments, cell tolerance concentration be lethal and/or
The material without modified cells propagation of suppression same cell type.In some embodiments, described material is fermentable sugars,
Described concentration is at least 80g/l, at least 100g/l, at least 150g/l, at least 200g/l, at least 300g/l.Some embodiment party
In case, with same cell type without compared with modified cells, the fatty acid of cell or the synthetic ratio of triacylglycerol increase to
Few 5 times or at least 10 times.In some embodiments, cell is with at least about 20g/g, at least about 25g/g or at least about 30g/g
Carbohydrate source is converted into fatty acid or triacylglycerol by conversion ratio.In some embodiments, cell be prokaryotic cell or
Eukaryotic cell.In some embodiments, cell is bacterial cell, alga cells, fungal cell or yeast cells.Real at some
Executing in scheme, cell is oleaginous yeast cell.In some embodiments, cell is yarrowia lipolytica cell.
Some aspects of the present invention relate to culture, its oil-producing cell comprising separation and carbohydrate source, described product
Oil cell comprise raising selected from hemoglobin, cytochrome, GLUT, malate dehydrogenase, ACC, SCD, FAA1, ACS, ACS2, FAT1,
The one or more of genes of FAT2, PCS60, ACLY, FAS, acyl-CoA synthetase, pyruvate carboxylase and AMPK gene
The genetic modification of expression, and/or reduce the genetic modification of the expression of JNK2 and/or Δ-12 delta 8 desaturase genes product.One
In a little embodiments, the oil-producing cell of separation is engineered microorganism provided in this article.In some embodiments, described carbon
Hydrate source is fermentable sugars.In some embodiments, described carbohydrate source is monosaccharide (monomeric
sugar).In some embodiments, described carbohydrate source is glucose and glycerol.In some embodiments, described
Carbohydrate source sterilized.In some embodiments, under described culture is maintained at non-sterilising conditions.Implement at some
In scheme, described culture does not comprise the oil-producing cell selectively antibiotic separated or antiproliferative.Implement at some
In scheme, described carbohydrate source is from plant or algal biomass.In some embodiments, described carbohydrate source
From cellulose, hemicellulose, starch, glycerol or derivatives thereof.In some embodiments, described culture also comprises fibre
Dimension element or hydrolysis of hemicellulose enzyme.In some embodiments, biomass or cellulose or hemicellulose at hot water or diluted acid or
Pretreatment in the process of ammonia filament expansion, utilizes hydrolytic enzyme pretreatment, steam pre-treatment and/or Calx preconditioning.Implement at some
In scheme, it is to the most modified wild type, identical not with the oil-producing cell type separated that described culture comprises concentration
The material of modified cell-lethal.In some embodiments, described material is (such as acetic acid class at pretreatment carbohydrate source
(acetate), furfural or aromatic compounds) period produce noxious substance.In some embodiments, described material is carbon water
Compound source.In some embodiments, described material is fermentable sugars.In some embodiments, described material is monosaccharide.
In some embodiments, described culture comprises concentration is at least 80g/l, at least 100g/l, at least 150g/l, at least
The fermentable sugars of 200g/l, at least 250g/l or at least 300g/l.
Some aspects of the present invention relate to a kind of method, and it includes making carbohydrate source and connects with the oil-producing cell separated
Touch, and under conditions of being suitable to make cell at least in part described carbohydrate source are converted into fatty acid or triacylglycerol
Hatch and the carbohydrate source of described cells contacting, described cell comprise raising selected from hemoglobin, cytochrome, GLUT,
Malate dehydrogenase, ACC, SCD, FAA1, ACS, ACS2, FAT1, FAT2, PCS60, ACLY, FAS, acyl-CoA synthetase, acetone
The genetic modification of expression of the one or more of genes of acid carboxylase and AMPK gene outcome, and/or reduce JNK2 and/or
The genetic modification that Δ-12 delta 8 desaturase genes is expressed.In some embodiments, the oil-producing cell of described separation is to be carried herein
The engineered microorganism of confession.In some embodiments, described carbohydrate source be sugar (such as glucose, xylose etc.) or from
Plant or the starch of algal biomass.In some embodiments, described carbohydrate source is from cellulose or hemicellulose.
In some embodiments, in the presence of cellulose or hydrolysis of hemicellulose enzyme, make described carbohydrate source with described carefully
Born of the same parents contact.In some embodiments, at 55 DEG C in the presence of every gram of biomass about 15IU cellulose or half fiber hydrolase,
Make described carbohydrate source and described cells contacting 48 hours.In some embodiments, fine by hot water or dilute acid or ammonia
Tie up expansion process and/or hydrolytic enzyme preprocessing biomass or cellulose or hemicellulose.In some embodiments, with separate
The carbohydrate source of oil-producing cells contacting comprise concentration pair identical with the described oil-producing cell type separated without repairing
Decorations cell is the material of lethasl concentration.In some embodiments, described material is in pretreatment carbohydrate source (such as second
Acids) period produce noxious substance.In some embodiments, described material is described carbohydrate source.Real at some
Executing in scheme, carbohydrate source is fermentable sugars, with oil-producing cells contacting after the concentration of described fermentable sugars be at least
80g/l, at least 100g/l, at least 200g/l or at least 300g/l.In some embodiments, under non-sterilising conditions, carbon water is made
Compound source and the oil-producing cells contacting separated.In some embodiments, hatch under non-sterilizing condition and the oil-producing separated
The carbohydrate source of cells contacting.In some embodiments, hatch in open reactor and connect with the oil-producing cell separated
The carbohydrate source touched.In some embodiments, in fed batch process (fed batch process), carbon aquation is made
Compound source and the oil-producing cells contacting separated also hatch described carbohydrate source is converted into fatty acid or triacylglycerol.?
In some embodiments, continuous process makes carbohydrate source and the oil-producing cells contacting separated hatching with by described carbon
Hydrate source is converted into fatty acid or triacylglycerol.In some embodiments, by solvent extraction from the oil-producing separated
The carbohydrate source extraction fatty acid of cells contacting or triacylglycerol.In some embodiments, described solvent extraction is molten
Agent hexane extracts.In some embodiments, by fatty acid or triacylglycerol from the carbon aquation with the oil-producing cells contacting separated
Compound source separates, then by ester exchange reaction (transesterification) refine.
Some aspects of the present invention relate to a kind of method, it include by improve selected from hemoglobin, cytochrome,
GLUT, malate dehydrogenase, ACC, SCD, FAA1, ACS, ACS2, FAT1, FAT2, PCS60, ACLY, FAS and AMPK gene outcome
The expression of one or more of gene outcomes, and/or the expression reducing JNK2 and/or Δ-12 delta 8 desaturase genes changes fat
Fat acid spectrum, triacylglycerol spectrum, fatty acid synthetic ratio (fatty acid synthesis rate), triacylglycerol synthetic ratio, cell
The degree of middle derivative of fatty acid accumulation, secretion rate (the rate of fatty acid derivative of derivative of fatty acid
Secretion) speed that, carbohydrate converts to fatty acid or derivative of fatty acid, carbohydrate are to fatty acid or fat
Effective productivity that pipecolic acid derivative converts, tolerance, multiplication rate, cell volume or cell to osmotic pressure are to for carbon hydrate
The tolerance of thing source noxious substance in the conversion of fatty acid or triacylglycerol.In some embodiments, described fat is changed
In acid spectrum, described triacylglycerol spectrum, described fatty acid synthetic ratio, described triacylglycerol synthetic ratio, cell, derivative of fatty acid amasss
The derivative of fatty acid secretion rate of tired degree or cell is to increase fatty acid, the fatty acid being synthesized by cell, accumulate or being secreted and spreads out
Biology and/or the amount of triacylglycerol.In some embodiments, the carbohydrate changing cell spreads out to fatty acid or fatty acid
The efficiency of bioconversion is that transformation efficiency increases at least 2 times, at least 3 times, at least 4 times or at least 5 times.Implement at some
In scheme, derivative of fatty acid is triacylglycerol.In some embodiments, cell is changed to the tolerance of osmotic pressure or to poisonous
The tolerance of material is to confer to resistance to without the osmotic pressure that modified cells is mortality levels or noxious substance to same cell type
It is subject to.In some embodiments, change multiplication rate be described multiplication rate is increased at least 2 times, at least 5 times, at least 10
Again, at least 20 times or at least 30 times.In some embodiments, changing described cell volume is to be increased to by described cell volume
At least 2 times.In some embodiments, described cell is yeast cells.In some embodiments, described yeast is oil-producing ferment
Female.In some embodiments, described oleaginous yeast is Yarrowia lipolytica.
Some aspects of the present invention relate to the nucleic acid molecules separated, and it comprises: a) coding SEQ ID NO:1 (solves fat Ye Shi
Yeast SCD) nucleotide sequence, or nucleotides sequence b) and a) shows the nucleotide sequence of homogeneity of at least 85%.One
In a little embodiments, the nucleotide sequence of coding SEQ ID NO:1 is SEQ ID NO:2.In some embodiments, nucleotide
The nucleotides sequence of sequence and SEQ ID NO:2 shows the homogeneity of at least 85%.In some embodiments, nucleotide sequence with
The nucleotides sequence of SEQ ID NO:2 shows the homogeneity of at least 90%.In some embodiments, nucleotide sequence and SEQ ID
The nucleotides sequence of NO:2 shows the homogeneity of at least 95%.In some embodiments, nucleotide sequence is with SEQ ID NO:2's
Nucleotides sequence shows the homogeneity of at least 97.5%.In some embodiments, nucleotide sequence and the nucleoside of SEQ ID NO:2
Acid sequence has the homogeneity of at least 99%.In some embodiments, it is provided that nucleic acid construct, it comprises as described herein
The nucleic acid molecules (nucleic acid molecules of separation the most described in this paragraph) separated and the promoter of the separation of allos.Some embodiment party
In case, promoter is constitutive promoter or inducible promoter.In some embodiments, described constitutive promoter is to turn over
Translate elongation factor (Translation Elongation Factor, TEF) promoter.In some embodiments, described induction
Type promoter is drug induced promoter.In some embodiments, the nucleic acid molecules of separation comprises modified SCD startup
Son.In some embodiments, modification is the wild type SCD promoter sequence that lacks wholly or in part and/or suddenly change, and causes correspondence
Answer the destruction of the feedback suppression of the described SCD promoter of, derivative of fatty acid sour in high levels of fat and/or triacylglycerol.?
In some embodiments, described modification is heterologous sequence to insert wild type SCD promoter region, optionally in combination with wholly or in part
Disappearance and/or sudden change wild type SCD promoter sequence, cause responding to high levels of fat acid, derivative of fatty acid and/or three
The destruction of the feedback suppression of the described SCD promoter of acyl glycerol.
Some aspects of the present invention relate to carrier, and it comprises expression cassette, any expression cassette the most mentioned herein.This
Some aspects of invention relate at least one of cell comprising expression cassette as described herein or carrier as described herein.
In some cases, the theme of the application can relate to associated products, the alternative solution of particular problem and/
Or individual system or the multiple different purposes of goods.
The further advantage of the present invention, feature and purposes are by by the described below of non-limiting embodiments of the present invention and tie
Close accompanying drawing and become obvious.In the case of this specification comprises conflicting disclosure with the file being incorporated by reference into,
Should be as the criterion with this specification.
Accompanying drawing explanation
The fatty acid profile of Fig. 1: Yarrowia lipolytica (Yarrowia lipolytica).A) in shake flat experiment, gas is used
Phase chromatograph-mass spectrometer coupling (GC-MS) measures total trip of the Yarrowia lipolytica logarithmic (log) phase culture being incubated in minimal medium
From fatty acid (free fatty acid, FFA).B) during stable trophophase, measure under the same conditions in identical culture
Total FFA.C) during stable phase, the TL (FFA and esterified fatty acid) in identical culture is measured.
Fig. 2: analyze the TL of Yarrowia lipolytica.A) in minimal medium, wildtyp Y. lipolytica bacterium is cultivated
Strain is until 72 hours stable phase cultures, and uses GC-MS to measure TL in shake flat experiment.B) cultivation is measured to stable phase
(72 hours) and half constitutive promoter control under process LAN SCD (natural Δ 9 desaturase) mutant strain in total fat
Matter.C) with Nile red to cultivating the confocal microscopy dyeed to the wild-type strain of stable phase.D) Nile red is used
The mutant strain cultivated to stable phase is dyeed and is analyzed with Laser Scanning Confocal Microscope.
Fig. 3: in shaking flask, Yarrowia lipolytica mutant-1 (overexpressing cell pigment B, hemoglobin, Glut1 and Δ
9-desaturase (SCD), (D9, ■)) and wild type (LS, ◆) glucose consumption to pure glucose.With wild type solution fat
Family name's Yeast Phase ratio, Yarrowia lipolytica mutant-1 show faster glucose consumption characteristic and with wild type in observed by arrive
Not exclusively consume the complete glucose consumption compared.
72 hour in Fig. 4: A), Yarrowia lipolytica mutant 1 (overexpressing cell in corn straw hydrolyzate (Hz)
Pigment B, hemoglobin, Glut1 and Δ 9-desaturase (SCD)) and mutant 2 (overexpressing cell pigment B, hemoglobin and
Glut1) sugar consumption.B) within a few hours, the generation of the oil of mutant 1 and mutant 2 in corn straw Hz.
Fig. 5: compare wild type and the growth characteristics of engineered microorganism.YL-eng: process LAN Δ 9-desaturase (SCD)
Sudden change Yarrowia lipolytica.YL-wild: wildtyp Y. lipolytica.In the basic training containing the sugar that concentration is 250g/l
Support and base is cultivated cell.Wild-type cell can not grow under these conditions, and mutant cell is resistant to high-caliber sugar also
Well-grown, shows to obtain higher bio-fuel in the method using mutant strain or bio-fuel precursor produces
Rate.Y-axis: OD value.X-axis: with the time hour represented.
Fig. 6: the sugar consumption of the Yarrowia lipolytica mutant of process LAN Δ 9-desaturase (SCD) and growth characteristics.?
Culture medium containing 160g/l sugar is cultivated cell, the OD of monitoring culture and sugar consumption.Mutant cell was at 48 hours internal consumptions
The sugar supplied, and after in batches supplementing sugar continued growth.This illustrates for fed-batch operation and semicontinuous biology
One embodiment of biofuel production process.
Fig. 7: engineered Yarrowia lipolytica (process LAN Δ 9-desaturase (SCD), CYB and hemoglobin)
Lipid produces.
Fig. 8: after cultivating 72 hours, mutant strain (process LAN Δ 9-desaturase (SCD), CYB and blood red egg
In vain;The often post in left side in group) and the fatty acid profile of wildtyp Y. lipolytica bacterial strain (the often post on right side in group).
Fig. 9: the growth kinetics of the different sudden change Yarrowia lipolytica strains compared with wildtyp Y. lipolytica.
CB: CYB process LAN body;D9:SCD process LAN body.
Figure 10: under different glucose levels, the different sudden changes compared with wildtyp Y. lipolytica solve fat Ye Shi ferment
The growth kinetics of mother strains.Wild: wildtyp Y. lipolytica;C18: the sudden change of process LAN Δ 9-desaturase (SCD)
Yarrowia lipolytica.
Figure 11: sudden change (process LAN Δ 9-desaturase (SCD)) and the growth of wildtyp Y. lipolytica and lipid are raw
Produce kinetics.
Figure 12: pYLEX1, the expression vector (A) of transgene expression in Yarrowia lipolytica.For people in the art
This carrier well known to Yuan can comprise selected marker or the deficiency URA3 labelling from Yarrowia lipolytica URA3 gene, its
Allow complementary uracil auxotrophy, as by LE DALL etc., Curr.Genet., the URA3d described in 26,38-44 (1994)
Labelling.Sequence such as activated promoter and terminator sequence in Ye Shi yeast for regulating and expressing.Some embodiment party
In case, this carrier comprises induction type or constitutive promoter.In some embodiments, can be from pYLEX1 mistake in microorganism
Expressing gene, such as, by being cloned into pYLEX1 by purpose construct (the SCD cDNA as under the control of promoter).Display
CYB under TEF promoter controls and the exemplary clones (B, C) of hemoglobin cDNA.
Figure 13: cultivate engineered microorganism in algal biomass.Obtain the algae being dried and go forward side by side horizontal high voltage process to split
Solve cell and make starch gelatinization.By α-amylase enzymatic treatment through the cell of HIGH PRESSURE TREATMENT to discharge glucose.With our contain
There is the mutant yeast cell inoculation gained culture medium of Δ 9-desaturase and cytochrome, Glut1 and hemoglobin.Figure shows
Go out Ye Shi yeast mutants Johnson & Johnson head in the fermentation medium not having any additive.Cell reached in 4-5 days
OD43.This shows that the growth of mutant yeast is not suppressed.
The microscope of Figure 14: the yeast cells being incubated in algae hydrolyzate is observed.Cultivate under the conditions of described in Figure 13
Cell.Harvesting also dyes with Nile red to identify oil.Microdroplet in yeast cells represents oil.
The microscope of Figure 15: the yeast cells being incubated in crude glycerol is observed.Harvesting and with Nile red dyeing with
Identify oil.Microdroplet in yeast cells represents oil.
Figure 16: for producing comprising Δ 12-delta 8 desaturase genes flank region and resisting of Δ 12-desaturase knock-out bacterial strain
The Δ 12-desaturase of raw element resistance sequence knocks out the schematic construction of construct.
Figure 17: engineered microorganism growth in 3% acetic acid class (84 little add 2% glycerol constantly).
Describe in detail
Introduce
In view of the minimizing of fossil fuel resource, numerous studies work is devoted to develop reproducible succedaneum.Before one has
The method of scape is that transformation microorganism is to produce bio-fuel (such as biodiesel or biodiesel precursor such as three from renewable carbon source
Acyl glycerol), such as by using generation fatty acid or the microorganism Microalgae as a raw of derivative of fatty acid
Material for biofuels production (Gouveia L, Oliveira Δ C.J Ind Microbiol
Biotechnol.2009Feb;36 (2): 269-74).Although some aspects of this invention are directed to use with photosynthetic microorganism (such as algae
Class) produce bio-fuel or bio-fuel precursor, but the use of photosynthetic microorganism creates a series of technological challenge (Cadoret
JP, Bernard O.J Lipid biofuel production with microalgae:potential and
challenges Soc Biol.2008;202 (3): 201-11).The focus of research work turns to transformation microorganism to send out dark
During ferment by renewable carbon source (fermentable sugars of Tathagata authigenic material (such as glucose or from Semen Maydis or the sugar of Caulis Sacchari sinensis) or
Person's not fermentable carbohydrate polymer (such as cellulose or hemicellulose)) be converted into bio-fuel or bio-fuel before
Body.
Produce bio-fuel needs: (i) identifies suitable microorganism viable economicallyly, and (ii) transforms in microorganism
Going out to need and/or desired phenotype, this phenotype can comprise multifrequency nature.This type of in this phenotype needs and/or desired spy
Property example include but not limited to that rapidly and effectively biomass produce, beyond the growth vigor of undesirably microorganism, effectively,
Ideally close to carbohydrate theoretically to the conversion ratio of oil, with to substrate and the high tolerance of end-product.In these characteristics
Some are the prerequisite producing bio-fuel based on microorganism the most viable economicallyly.It is desirable that it is engineered
Microorganism should show the combination of advantageous feature, and it gives and allows by can be by abundant in the way of scale, cost savings
Carbon source is efficiently converted into bio-fuel or the phenotype of bio-fuel precursor.Bio-fuel or the micro-organisms of bio-fuel precursor
Some aspects of the present invention relate to bio-fuel or the production of bio-fuel precursor of microbe-mediated.Term is " raw
Thing fuel " refer to the fuel of biological origin (such as living cells, microorganism, fungus or plant).This term includes the most direct
The fuel (such as by traditional extraction, distillation or method of refining) that obtains from biogenetic derivation and by processing to obtain biological origin
The fuel (such as by chemical modification such as ester exchange method) that bio-fuel precursor produces.The example of the bio-fuel that can directly obtain
Son is alcohol (such as ethanol, propanol and butanol), fatty and oily.The life obtained by processing bio-fuel precursor (such as, lipid)
The example of thing fuel is biodiesel (such as, being produced) by the ester exchange reaction of lipid and green diesel/modified oil fires
Material (such as, is produced by the hydrogenation of oil).Biodiesel is also referred to as fatty acid methyl (or second) ester, and it is the most most important
One of bio-fuel, and can be produced on an industrial scale by the ester exchange reaction of lipid, in ester exchange reaction, hydrogen-oxygen
Change sodium and methanol (or ethanol) to react to produce biodiesel and glycerol with lipid (such as triacylglycerol).For on an industrial scale
The raw material producing biodiesel includes Animal fat, vegetable oil, Petiolus Trachycarpi oil, Fructus Cannabis, Semen sojae atricolor, Semen Brassicae campestris, Caulis et Folium Lini, Helianthi and contains
Oil algae.In other methods, microorganism converts biomass into bio-fuel precursor such as lipid, and then it is extracted and goes forward side by side
One step is processed to produce bio-fuel.Term " biomass " refers to grown by living cells or biology (such as microorganism) and/or bred
The material produced.Biomass can include cell, microorganism and/or intracellular inclusions (such as cell fatty acid and TAG) with
And extracellular material.Extracellular material includes but not limited to fatty acid or the TAG such as secreted by the compound of emiocytosis.With
In the important kind of biomass producing bio-fuel be algal biomass and the biomass from plant, such as corn straw and
The wood fiber.In some embodiments, the biomass being used for producing bio-fuel or bio-fuel precursor can include from planting
The sugar of thing, such as from Caulis Sacchari sinensis or the sugar of Semen Maydis.
It is raw that some aspects of the present invention relate to identifying, transform and be developed for viable economically ground commercial scale biodiesel
The microbial source of the lipid produced, these be not the most all reported.Term " lipid " refers to fatty acid and derivant thereof.Cause
This, the example of lipid includes fatty acid (FA, saturated and unsaturation);Glyceride or glycerol lipid, also referred to as acylglycerol
Such as monoglyceride (monoacylglycerol), diglyceride (diacylglycerol), triglyceride (triacylglycerol, TAG or natural fat);Phosphoric acid
Glyceride (phosphoglyceride);(sphingolipid, sterin fat include terpene including cholesterol and steroid hormone, pregnant amylene alcohol ester to nonglyceride
Class, fatty alcohol, wax and polyketone);And complex lipid derivant (connecting sugared lipid or glycolipid and the lipid of connection protein).
Lipid is living cells and the pith of microorganism plasma membrane.Some cells and microorganism also produce lipid to store energy, such as
Form with the triacylglycerol in lipid microdroplet.
Some aspects of the present invention relate to the suitable lipid metabolism according to microorganism and identify for producing bio-fuel or life
The microorganism of thing fuel precursor.Term " lipid metabolism " refers to producing or the molecular process of degraded of lipid.Fatty acid closes
One-tenth, fatty acid oxidation, fatty acid desaturation, TAG synthesis, TAG storage and TAG degraded are the parts as cytolipin metabolism
The example of process.Therefore, term " fatty acid " metabolism " refer to fatty acid synthesis, produce, convert or degrade all
Cell or organic process.Fatty acid synthesis, fatty acid oxidation, TAG synthesis and TAG degraded are as cellular fatty acid metabolism
The example of the process of part.
Term " triacylglycerol " (TAG, otherwise referred to as triglyceride) refers to such molecule: its comprise by ester bond with
A part glycerol that three fatty acid molecules (aliphatic monocarboxylic acid) are covalently bound, each fatty acid is connected to glycerol molecule
One of three hydroxyls (OH).Due to reduction, the anhydrous nature of triacylglycerol, so it is the highly enriched storage shape of metabolisable energy
Formula, and be the raw material being suitable for production of biodiesel.
Many cells and the biological form with fatty acid and derivative of fatty acid (such as TAG) store metabolisable energy.Fatty acid
And derivant (such as TAG) provides the ideal form storing metabolisable energy.It is contained in the energy in C-C key and can pass through β-oxygen
Changing and effectively discharge, beta oxidation is the reaction of the reverse being in form equivalent to fatty acid biological synthesis, but it is by constituting difference
The different enzymes mediation of molecular pathways and regulation.Microorganism can be supplied from outside, and endogenous conversion and de novo synthesis produce fat
Acid.Some aspects of the present invention relate to being effectively synthesized also depot fat acid or fatty acid according to the carbon source that microorganism is externally supplied
The ability of derivant is identified for producing bio-fuel or the microorganism of bio-fuel precursor.
A kind of microorganism produced for bio-fuel
Some aspects of the present invention relate to the general on an industrial scale identified for producing bio-fuel or bio-fuel precursor
The carbohydrate-modifying applicable microorganism for lipid.The most not yet identify allow the most viable economicallyly from
Carbohydrate source produces bio-fuel or the microorganism of bio-fuel precursor.Some aspects of the present invention relate to according to solving fat
Oleaginous yeast Yarrowia lipolytica is accredited as production bio-fuel by the favourable alkali metabolism (base metabolism) of family name's yeast
Or the biology of bio-fuel precursor.
Yarrowia lipolytica is non-pathogenic oleaginous yeast, and it can utilize several kinds of carbon source to include organic acid, hydrocarbon and multiple
Fatty and oily.Term " oil-producing " refers to that the microorganism that can accumulate the lipid more than 20% of its dry cell weight (sees
C.Ratledge etc., Microbial routes to lipids.Biochem Soc Trans.1989Dec;17 (6): 1139-
41).According to certain aspects of the invention, Yarrowia lipolytica is the micro-life for producing bio-fuel or bio-fuel precursor
Thing, because Yarrowia lipolytica is the obligate need that can assimilate carbohydrate (such as glucose) or glycerol as sole carbon source
Oxygen animalcule, and compared with other yeast strain, in Yarrowia lipolytica, glucose is to fatty acid and triacylglycerol (TAG)
Convert higher and lipid storage ability is higher.See for example Beopoulos A, Cescut J, Haddouche R,
Uribelarrea JL, Molina-Jouve C, Nicaud JM, Yarrowia lipolytica as a model for
bio-oil production.Prog Lipid Res.2009Nov;48 (6): 375-87.Additionally, Yarrowia lipolytica is to grind
Study carefully one of the most deep " unconventional " yeast species, and be recently completed the gene order-checking of Yarrowia lipolytica, including
MtDNA sequencing.Kerscher S, Durstewitz G, Casaregola S, Gaillardin C, Brandt U., Th
e complete mitoch ondrial genome of Yarrowia lipolytica.Comp Funct
Genomics.2001;2 (2): 80-90.Even if not yet completing the functional annotation of genome sequence, genomic sequence data can
The most more convenient genetic manipulation of property.See, e.g. Sokolova L, Wittig I, B arth HD, Schigger H,
Brutschy B, Brandt U., LILBID-mass spectrometry of protein complexes from blue-
Nativegels, a sensitive top-down proteomic approach.Proteomics. discloses 2010 on the net
Feb 1, PMID:20127694.
In wildtyp Y. lipolytica, start the fatty acid from carbon source and TAG synthesis at stable trophophase, show to deposit
In the tight regulatory mechanism controlling lipid metabolism.This regulatory mechanism controls the amount of the lipid that can be synthesized and store, and it is notable
Limit the raw material conversion yield to lipid.Therefore, the metabolizing parameters of wildtyp Y. lipolytica is unsuitable for viable economically
Ground produces bio-fuel or bio-fuel precursor on an industrial scale.
A kind of key regulator of microbial fatty acid metabolic
Some aspects of the present invention relate to it was unexpectedly found that: (i) satisfied fatty acid by feedback circuit suppression fat
The de novo synthesis of acid and TAG store, and (ii) (such as solves fat in the microorganism being suitable to produce bio-fuel or bio-fuel precursor
Ye Shi yeast) in process LAN SCD, Δ 9-desaturase be enough to restrain fatty acid synthesis and TAG stores this feedback suppression, cause
Fatty acid and/or TAG synthesis, store dramatically increase.
Some aspects of the present invention relate to it has unexpectedly been discovered that, except make fatty acid and/or the synthesis of TAG and store increase
In addition, in microorganism, process LAN SCD also gives microorganism (such as, Yarrowia lipolytica) and produces bio-fuel or bio-fuel
The advantageous phenotypes of precursor, it includes but not limited to: (i) TAG stores the superactivation of approach, (ii) growth vigor, and (iii) continues
Oil production, (iv) to carbohydrate source material in culture medium (such as, glucose and other sugar) tolerance strengthen, (v)
Fatty acid profile changes, and such as, the beneficially ratio of the saturated and unsaturated fatty acid that bio-fuel or bio-fuel precursor produce becomes
Change.
The SCD of the present invention be in oleaginous microorganism fatty acid metabolism and TAG synthesis key regulator discovery for
The method being intended to renewable carbon source be changed into bio-fuel or bio-fuel precursor by engineered cell is significant.
Some aspects based on the present invention, it now is possible to change the fatty acid of microorganism (such as oleaginous yeast such as Yarrowia lipolytica)
And/or TAG spectrum, this change gives to be managed the carbohydrate-modifying pole for bio-fuel or bio-fuel precursor on an industrial scale
Think phenotype, as dramatically increased fatty acid synthesis, TAG synthesis, fatty acid and TAG, yield of biomass and strengthening in culture medium
The tolerance of high concentration substrate, product and/or toxin.
According to certain aspects of the invention, the lipid in microorganism or fatty acid generation are changed according to method provided herein
Thank (such as by independent process LAN SCD or with other hereditary or non-genetic modification provided in this article combine) allow produce for
The microorganism that bio-fuel or bio-fuel precursor production process are optimized.Some aspects of the present invention relate to engineered micro-
Fatty acid metabolism in biology, causes fatty acid and derivative of fatty acid synthesis rate and accumulation in microorganism to increase.
Natural fat acid molecule is generally of branchiess aliphatic chain or the tail of 4 to 28 carbon atoms.If aliphatic
All carbon atoms of chain are all connected by C--C single bond, then fatty acid is referred to as " saturated ", if or two or more carbon
Atom is connected by C-C double bond, then fatty acid is referred to as " undersaturated ".Unsaturated fatty acid membrane fluidity, cytoactive,
Metabolism, control genetic transcription nuclear incident regulation in play an important role.
In yeast, fatty acid profile is mainly by C16 and C18 fatty acid (such as Palmic acid (C16), palmitoleic acid (C16), tristearin
Acid (C18) and oleic acid (C18)) composition.Palmic acid is the unbranched satisfied fatty acid (carbon of the aliphatic chain with 16 carbon atoms
Atom/unsaturated bond: 16.0).Stearic acid is the unbranched satisfied fatty acid (18.0) of the aliphatic chain with 18 carbon atoms.
Palmitoleic acid is the monounsaturated fatty acid (16.1) of the aliphatic chain of 16 carbon atoms.Oleic acid is the aliphatic of 18 carbon atoms
The monounsaturated fatty acid (18.1) of chain.In yeast, minority fatty acid species includes C14 and C26 fatty acid, and they are at protein
Modification has critical function or respectively as sphingolipid and the component of GPI anchor.
The de novo synthesis of fatty acid uses macrometabolic element, acetyl group coenzyme A, ATP and NADPH, thus with depend on this
Other cell processes of a little compounds has competition.Needed for NADPH is two reduction steps in fatty acid prolonging circulation, this is by fat
Fat acid synthesis associates with the metabolism state of cell, cause fatty acid synthesis be limited to cell have high-energy load condition (by
The acetyl group coenzyme A deposit instruction of the ATP/AMP ratio, the reducing equivalent of rising and the rising that increase) under.In fatty acid metabolism
Relate to nearly all subcellular organelle, demonstrate the need for being adjusted maintaining fatty acid stable state in multiple levels.
Most of biologies (including yeast) can be from several kinds of carbon source de novo synthesis fatty acid.In initial step, by by
Acetyl-CoA carboxylase (ACC;Being encoded by ACC1 and HFA1 in yeast) add CO to malonyl coenzyme A2Carry out carboxylation acetyl
Coenzyme A.Biotin is the important cofactor in this reaction, and passes through biotin: apolipoprotein ligase (in yeast by
BPL1/ACC2 encodes) covalently bound with ACC apolipoprotein (apoprotein).ACC is three functional enzymes, with biotin carboxyl
Carrier protein (BCCP) domain, biotin carboxylase (BC) domain and carboxyl transferase (CT) domain.Most of thin
In bacterium, these domains are expressed as single polypeptide and are assembled into different complex.On the contrary, eucaryon ACC (includes that mitochondrion ACC becomes
Body (Hfa1 in yeast)) on single polypeptide with these functions.The malonyl coenzyme A produced by ACC is being closed by fatty acid
As the donor of two carbon in enzyme, FAS and prolongation enzymatic circulation serial reaction.
In yeast, in the synthesis of endochylema fatty acid, involved independent function shows as one or two not homopolypeptide respectively
Separated domains on chain.Yeast endochylema fatty acid synthase (FAS) is by two subunit Fas1 (β subunit) and Fas2 (α subunit)
The complex constituted, it is organized as six poly-α 6 β 6 complex.Fas1 is with acetyltransferase, enoyl reductase, dehydratase
With malonyl palmitoyl transferase activity.Fas2 comprises acyl carrier protein, chlC4,3-ketone group synthase and phosphoric acid
Pantetheine transferase active.
Yeast mitochondrial fatty acid synthesis carried out by Type II FAS system, its on not homopolypeptide with individually
Enzymatic activity: Acp1, carries phosphopantetheine group prothetic group (prosthetic phosphopantetheine
Group) acyl carrier protein;Cem1, beta-keto acyl base-ACP synthase;Oar1,3-oxoacyl-[acyl carrier protein] is also
Protoenzyme;Htd2,3-hydroxyl acyl group-thioesters dehydratase;Etr1, enoyl-ACP reductase.The function of Ppt2 is phosphopan tetheine mercapto
The connection of base ethamine: protein transferase, its catalytic phosphatase pantetheine prothetic group and apoACP.
The direct product of fatty acid de novo synthesis is satisfied fatty acid.Known in eukaryote (including yeast), saturated
Fatty acid is the precursor of unsaturated fatty acid.Unsaturated fatty acid is typically passed through saturated fat by enzyme-specific (referred to as desaturase)
The desaturation of C--C single bond in fat acid and produce.The regulatory mechanism that control satisfied fatty acid is converted into unsaturated fatty acid is the completeest
Full understanding.In eukaryote, unsaturated fatty acid is in the core thing of membrane fluidity, cytoactive, metabolism and control genetic transcription
The regulation of part is played an important role.Generally, the yeast fat acid of about 80% is monounsaturated, it is intended that they are at its fat
Race's chain comprises a unsaturated bond.
A vital step in monounsaturated fatty acid biosynthesis is to draw at Δ 9 (between carbon 9 and 10)
Enter the first cis-double bonds.It is catalyzed this oxidation reaction by stearyl-coenzyme A desaturase (SCD, also referred to as Δ 9-desaturase).Though
So the insertion of double bond betides several different acyl CoA substrate wherein with methylene, it is preferable that the end of SCD
Thing is palmityl (16.0) coenzyme A and the stearoyl being separately converted to palmitoleoyl (16.1) coenzyme A and oleoyl (18.1) coenzyme A
(18.0) coenzyme A (Ntambi, J.Lipid Res., 1999,40,1549-1558).
It is Ole1 by stearyl-coenzyme A desaturase gene identification in nineteen ninety in saccharomyces cerevisiae (S.cerevisiae)
(Stukey JE etc., J Biol Chem., 1990,265 (33): 20144-9).In 1994, by separating from human fat tissue
The Partial cDNA of 0.76kb partly characterize human stearoyl coa desaturase gene (Li etc., Int.J.Cancer, 1994,
57,50348-352).Characterized completely at this gene in 1999, and it was found that the alternative of polyadenylation site uses and produces
Two kinds of transcripts (Zhang etc., Biochem.J., 1999,340,255-264) of 3.9kb and 5.2kb.In saccharomyces cerevisiae, by
Endoplasmic reticulum (ER) resident and basic Δ 9-desaturase Olel catalysis fatty acid single desaturation (Martin CE, Oh CS,
Jiang Y, Regulation of long chain unsaturated fatty acid syntnesis in
yeast..Biochim Biophys Acta.2007Mar;1771 (3): 271-85.Epub 2006 Jul 13).
Some aspects (at least partly) of the present invention relate to identifying saccharomyces cerevisiae in Yarrowia lipolytica as herein described
The homologue SCD of Ole1.
The non-limitative example of the representative series of Yarrowia lipolytica SCD described below:
> gi | 0548053 | ref | XP_501496.1 | YALl0C05951p [Yarrowia lipolytica]
MVKNVDQVDLSQVDTIASGRDVNYKVKYTSGVKMSQGAYDDKGRHISEQPFTWANWHQHINWLNFILV
IALPLSSFAAAPFVSFNWKTAAFAVGYYMCTGLGITAGYHRMWAHRAYKAALPVRIILALFGGGAVEG
SIRWWASSHRVHHRWTDSNKDpYDARKGFWFSHFGNMLLVpNpKNKGRTDISDLNNDWVVRLQHKYYV
YVLVFMAIVLpTLVCGFGWGDWKGGLVYAGIMRYTFVQQVTFCVNSLAHWIGEQpFDDRRTPRDHALT
ALVTFGEGYHNFHHEFpSDYRNALIWYQYDpTKWLIWTLKQVGLAWDLQTFSQNAIEQGLVQQRQKKL
DKWRNNLNWGIPIEQLpVIEFEEFQEQAKTRDLVLISGIVHDVSAFVEHHPGGKALIMSAVGKDGTAV
FNGGVYRHSNAGHNLLATMRVSVIRGGMEVEVWKTAQNEKKDQNIVSDESGNRIHRAGLQATRVENPG
MSGMAA (SEQ ID NO:1)
> gi | 50548052 | ref | XM_501496.1 | Yarrowia lipolytica YALI0C05951p (YALI0C05951g)
MRNA, complete cds
ATGGTGAAAAACGTGGACCAAGTGGATCTCTCGCAGGTCGACACCATTGCCTCCGGCCGAGATGTCAA
CTACAAGGTCAAGTACACCTCCGGCGTTAAGATGAGCCAGGGCGCCTACGACGACAAGGGCCGCCACA
TTTCCGAGCAGCCCTTCACCTGGGCCAACTGGCACCAGCACATCAACTGGCTCAACTTCATTCTGGTG
ATTGCGCTGCCTCTGTCGTCCTTTGCTGCCGCTCCCTTCGTCTCCTTCAACTGGAAGACCGCCGCGTT
TGCTGTCGGCTATTACATGTGCACCGGTCTCGGTATCACCGCCGGCTACCACCGAATGTGGGCCCATC
GAGCCTACAAGGCCGCTCTGCCCGTTCGAATCATCCTTGCTCTGTTTGGAGGAGGAGCTGTCGAGGGC
TCCATCCGATGGTGGGCCTCGTCTCACCGAGTCCACCACCGATGGACCGACTCCAACAAGGACCCTTA
CGACGCCCGAAAGGGATTCTGGTTCTCCCACTTTGGCTGGATGCTGCTTGTGCCCAACCCCAAGAACA
AGGGCCGAACTGACATTTCTGACCTCAACAACGACTGGGTTGTCCGACTCCAGCACAAGTACTACGTT
TACGTTCTCGTCTTCATGGCCATTGTTCTGCCCACCCTCGTCTGTGGCTTTGGCTGGGGCGACTGGAA
GGGAGGTCTTGTCTACGCCGGTATCATGCGATACACCTTTGTGCAGCAGGTGACTTTCTGTGTCAACT
CCCTTGCCCACTGGATTGGAGAGCAGCCCTTCGACGACCGACGAACTCCCCGAGACCACGCTCTTACC
GCCCTGGTCACCTTTGGAGAGGGCTACCACAACTTCCACCACGAGTTCCCCTCGGACTACCGAAACGC
CCTCATCTGGTACCAGTACGACCCCACCAAGTGGCTCATCTGGACCCTCAAGCAGGTTGGTCTCGCCT
GGGACCTCCAGACCTTCTCCCAGAACGCCATCGAGCAGGGTCTCGTGCAGCAGCGACAGAAGAAGCTG
GACAAGTGGCGAAACAACCTCAACTGGGGTATCCCCATTGAGCAGCTGCCTGTCATTGAGTTTGAGGA
GTTCCAAGAGCAGGCCAAGACCCGAGATCTGGTTCTCATTTCTGGCATTGTCCACGACGTGTCTGCCT
TTGTCGAGCACCACCCTGGTGGAAAGGCCCTCATTATGAGCGCCGTCGGCAAGGACGGTACCGCTGTC
TTCAACGGAGGTGTCTACCGACACTCCAACGCTGGCCACAACCTGCTTGCCACCATGCGAGTTTCGGT
CATTCGAGGCGGCATGGAGGTTGAGGTGTGGAAGACTGCCCAGAACGAAAAGAAGGACCAGAACATTG
TCTCCGATGAGAGTGGAAACCGAATCCACCGAGCTGGTCTCCAGGCCACCCGGGTCGAGAACCCCGGT
ATGTCTGGCATGGCTGCTTAG (SEQ ID NO:2)
Stearyl-coenzyme A desaturase or SCD introduce double bond at the A9-C of its fatty acid substrate being esterified by coenzyme A.
This activity influence satisfied fatty acid and the ratio of unsaturated fatty acid (such as stearic acid and oleic acid).Stearic acid is the main of SCD
Substrate, but other chain length fatty acid can also be processed by SCD.Think that the stearyl-coenzyme A desaturase in human body is fat
Fat generates enzyme, is not only as its key player in the biosynthesis of monounsaturated fatty acid, due also to it passes through meals
The pattern (Ntambi, Lipid Res., 1999,40,1549-1558) that food and insulin are adjusted.Therefore, stearoyl-coenzyme
The regulation of A desaturase the most important and its active to changes in diet, hormonal imbalance, growth course, temperature become
Change, metal, alcohol, Pexoxisome proliferator and phenolic compound sensitive (Ntambi, Lipid Res., 1999,40,1549-
1558)。
Animal model is non-in the research by polyunsaturated fatty acids (PUFA) regulation stearyl-coenzyme A desaturase
Chang Youyong.Such as, observe, when two groups are all fed in the thin fatty tissue with fatty Zucker rats (Jones etc.)
During the meals that PUFA content is high compared with control diet, stearyl-coenzyme A desaturase mRNA decrease 75% (Jones etc.,
Am.J.Physiol., 1996,271, E44-49).Similar result is obtained with tissue culture system.At Mus 3T3-L1 fat
In cell line, arachidonic acid, linoleic acid, linolenic acid and eicosapentaenoic acid make stearoyl-coenzyme in dose-dependent mode
The expression of A desaturase reduces (Sessler etc., J.Biol.Chem., 1996,271,29854-29858).
The molecular mechanism of PUFA regulation stearyl-coenzyme A desaturase gene expression in different tissues is still understood seldom.
Understanding to regulatory mechanism at present relates to PUFA and combines with the PUFA associated proteins of presumption, then, by PUFA associated proteins
Combination generation Transcription inhibition with cis acting PUFA response element (SREBP) of stearyl-coenzyme A desaturase gene
(Ntambi, Lipid Res., 1999,40,1549-1558;Zhang etc., Biochem.J., 2001,357,183-193).
Although, in different biologies, have studied the regulation of SCD gene catalysis activity, but the expression of SCD gene and tune
Save the meaning itself to lipid metabolism and do not become the object of further investigation yet.Have pointed out SCD and affect satisfied fatty acid and unsaturation
The ratio of fatty acid (such as stearic acid and oleic acid).
Some aspects of the present invention relate to it was unexpectedly found that SCD is also as (such as Yarrowia lipolytica in microorganism
In) key regulator of fatty acid and TAG metabolism plays a role.Some aspects of the present invention relate to it was unexpectedly found that single
Solely process LAN SCD gene outcome not only changes the ratio of the satisfied fatty acid in impacted cell and unsaturated fatty acid, and
Be enough to cause significantly and unexpectedly increasing of fatty acid and/or TAG synthesis rate and/or storage.Individually operated desaturation
Expression of enzymes is to give very good by the carbohydrate-modifying microorganism for lipid (such as oleaginous yeast cell) on an industrial scale
Phenotype should be it has unexpectedly been discovered that effectively produce bio-fuel from renewable carbon source to by the sweat of microbe-mediated
Or bio-fuel precursor has far reaching significance.The downward that fatty acid synthesizes and stores is restrained by process LAN SCD in microorganism
Not only give fatty acid synthetic ratio and accumulation that microorganism increases, also overcome FA/TAG synthesis in cultivation and be limited to the steady of microorganism
Regularly limit.Unexpectedly, SCD in microorganism (such as producing bio-fuel or the microorganism of bio-fuel precursor)
Process LAN also give microorganism to high concentration substrate (such as fermentable sugars) and noxious substance (the such as substrate relevant to substrate
The by-product of preprocessing process) tolerance.The phenotype (the most above-mentioned tolerance improves phenotype) given by SCD process LAN allows inciting somebody to action
(see Figure 11 overcomes FA by SCD process LAN to the lipid of the acquisition high concentration that sugar is converted in the industrial fermentation processes of lipid
Synthesis negative regulator).
According to certain aspects of the invention, operate other gene to can help to be given birth on a large scale from carbon source by fermentable
Produce bio-fuel or bio-fuel precursor.Such as, impact (such as sugar) containing carbon substrate turns to the gene that fatty acid synthesizes.Therefore,
Some aspects of the present invention provide operation regulation carbon and flow in or out the expression of the involved gene of lipid synthesis approach with reality
The method of the improvement of existing lipid production parameter.
Some aspects of the present invention provide the lipid of the microorganism that regulation produces bio-fuel or bio-fuel precursor
The method that the expression of other gene outcome of metabolism and/or activity carry out operating.Present invention operation in terms of some is intended to increase
Carbohydrate to the conversion of fatty acid and/or TAG with for from carbohydrate source large-scale production lipid to operated life
Thing is optimized.Some aspects of the present invention provide operation such as specific gene product process LAN, knock out, strike low, activation and/
Or suppress alone or in combination, and/or to implement with other operative combination well known by persons skilled in the art.Term " operates "
Refer to genetic manipulation (process LAN of such as specific gene product, knock out, strike low, activate and/or suppress) and non-genetic manipulation is (such as
The operation of culture medium, substrate, substrate pretreatment, pH, temperature, method for transformation etc.) the two.
Gene expression manipulations (referred to herein as the regulation and control of gene expression) can be natural to given gene expression
The destruction of regulation or suppression, process LAN, the suppression of expression or being completely eliminated of expressing.At native gene sequence (the most natural SCD
Gene order) upstream insert allogeneic promoter or in promoter deleting regulatory sequences (such as mediation SCD gene pass through saturated fat
The regulation sequence of the feedback suppression of fat acid) it is the example destroying or suppressing the natural regulation expressed.The strategy that controlling gene is expressed
Hereditary change (such as by recombinant technique such as gene target or viral transduction) can be included, or non-hereditary change is (the most
Know that the environment causing gene expression to raise or to lower changes, or medicine or tiny RNA are such as divided by the instantaneous delivery of regulatory factor
Son is instantaneous is delivered to target cell).The method of hereditary and non-hereditary change microorganism is known to those skilled in the art and retouches
It is set forth in such as: J.Sambrook and D.Russell, Molecular Cloning:A Laboratory Manual, Cold
Spring Harbor Laboratory Press;3rd edition (January 15,2001);David C.Amberg, Daniel
J.Burke;With Jeffrey N.Strathern, Methods in Yeast Genetics:A Cold Spring Harbor
Laboratory Course Manual, Cold Spring Harbor Laboratory Press (April 2005);John
N.Abelson, Melvin I.Simon, Christine Guthrie and Gerald R.Fink, Guide to Yeast
Genetics and Molecular Biology, Part A, Volume 194 (Methods in Enzymology
Series, 194), Academic Press (March 11,2004);Christine Guthrie and Gerald R.Fink,
Guide to Yeast Genetics and Molecular and Cell Biology, Part B, the 350th volume (Methods
In Enzymology, volume 350), Academic Press;1st edition (July2,2002);Christine Guthrie and
Gerald R.Fink, Guide to Yeast Genetics and Molecular and Cell Biology, Part C,
Volume 351, Academic Press;1st edition (July 9,2002);Gregory N.Stephanopoulos, Aristos
A.Aristidou and Jens Nielsen, Metabolic Engineering:Principles and Methodologies,
Academic Press;1st edition (October 16,1998);And Christina Smolke, The Metabolic
Pathway Engineering Handbook:Fundamentals, CRC Press;1st edition (July28,2009), they are whole
It is incorporated herein by.
Term as used herein " process LAN " refer to with reference to cell (wild-type cell of such as same cell type or
Same cell type but lack the cell of specific modification such as genetic modification) compare, given cell, cell type or cell state
In the increase of given gene expression dose.The satisfied fatty acid of SCD gene expression in wild-type cell can be suppressed dense showing
In the yarrowia lipolytica cell of degree, continuous expression SCD gene is an example of gene overexpression forcibly.
Term as used herein " knocks out " the functional of expression referred to gene outcome (such as RNA or protein) and breaks
Bad.It generally by causing gene outcome (the such as mRNA from recombination with targeting construct targeting each genome district
Or protein) completely inhibiting of expressing, the specific part in described targeting construct and described genome district is recombinated and lacks
The part in described district and/or insert HETEROLOGOUS NUCLEOTIDE or nucleotide sequence.In diploid, such homologous recombination events leads to
The most only affect in two allele.Homozygosity can by multiple strategy obtain, such as by breeding heterozygote and
Screening filial generation.In diplont (such as yeast), term " knock-out bacterial strain " generally refers to non-functional allele and isozygotys
Bacterial strain.
Term as used herein " strikes " to refer to the expression of part suppressor gene product (such as mRNA or protein) low.This
The known several genes in field strike low strategy can be used for inhibition of gene expression (such as suppression or resource transfers is gone out lipid synthesis approach
The expression of gene, ACS2, FAT1, PCS60 and/or the AMPK as in oleaginous yeast such as Yarrowia lipolytica).Such as, may be used
RNA interference (RNAi) and/or micro RNA (miRNA) approach is utilized (to include that siRNA (siRNA), bob press from both sides to use
RNA (shRNA), double-stranded RNA (dsRNA), miRNA and other little disturbing molecule based on nucleic acid known in the art) gene
Strike low strategy.In one embodiment, (such as shRNA or shRNA-mir expresses structure to use RNAi pattern based on carrier
Body) reduce (such as in oleaginous yeast cell such as yarrowia lipolytica cell) gene in cell and (such as suppress or by resource transfers
Go out the gene of lipid synthesis approach, such as ACS2, FAT1, PCS60 and/or AMPK) expression.According to the present invention in terms of some point
From plasmid can comprise the promoter that is effectively connected of gene with coding small RNA (such as shRNA).Implement at some
In scheme, it is possible to use the plasmid vector of separation produces can the virus of infection cell (such as yeast cells or bacterial cell)
Grain (such as retrovirus or phage).Exemplary viral include adenovirus, retrovirus, slow virus, adeno-associated virus,
Phage and other virus known in the art and disclosed herein.
Some aspects of the present invention provide and operate in the microorganism for producing bio-fuel or bio-fuel precursor
The method of stearyl-coenzyme A desaturase (SCD) activity.SCD be with the interleaving of stearic C9 and C10 of coenzyme A coupling
Enter Δ 9 desaturase of double bond, as other place in this article is described in detail, this inserting step be produce desat fatty acid and
The committed step of its derivant.In some embodiments, this operation is process LAN.In some embodiments, operation is passed through
Make the microorganism of production bio-fuel or bio-fuel precursor and be effectively connected allogeneic promoter (such as, composing type or induction type
Promoter) the expression construct comprising SCD gene outcome (such as SCD albumen) code nucleic acid contact carry out.Real at some
Executing in scheme, the nucleic acid of coding SCD gene outcome comprises the coded sequence of SEQ ID NO:2.In some embodiments, SCD
It is Yarrowia lipolytica SCD, such as, comprises the Yarrowia lipolytica SCD of the aminoacid sequence of SEQ ID NO:1.Implement at some
In scheme, microorganism is Yarrowia lipolytica.In some embodiments, carry out in microorganism to SCD activity operation with
Give on a large scale by the carbohydrate-modifying advantageous phenotypes for lipid, the lipid synthesis rate such as increased, increase
Carbohydrate is to the efficiency of lipid Transfer, the lipid storage of increase and the growth rate of increase, the carbon source raising concentration
Or the tolerance of the enhancing of lipid products.Stearyl-coenzyme A desaturase gene and gene outcome sequence are those skilled in the art
Well known to.Visible exemplary representative under GeneID:852825 entrance in ncbi database (www.ncbi.nlm.nih.gov)
Property gene and gene outcome sequence.
Some aspects of the present invention provide and operate in the microorganism for producing bio-fuel or bio-fuel precursor
The method of the activity of c-Jun N-terminal Kinase 2 (JNK2).JNK2 is positioned in Cytoplasm and is catalyzed fatty acid during hunger
Decompose and be used for producing energy and carbon shielding (carbonblock).JNK2 is that energy homeostasis is required and responding to the low sucrose solution of cell
Flat lipase activation plays key player.See Grimard V, Massier J, Richter D, Schwudke D,
Kalaidzidis Y, Fava E, Hermetter A, Thiele C., siRNA screening revealsJNK2 as an
evolutionary conserved regulator of triglyceride homeostasis.JLipid
Res.2008Nov;49 (11): 2427-40.Epub 2008 Jul 8.In some embodiments, eliminate or reduce production life
JNK2 activity in the microorganism of thing fuel or bio-fuel precursor is low by knocking out or striking the most respectively.Some embodiment party
In case, reduce JNK2 activity in the microorganism producing bio-fuel or bio-fuel precursor with increase product stability and/or
Reduce decomposition product metabolism.In some embodiments, employ conditionality suppression system, and at carbohydrate source (such as
Fermentable sugars) suppress JNK2 activity during little production process.In some embodiments, to JNK2 gene in microorganism
The activity of product carries out operating to give on a large scale by the carbohydrate-modifying advantageous phenotypes as lipid, such as increasing
Lipid synthesis rate, increase carbohydrate to the efficiency of lipid Transfer, the lipid storage of increase and increase growth speed
The tolerance that rate, the carbon source raising concentration or lipid products strengthen.JNK2 gene and gene outcome sequence are people in the art
Well known to member.Visible exemplary representative under GeneID:5601 entrance in ncbi database (www.ncbi.nlm.nih.gov)
Property gene and gene outcome sequence.
Some aspects of the present invention provide and operate in the microorganism for producing bio-fuel or bio-fuel precursor
The method of the activity of Δ-12 delta 8 desaturase genes product.It is senior chain that Δ-12 desaturase participates in the lipid Transfer containing oleic acid
Lipid.In some embodiments, such as in view of the cold flow characteristic of gained bio-fuel, it is desirable to avoid the life of long-chain fatty acid
Produce or minimize it to produce bio-fuel.In some embodiments, production bio-fuel or biological combustion are eliminated or reduce
The activity of Δ-12 desaturase in the microorganism of material precursor, the most respectively by (such as, knocking out) or partial gene deletion completely
Or strike low.In some embodiments, the Δ-12 reduced in the microorganism for producing bio-fuel or bio-fuel precursor goes
Saturated enzymatic activity is to increase product stability, obtain desired TAG spectrum and/or reduce the catabolism of product in microorganism.
In some embodiments, conditionality suppression system suppression Δ-12 desaturase activity is used.In some embodiments, exist
In microorganism, activity to Δ-12 delta 8 desaturase genes product operates and to give by carbohydrate-modifying is on a large scale
The advantageous phenotypes of lipid, the lipid synthesis rate such as increased, the carbohydrate of increase is to the efficiency of lipid Transfer, the fat of increase
Matter stores, and the content of the C18 fatty acid of increase, the total fatty acids of the microorganism of increase stores up the percent of middle C18 fatty acid, institute
The cold flow characteristic of the increase of the lipid, oil or the TAG that produce, the growth rate of increase, the carbon source that concentration is raised or lipid products
The tolerance strengthened.Δ-12 delta 8 desaturase genes and gene outcome sequence are known to those skilled in the art.Ncbi database
(www.ncbi.nlm.nih.gov) visible exemplary representative gene and gene outcome under GeneID:2909806 entrance in
Sequence.
Some aspects of the present invention provide and operate in the microorganism for producing bio-fuel or bio-fuel precursor
The method of the activity of hemoglobin gene product.Hemoglobin gene product (is included for some embodiments of the invention
Hemoglobin gene product) general introduction, see Frey AD, Kallio PT.Bacterial hemoglobins and
Flavoh emoglobins:versatile proteinsand their impactonmicrobiology and
biotechnology.FEMS MicrobiolRev.2003Oct;27 (4): 525-45.In some embodiments, the most logical
Cross the nucleic acid of process LAN encoding haemoglobin protein to increase (the such as hemoglobin egg of hemoglobin gene product in microorganism
White matter) activity.In some embodiments, in microorganism, the process LAN of hemoglobin causes oxygen transmission in microorganism to increase.
In some embodiments, the oxygen owing to increasing flows into and needs the route of synthesis (such as fatty acid synthesis pathway) of hyperoxia, so
The hemoglobin activity increased causes bio-fuel or the synthesis of bio-fuel precursor to increase.In some embodiments, in micro-life
In thing, the activity of operation hemoglobin gene product is to give on a large scale by the carbohydrate-modifying advantageous phenotypes as lipid,
The lipid synthesis rate that such as increases, the carbohydrate of increase are to the efficiency of lipid Transfer, the lipid storage of increase and increase
Growth rate, to concentration raise carbon source or lipid products strengthen tolerance.Hemoglobin gene and gene outcome sequence are
Known to one of skill in the art.GeneID:7738539 (Deide in ncbi database (www.ncbi.nlm.nih.gov)
12990) visible exemplary representative gene and gene outcome sequence under entrance.
Some aspects of the present invention provide and operate in the microorganism for producing bio-fuel or bio-fuel precursor
The method of the activity of cytochrome genes product, described cytochrome genes product such as cytochrome b gene product, particularly
Ground is cytochrome B5 gene outcome.In some embodiments, by the nucleic acid of such as process LAN Codocyte chromoprotein
Increase the activity of cytochrome genes product in microorganism (such as cytochrome protein).In some embodiments, micro-
In biology, overexpressing cell pigment causes the oxygen transmission in microorganism to increase.In some embodiments, due to the oxygen stream increased
Enter to need the route of synthesis (such as fatty acid synthesis pathway) of hyperoxia, thus increase cytochrome activity cause bio-fuel or
The synthesis of bio-fuel precursor increases.In some embodiments, in microorganism operate cytochrome genes product activity with
Give on a large scale by the carbohydrate-modifying advantageous phenotypes for lipid, such as the lipid synthesis rate increased, the carbon water of increase
Compound is to the efficiency of lipid Transfer, the lipid storage of increase and the growth rate of increase, the carbon source raising concentration or fat
The tolerance of the enhancing of matter product.Cytochrome genes and gene outcome sequence are known to those skilled in the art.NCBI data
Visible exemplary representative gene and gene outcome sequence under GeneID:1528 entrance in storehouse (www.ncbi.nlm.nih.gov)
Row.
Some aspects of the present invention provide and operate in the microorganism for producing bio-fuel or bio-fuel precursor
The method of the activity of glucose transporter (GLUT) gene outcome (such as Glut 1 gene outcome).In some embodiments
In, increase (the such as GLUT albumen of GLUT gene outcome in microorganism by the nucleic acid of such as process LAN coding GLUT protein
Matter) activity.In some embodiments, in microorganism, the nucleic acid of process LAN coding GLUT protein causes the Portugal of microorganism
Grape Sugar intake increases.In some embodiments, owing to the picked-up of glucose increases, so the GLUT activity increased causes biology
Fuel or the synthesis of bio-fuel precursor increase.In some embodiments, in microorganism, operate the activity of GLUT gene outcome
To give on a large scale by the carbohydrate-modifying advantageous phenotypes as lipid, such as the lipid synthesis rate increased, the carbon of increase
Hydrate to the efficiency of lipid Transfer, the lipid storage of increase and the growth rate of increase, to concentration raise carbon source or
The tolerance that lipid products strengthens.GLUT gene and gene outcome sequence are known to those skilled in the art.Ncbi database
(www.ncbi.nlm.nih.gov) visible exemplary representative gene and gene outcome sequence under GeneID:38109 entrance in
Row.
Some aspects of the present invention provide and operate in the microorganism for producing bio-fuel or bio-fuel precursor
The method of the activity of pyruvate carboxylase (PC) gene outcome.In some embodiments, PC egg is encoded by such as process LAN
The nucleic acid of white matter increases the activity of PC gene outcome in microorganism (such as PC protein).In some embodiments, micro-
In biology, the nucleic acid of process LAN coding PC protein causes the glucose uptake of microorganism to increase.In some embodiments, by
Picked-up in glucose increases, so the PC activity increased causes bio-fuel or the synthesis of bio-fuel precursor to increase.At some
In embodiment, in microorganism operate PC gene outcome activity with give on a large scale by carbohydrate-modifying as lipid
Advantageous phenotypes, the lipid synthesis rate such as increased, the carbohydrate of increase to the efficiency of lipid Transfer, increase lipid store up
The tolerance that the growth rate deposited and increase, the carbon source raising concentration or lipid products strengthen.PC gene and gene outcome sequence
It is classified as known to one of skill in the art.In ncbi database (www.ncbi.nlm.nih.gov) under GeneID:5091 entrance
Visible exemplary representative gene and gene outcome sequence.
Some aspects of the present invention provide and operate in the microorganism for producing bio-fuel or bio-fuel precursor
The method of the activity of malate dehydrogenase (ME) gene outcome.ME catalysis (S)-malate oxidation decarboxylation becomes acetone acid, simultaneously with two
The release of carbonoxide and the conversion of NADP+ to NADPH.In some embodiments, ME protein is encoded by such as process LAN
Nucleic acid increase the activity of ME gene outcome in microorganism (such as ME protein).In some embodiments, in microorganism
The nucleic acid of middle process LAN coding ME protein causes NADPH level in microorganism to increase, and causes the reductivemetabolism of adequate level
Thing (such as NADPH) is used for increasing fatty acid synthesis.In some embodiments, owing to NADPH level increases, so increase
ME activity causes bio-fuel or the synthesis of bio-fuel precursor to increase.In some embodiments, microorganism operates ME base
Because the activity of product is to give on a large scale by the carbohydrate-modifying advantageous phenotypes as lipid, the such as lipid synthesis increased
Rate, increase carbohydrate to the efficiency of lipid Transfer, the lipid storage of increase and the growth rate of increase, to concentration liter
The tolerance that high carbon source or lipid products strengthen.ME gene and gene outcome sequence are known to those skilled in the art.NCBI
Visible exemplary representative gene and gene under GeneID:17436 entrance in data base (www.ncbi.nlm.nih.gov)
Product Sequence.
Some aspects of the present invention provide in the microorganism for producing bio-fuel or bio-fuel precursor (such as
In Yarrowia lipolytica) operation acetyl-CoA carboxylase (ACC) gene outcome method.ACC gene outcome mediation acetylcoenzyme
A (the main C2 precursor in fatty acid synthesis) is converted into malonyl coenzyme A, and this conversion is considered as first in fatty acid synthesis
Committed step and also be considered as fatty acid synthesis in rate-limiting step (see Cao Y, Yang J, Xian M, Xu X, Liu
W.Increasing unsaturated fatty acid contents in Esch erich ia coli by
coexpression of three different genes.Appl Microbiol Biotechnol.2010).At some
In embodiment, the operation of ACC activity is ACC process LAN.In some embodiments, in microorganism, ACC process LAN increases fat
Acid synthetic ratio and/or give on a large scale by carbohydrate-modifying for bio-fuel or the advantageous phenotypes of bio-fuel precursor,
The lipid synthesis rate that such as increases, the carbohydrate of increase are to the efficiency of lipid Transfer, the lipid storage of increase, the life of increase
Long speed, tolerance to the enhancing of material (such as carbon source, bio-fuel or bio-fuel precursor or noxious substance) concentration.ACC
Gene and gene outcome sequence are known to those skilled in the art.In ncbi database (www.ncbi.nlm.nih.gov)
Visible exemplary representative gene and gene outcome sequence under GeneID:855750 entrance.
Some aspects of the present invention provide and operate in the microorganism for producing bio-fuel or bio-fuel precursor
The method of the activity of acyl-CoA synthetase (ACS).ACS is that catalysis has the thioesterification of the fatty acid of coenzyme A to form activation
The enzyme family of intermediate (sees Lu X, Vora H, Khosla C., Ov erproduction of free fatty acids
In E.coli:implications for biodiesel production Metab Eng.2008 Nov;10 (6): 333-
9).These intermediate are phospholipid, fatty acid cholesterol ester or the precursor of alcohol fatty acid ester (such as TAG).Yarrowia lipolytica comprises
With two kinds of acyl-CoA synthetase predicted known to two kinds.In some embodiments of the present invention, seviparous life is being produced
In thing, process LAN ACS enzyme is to give on a large scale by the carbohydrate-modifying advantageous phenotypes as lipid, the such as lipid increased
Synthetic ratio, increase carbohydrate to the efficiency of lipid Transfer, the lipid storage of increase and/or secretion, increase growth speed
The tolerance that rate, the carbon source raising concentration or lipid products strengthen.ACS gene and gene outcome sequence are those skilled in the art
Well known to.Visible exemplary representative under GeneID:851245 entrance in ncbi database (www.ncbi.nlm.nih.gov)
Property gene and gene outcome sequence.
Some aspects of the present invention provide and operate in the microorganism for producing bio-fuel or bio-fuel precursor
The method of the activity of acyl-CoA synthetase 2 (ACS2), enzyme that ACS2 is in peroxisome and participate in fatty acid
Degraded.In some embodiments, suppression ACS2 stops or suppression fatty acid is degraded by yeast catabolism, and one
In a little embodiments, this suppression supplements the increase of FAA1 gene product activity so that the fatty acid increased is secreted into culture medium
In.Yarrowia lipolytica comprises ACS2 acetyl group CoA synthase and (sees Beopoulos A, Cescut J, Haddouche
R, Uribelarrea JL, Molina-Jouve C, Nicaud JM., Yarrowia lipolytica as a model for
bio-oil production.Prog Lipid Res.2009Nov;48 (6): 375-87).In some embodiments, micro-
Biology knocks out, strikes low and/or suppression ACS2 gene product expression or activity to give on a large scale by carbohydrate-modifying
For bio-fuel or the advantageous phenotypes of bio-fuel precursor, the lipid synthesis rate such as increased, the carbohydrate of increase are to fat
Matter convert efficiency, the lipid storage of increase and the growth rate of increase, to material (such as carbon source, bio-fuel or biology
Fuel precursor or noxious substance) tolerance of enhancing of concentration.ACS2 gene and gene outcome sequence are those skilled in the art institutes
Known.Visible exemplary representativeness under GeneID:850846 entrance in ncbi database (www.ncbi.nlm.nih.gov)
Gene and gene outcome sequence.
Some aspects of the present invention provide and operate in the microorganism for producing bio-fuel or bio-fuel precursor
The method of the activity of FAA1 gene outcome.The catalysis of FAA1 gene outcome has the Cytoplasm thioesterification of the long-chain fatty acid of coenzyme A
To produce the intermediate of activation.Yarrowia lipolytica FAA1 is saccharomyces cerevisiae P30624FAA1 long chain fatty acid coa ligase
Homologue.This enzyme participates in generation and the secretion of fatty acid that free fatty stores up.In some embodiments, it is being used for
In the microorganism of production bio-fuel or bio-fuel precursor, process LAN FAA1 gene outcome is to give on a large scale by carbon aquation
Compound is converted into the advantageous phenotypes of lipid, and the lipid synthesis rate that such as increases, the carbohydrate of increase are to the effect of lipid Transfer
The tolerance that rate, the lipid storage of increase and the growth rate of increase, the carbon source raising concentration or lipid products strengthen.FAA1
Gene and gene outcome sequence are known to those skilled in the art.In ncbi database (www.ncbi.nlm.nih.gov)
Visible exemplary representative gene and gene outcome sequence under GeneID:854495 entrance.
Some aspects of the present invention provide and operate in the microorganism for producing bio-fuel or bio-fuel precursor
The very method of long-chain fatty acid CoA synthase (FAT1) activity.Think that FAT1 controls the very long-chain fat with coenzyme A
The fatty acid transport of acid and thioesterification.Yarrowia lipolytica comprises FAT1 very long-chain fatty acid CoA synthase.Real at some
Execute in scheme, suppress FAT1 activity to stop synthesis and/or the increasing of very length fatty acids derivant by such as genetic manipulation
Add storing up of free fatty.In some embodiments, knock out in microorganism, strike low and/or suppression FAT1 gene outcome
Expression or activity with give on a large scale by carbohydrate-modifying as bio-fuel or the advantageous phenotypes of bio-fuel precursor,
The lipid synthesis rate that such as increases, the carbohydrate of increase are to the efficiency of lipid Transfer, the lipid storage of increase and increase
Growth rate, tolerance to the enhancing of material (such as carbon source, bio-fuel or bio-fuel precursor or noxious substance) concentration.
FAT1 gene and gene outcome sequence are known to those skilled in the art.Ncbi database (www.ncbi.nlm.nih.gov)
Visible exemplary representative gene and gene outcome sequence under middle GeneID:852329 entrance.
Some aspects of the present invention provide the method for operation PCS60, and PCS60 is also referred to as FAT2, AMP associated proteins acyl group
CoA synthase or peroxisome CoA synthase, it is the peroxisome acyl having and not determining substrate specificity
Base CoA synthase.Yarrowia lipolytica comprises saccharomyces cerevisiae PCS 60 homologue.Suppression PCS60 will stop very long fat
The synthesis of acid derivative also increases storing up of free fatty.In some embodiments of the present invention, knock out in microorganism,
Strike the low and/or expression of suppression PCS60 gene outcome or activity to fire carbohydrate-modifying for biological on a large scale to give
Material or the advantageous phenotypes of bio-fuel precursor, the lipid synthesis rate such as increased, the carbohydrate of increase are to lipid Transfer
Efficiency, the lipid storage of increase and the growth rate of increase, to material (such as carbon source, bio-fuel or bio-fuel precursor
Or noxious substance) tolerance of enhancing of concentration.FAT2 gene and gene outcome sequence are known to those skilled in the art.NCBI
Visible exemplary representative gene and base under GeneID:852523 entrance in data base (www.ncbi.nlm.nih.gov)
Because of Product Sequence.
Some aspects of the present invention provide for large-scale production bio-fuel or the microorganism of bio-fuel precursor
The method of process LAN ATP citrate-lyase (ACLY) in (such as Yarrowia lipolytica).Be suitable to produce on an industrial scale biology
Some microorganisms of fuel or bio-fuel precursor generally produce a large amount of citric acid at (including Yarrowia lipolytica).ACLY mediates lemon
Lemon acid is converted into coenzyme A, according to certain aspects of the invention, this reaction can by ACLY express promote (see Holz M,A, Mauersberger S, Barth G, Aconitase overexpression changes theproduct
ratio of citric acidproduction by Yarrowia lipolytica.Appl Microbiol
Biotechnol.2009Jan;81 (6): 1087-96).In some embodiments, ACLY process LAN reduces less desirable Fructus Citri Limoniae
Acid produces and/or provides other S-acetyl-coenzyme-A originated for synthesising biological fuel or bio-fuel precursor.Some embodiment party
In case, suppression citric acid in the microorganism (including Yarrowia lipolytica) for producing bio-fuel or bio-fuel precursor
Excess produces.In some embodiments, in microorganism, (such as in Yarrowia lipolytica), ACLY process LAN increases fatty acid conjunction
One-tenth rate and/or give on a large scale by carbohydrate-modifying for bio-fuel or the advantageous phenotypes of bio-fuel precursor, such as
Increase lipid synthesis rate, increase carbohydrate to the efficiency of lipid Transfer, the lipid storage of increase and the life of increase
Long speed, tolerance to the enhancing of material (such as carbon source, bio-fuel or bio-fuel precursor or noxious substance) concentration.Also join
See Lasserre JP, Nicaud JM, Pagot Y, Joubert-Caron R, Caron M, Hardouin
J.Talanta.First complexomic study of alkane-binding protein complexes in the
yeast Yarrowia lipolytica. 2010 Feb 15;80 (4): 1576-85.ACLY gene and gene outcome sequence are
Known to one of skill in the art.Can under GeneID:108728 entrance in ncbi database (www.ncbi.nlm.nih.gov)
See exemplary representative gene and gene outcome sequence.
The method that some aspects of the present invention provide process LAN fatty acid synthase complex (FAS).Although ACC is probably
Rate-limiting enzyme in fatty acid synthesis, but also have pointed out other step and this approach is controlled, most notably FAS
(see Schweizer E,H, Regler R, Rottner G.J, Genetic control of Yarrowia
lipolytica fatty acid synthetase biosynthesis and function.Basic
Microbiol.1988;28 (5): 283-92).This complex is the strongest (most of substrate in whole lipid synthesis approach
Substrate-intensive) multifunctional polypeptides of fatty acid chain is extended during.In some embodiments, microorganism
In (such as in Yarrowia lipolytica) ACLY process LAN add fatty acid synthetic ratio and/or give on a large scale by carbon hydrate
Thing is converted into bio-fuel or the advantageous phenotypes of bio-fuel precursor, the lipid synthesis rate that such as increases, the carbon hydrate of increase
Thing to the efficiency of lipid Transfer, the lipid storage of increase and/or secretion, the growth rate of increase, to material (such as carbon source, life
Thing fuel or bio-fuel precursor or noxious substance) tolerance that strengthens of concentration.FAS gene and gene outcome sequence are this area skill
Well known to art personnel.GeneID:853653 and GeneID:855845 in ncbi database (www.ncbi.nlm.nih.gov)
Visible exemplary representative gene and gene outcome sequence under entrance.
Some aspects of the present invention provide the method for suppression AMP activated protein kinase (AMPK).AMPK is by response
In cell AMP:ADP ratio by phosphorylation regulate other oroteins activity regulatory enzyme (see Lee-Young RS,
Palmer MJ, Linden KC, LePlastrier K, Canny BJ, Hargreaves M, Wadley GD, Kemp BE,
McConell GK.Carbohydrate ingestion does not alter skeletal muscle AMPK
signaling during exercise in humans.Am J Physiol Endocrinol Metab.2006Sep;291
(3): E566-73).In yeast, AMPK shows targeting ACC and INO 1, needed for INO1 is lipids, biological synthesis step in early days
Gene.In AMPK knocks out mutant, lack ACC phosphorylation cause the ACC of superactivation and the excess generation of fatty acid.One
In a little embodiments, AMPK is suppressed to cause the superactivation of lipid synthesis in microorganism.In some embodiments, by such as
Knock out the AMPK activity that AMPK gene is completely eliminated in microorganism.In some embodiments, by the most hereditary or non-heredity
The activity of AMPK in operation suppression microorganism.The suppression (different from being completely eliminated) of AMPK activity can be avoided being regulated by AMPK
The negative interaction of other cell processes.In some embodiments, knock out in microorganism (such as Yarrowia lipolytica), strike low
And/or the suppression expression of AMPK gene outcome or activity with give on a large scale by carbohydrate-modifying as bio-fuel or life
The advantageous phenotypes of thing fuel precursor, the lipid synthesis rate such as increased, the carbohydrate of increase are to the efficiency of lipid Transfer, increasing
The lipid storage added and/or secretion, the growth rate of increase, to material (such as carbon source, bio-fuel or bio-fuel precursor or have
Poisonous substance matter) concentration strengthen tolerance.AMPK gene and gene outcome sequence are known to those skilled in the art.Ncbi database
(www.ncbi.nlm.nih.gov) in, under GeneID:100145903 entrance, visible exemplary representative gene and gene produce
Thing sequence.
The nucleic acid separated
Some aspects of the present invention provide to give into microorganism (such as Yarrowia lipolytica) and produce bio-fuel or life
The needs of thing fuel precursor and/or the code nucleic acid of the gene outcome of expectation phenotype.In some embodiments, this nucleic acid comes
From the nucleic acid of Yarrowia lipolytica.In some embodiments, this nucleic acid coding desaturase, such as Δ 9 desaturase.One
In a little embodiments, this nucleic acid coding Yarrowia lipolytica Δ 9 desaturase.In some embodiments, this nucleic acid comprises SEQ
ID NO:1.In some embodiments, this nucleic acid is SEQ ID NO:1.In some versions, this nucleic acid coding gene outcome,
Such as by the protein of SEQ ID NO:1 coding.
Some aspects of the present invention provide gene outcome (such as protein), and it is that microorganism (such as solves fat Ye Shi ferment
Female) give production bio-fuel or the needs of bio-fuel precursor and/or expectation phenotype.In some embodiments, this albumen
Matter is the protein from Yarrowia lipolytica.In some embodiments, this protein is desaturase, and such as Δ 9 goes to satisfy
And enzyme.In some embodiments, this protein is Yarrowia lipolytica Δ 9 desaturase.In some embodiments, this egg
The aminoacid sequence of white matter is provided in the aminoacid sequence in SEQ ID NO:2.
Term " nucleic acid " refers to comprise the molecule of the nucleotide of multiple connection." nucleic acid " and " nucleic acid molecules " exchanges and uses also
And mean oligoribonucleotide and oligodeoxyribonucleotide.This term is also contemplated by many nucleoside (i.e. polynucleotide removing phosphoric acid)
With other organic base any comprising nucleic acid.Organic base includes adenine,uracil,guanine, thymus pyrimidine, cytosine and flesh
Glycosides.Nucleic acid can be strand or double-strand.Nucleic acid can be natural or non-natural.Nucleic acid can obtain from natural origin or
Nucleic acid synthesizer can be used to synthesize (i.e. synthesizing).The separation and the suitably method that carry out nucleic acid routinely in the art can
See standard molecular biology textbook.(see, e.g. Maniatis ' Handbook of Molecular Biology.) such as this
Literary composition is described, and nucleic acid can be DNA or RNA, such as genomic DNA, mitochondrial DNA, mRNA, cDNA, rRNA, miRNA, PNA or LNA
Or a combination thereof.It is used as unnatural nucleic acids such as bacterial artificial chromosome (BAC) and yeast according to certain aspects of the invention
Artificial chromosome (YAC).
Some aspects of the present invention are directed to use with nucleic acid derivative.As will be described herein, some nucleic acid is used to spread out
Biology can increase its stability by preventing the digestion of nucleic acid of the present invention, particularly may comprise nucleic acid when they are exposed to
During the biological specimen of enzyme.Nucleic acid derivative used herein is unnatural nucleic acids or its unit.Nucleic acid derivative can wrap
Connect containing non-natural element such as non-natural nucleotides and non-natural backbone.Permissible according to present invention nucleic acid derivative in terms of some
Comprise backbone modification such as but be not limited to thiophosphate connect, di-phosphate ester modify nucleic acid, di-phosphate ester and sulfur for phosphorus
The combination of acid esters nucleic acid, methyl orthophosphoric acid, alkylphosphonate, phosphate ester, D2EHDTPA Arrcostab, phosphoramidate, carbamic acid
Ester, carbonic ester, phosphotriester, acetamide ester (acetamidate), carboxymethyl ester, D2EHDTPA methyl ester, phosphorodithioate,
To ethyoxyl and combinations thereof.The skeleton composition of nucleic acid can be homology or allos.
Nucleic acid derivative according to certain aspects of the invention can comprise the replacement in sugar and/or alkali or modification.Such as,
Some nucleic acid derivatives can include the nucleic acid with skeleton sugar, and skeleton sugar is covalently bound in addition to the hydroxyl at 3 ' positions and removes 5 '
Low-molecular-weight organic group (such as 2 '-O-alkylated ribose group) outside phosphate at Wei.Nucleic acid derivative can include
Non-ribose sugar arabinose.Nucleic acid derivative can comprise substituted purine and pyrimidine such as C-5 propine modified base, 5-methyl born of the same parents
Pyrimidine, 2-aminopurine, 2-amido-6-chloropurine, 2,6-diaminopurine, hypoxanthine, 2-deracil and the different born of the same parents of vacation are phonetic
Pyridine.
In some embodiments, nucleic acid can include peptide nucleic acid(PNA) (PNA), lock nucleic acid (LNA), DNA, RNA or above-mentioned
Combined nucleic acid (co-nucleic acid) is such as DNA-LNA combined nucleic acid.
The nucleic acid that term as used herein " nucleic acid molecules of separation " refers to not in its natural surroundings, such as, (i) leads to
Cross means known in the art to extract from cell or microorganism (such as antibacterial or yeast) and or the nucleic acid of/purification, described ability
Known method such as alkaline bleach liquor cleavage host cell in territory is the most such as by silicon oxide purification via adsorption-based process nucleic acid;(ii) by the most poly-
The nucleic acid of synthase chain reaction (PCR) amplification in vitro;(iii) produced by clone (such as nucleic acid clone being entered expression vector) restructuring
Nucleic acid;(iv) digested by such as vitro enzyme or pass through to shear fragmentation and the nucleic acid of size separation that then glue separates;Or
The nucleic acid that person (v) is synthesized by such as chemosynthesis.In some embodiments, by recombinant DNA skill well known in the art
The nucleic acid of the easily operated separation of art.It is therefore contemplated that be cloned into the nucleic acid of carrier or be delivered to host cell and be integrated into host's base
Because the nucleic acid of group is to separate, but under the native state in its natural host nucleic acid (such as in the genome of host) is then
It is not.The nucleic acid separated can be basic purification, but need not so.Such as, the core of separation in clone or expression vector
Acid is not pure, its can only comprise little percentage ratio its residing for material in cell.But it is this in term as used herein
Nucleic acid is to separate.
Some aspects of the present invention relate to giving and produce that the microorganism of bio-fuel or bio-fuel precursor is required or expectation
The code nucleic acid of the gene outcome of phenotype, it is connected with promoter or other transcriptional activation element.In some embodiments,
Encoding gene product and the nucleic acid being connected with promoter are contained in expression vector or expression construct.Term as used herein
" expression vector " or " expression construct " refers to a series of permission specific nucleic acids in host microorganism (such as oleaginous yeast)
The nucleic acid construct that the specific nucleic acid element transcribed recombinantly or synthetically produces.In some embodiments, expression vector can be
A part for plasmid, virus or nucleic acid fragment.In some embodiments, expression vector comprises treating of being effectively connected with promoter
The code nucleic acid transcribed.Promoter is to promote to treat that transcribed nucleic acid carries out the nucleic acid elements transcribed.Promoter is usually located at same chain
The upstream (or 5 ') of the nucleotide sequence transcribed is controlled with it.In some embodiments, expression vector comprises and allos startup
The code nucleic acid to be transcribed that son effectively connects.The startup that allogeneic promoter right and wrong are effectively connected with given nucleotide sequence natively
Son.Such as, the SCD gene in Yarrowia lipolytica is effectively connected with Yarrowia lipolytica SCD gene promoter natively.Cause
This, any startup being effectively connected with SCD gene or its part in addition to wildtyp Y. lipolytica SCD gene promoter
Son (such as in expression construct) is allogeneic promoter.
In some embodiments, expression vector comprises the code nucleic acid effectively connecting constitutive promoter, such as, encode
The nucleic acid of SCD gene outcome.Term " constitutive promoter " refers to the promoter of the gene processive transcription allowing it to be associated.?
In some embodiments, expression vector comprises the code nucleic acid effectively connecting inducible promoter, and such as, coding SCD gene produces
The nucleic acid of thing.Replace the term " inducible promoter " used in this article to refer to only exist with term " conditional promoter "
Or when there is not biology or abiotic component, allow the promoter of its genetic transcription that is associated.Induction type well known in the art starts
The example of son is that (such as tetracycline/doxycycline inducible promoter, tamoxifen induction type start drug induced promoter
Son) and depend on the promoter (restructuring in the loxP site of such as crc-mediation) that recombination event activates.
As well known to those skilled in the art expression vector or expression construct are delivered in microorganism (such as yeast cells)
Method.Nucleic acid (including expression vector) can be delivered to former by multiple method known to biological various equivalent modifications
Core microorganism or eukaryotic microorganisms.According to certain aspects of the invention the method in delivery of nucleic acids to microorganism is included but not
Being limited to different chemistry, electrochemistry and biological methods, such as, heat-shock transformed, electroporation, transfection are (the most liposome-mediated
Transfection, the transfection of DEAE-Dextran mediation or calcium phosphate transfection).In some embodiments, use for transfer thing
Nucleic acid construct (such as SCD expression construct) is introduced in host microorganism by supporting agent or the carrier of matter.For by hereditary material
Transfer to the carrier in microorganism known to those skilled in the art, including such as plasmid, artificial chromosome and viral vector.
(include comprising composing type or the expression construct of induction type allogeneic promoter, knocking out or strike low structure for building nucleic acid construct
Build body) method and be people in the art for method that nucleic acid or nucleic acid construct are delivered in microorganism and carrier
Well known to member, and be described in such as following in: J.Sambrook and D.Russell, Molecular Cloning:
ALaboratory Manual, Cold Spring Harbor LaboratoryPress;3rd edition (January 15,2001);
David C.Amberg, Daniel J.Burke and Jeffrey N.Strathern, Methods in Yeast Genetics:
ACold Spring Harbor Laboratory Course Manual, Cold Spring Harbor Laboratory
Press(April 2005);John N.Abelson, Melvin I.Simon, Christine Guthrie and Gerald
R.Fink, Guide to Yeast Genetics and Molecular Biology, Part A, the 194th volume (Methods
In Enzymology Series, 194), Academic Press (March 11,2004);Christine Guthrie and
Gerald R. Fink, Guide to Yeast Genetics and Molecular and Cell Biology, Part B,
Volume 350 (Methods in Enzymology, volume 350), Academic Press;1st edition (July 2,2002);
Christine Guthrie and
Gerald R, Fink, Guide to Yeast Genetics and Molecular and Cell
Biology, Part C, volume 351, Academic Press;1st edition (July 9,2002);Gregory
N.Stephanopoulos, Aristos A.Aristidou and Jens Nielsen, Metabolic Engineering:
Principles and Methodologies, Academic Press;1st edition (October 16,1998);And
Christina Smolke, The Metabolic Pathway Engineering Handbook:Fundamentals, CRC
Press;1st edition (July 28,2009), it is all incorporated herein by.
In some embodiments, to giving needed for microorganism or the coding of gene outcome of expectation phenotype in microorganism
The natural promoter (the most natural SCD promoter) of gene carries out modifying to change the regulation of its transcriptional activity.Implement at some
In scheme, compared with the most modified homologue, modified promoter shows the transcriptional activity of increase.Art used herein
Language " modified promoter " refers to that its nucleotide sequence is by the promoter of manual change.The example of such manual change is single
Only or the nucleotide deletion of combination, insert or suddenly change.Artificial promoters's change can be carried out in the way of targeting, such as, pass through
Methods of homologous recombination, such as gene target, knocks out, strikes low, rite-directed mutagenesis or the most Zinc finger nuclease-mediated strategy.Or, can
With by random or semi-random event as irradiated or non-targeted nucleotide incorporation is subsequently selected carries out such change.Typically
Carry out promoter to modify to regulate and control the transcription activating characteristic of each promoter.Such as, destroy or lack mediation respond to intracellular fat
Sour water is put down rising and is suppressed the regulating element of SCD promoter to be activated by the processive transcription causing SCD gene, even if at intracellular fat
Also it is such under conditions of the flat rising of sour water.Similarly, the transcriptional activation element that composing type activates is inserted conditional promoter
District can make each gene process LAN under the conditions of normal inhibitory.Targeting destruction in microorganism as well known to those skilled in the art
The method of (targeting such as causing transcription rate to increase destroys) natural promoter (the most natural SCD promoter).
In some embodiments, it is provided that nucleic acid construct is for producing bio-fuel or micro-life of bio-fuel precursor
Thing knocks out Δ-12 delta 8 desaturase genes.In some embodiments, knock out construct and comprise microorganism Δ-12 desaturase
The genome sequence of gene, the nucleotides sequence of its flank destroys Δ-12 desaturase when being listed in insertion Δ-12 delta 8 desaturase genes
The expression of gene outcome.In some embodiments, the nucleic acid destroying Δ-12 delta 8 desaturase genes Product Expression is that antibiotic resists
Property label, such as phleomycin resistant gene.In some embodiments, Δ-12 desaturase knockout carrier comprises SEQ
The sequence that IDNO:28 is provided.The method being delivered in microorganism by knockout carrier is known to those skilled in the art, micro-
The method carrying out homologous recombination in biology (such as in yeast) is known to those skilled in the art.The present invention is not limited to the party
Face.
Microorganism remodeling method
Some aspects of the present invention relate to engineered microorganism (such as Yarrowia lipolytica) to show with extensive raw
Produce the required and/or expectation phenotype of bio-fuel or bio-fuel precursor.Some aspects of the present invention relate to Metabolically engineered SCD way
Footpath is to obtain for producing the microorganism that bio-fuel is optimized.Some aspects of the present invention relate to Metabolically engineered regulation carbon
Flow in or out the gene of fatty acid synthesis pathway to obtain for producing the microorganism that bio-fuel is optimized.
Some aspects of the present invention provide and are greatly increased solution fat by the natural grease metabolism of regulation Yarrowia lipolytica
The carbon source of family name's yeast mediation is to the method for the transformation efficiency of lipid.Some aspects of the present invention relate to such discovery: process LAN
The gene (such as SClD) increasing fatty acid or triacylglycerol accumulation not only causes lipid accumulation to increase, and causes lipid synthesis
Rate, lipid content and/or growth rate increase.Significantly and unexpectedly, according to certain methods provided by the present invention
Lipid metabolism regulation also gives other favorable property, such as to raw material (including high concentration substrate (such as glucose))
And/or the tolerance generally polluting the noxious substance of raw material (the most pretreated raw material) strengthens.The one of such polluter
A little non-limitative examples are furfural, 5 hydroxymethyl furfural and acetic acid class.The raw material thing of the noxious substance of pollution is produced after pretreatment
The non-limiting examples of matter is the raw material from timber, corn straw and bagasse.
Some aspects of the present invention relate in Yarrowia lipolytica by restraining the key regulator of lipid metabolism
Transcription inhibition (such as by restraining the Transcription inhibition of SCD) transforms out required and/or expectation phenotype.Also contemplate and producing life
Key regulator (the example of operation lipid metabolism in other microorganisms (such as yeast, antibacterial, fungus or algae) of thing fuel
As, SCD).
In order to transform the biology (such as oleaginous yeast) for producing bio-fuel on an industrial scale, it is important that manage in detail
Solve and each biology regulates and controls fatty acid and the molecular mechanism of lipid metabolism.Until the present invention, the generation oil produced for bio-fuel
Microorganism (such as oleaginous yeast) in fatty acid and the qualification of lipid metabolism regulatory factor and functional annotation the most unresolved.This
Some aspects of invention provide qualification and the function note of the key regulator gene SCD in oleaginous yeast Yarrowia lipolytica
Release.Additionally provide SCD nucleic acid and the protein molecule of separation.
Some aspects of the present invention relate to being transformed out in microorganism for producing bio-fuel or life by genetic modification
The expectation phenotype of thing fuel precursor.Some aspects of the present invention relate to operation in microorganism and participate in producing bio-fuel or biology
The gene of fuel precursor (such as fatty acid or triacylglycerol).Some aspects of the present invention relate to operating abreast in microorganism
Participate in producing bio-fuel or multiple genes of bio-fuel precursor.
In some embodiments, the method operation individual gene provided by some aspects of the present invention transforms micro-life
Thing is used for producing bio-fuel or bio-fuel precursor, and described gene such as Δ 9 desaturase (such as, SCD), GLUT are (such as,
Glut1), hemoglobin, cytochrome (such as, cytochrome B5), malate dehydrogenase, ACC, ACS, ACS2, FAA1, FAT1,
FAT2, ACLY, FAS, AMPK, JNK2 or Δ-12 desaturase.In some embodiments, by some aspects of the present invention
The method provided operates multiple genes and transforms microorganism for producing bio-fuel or bio-fuel precursor, and described gene is such as
Δ 9 desaturase (such as, SCD), GLUT (such as, Glut1), hemoglobin, cytochrome (such as, cytochrome B5), Herba Marsileae Quadrifoliae
In fruit acid enzyme, ACC, ACS, ACS2, FAA1, FAT1, FAT2, ACLY, EAS, JNK2, Δ-12 desaturase and/or AMPK two
Individual or more combination in any.In some embodiments, transformation microorganism with comprise increase level SCD gene outcome and
Other operation (such as genetic manipulation) of other gene product expression, described other gene outcome such as GLUT is (such as,
Glut1), hemoglobin, cytochrome (such as, cytochrome B5), malate dehydrogenase, ACC, ACS, ACS2, FAA1, FAT1,
FAT2, ACLY, FAS, JNK2, Δ-12 desaturase or AMPK gene outcome.In some embodiments, transformation microorganism with
Comprise SCD gene outcome and the hemoglobin gene product of increase level.In some embodiments, transformation microorganism is to comprise
The SCD gene outcome of increase level and GLUT gene outcome (such as Glut1 gene outcome).In some embodiments, transformation
Microorganism is to comprise the SCD gene outcome of increase level, GLUT gene outcome (such as Glut1 gene outcome) and hemoglobin
And/or cytochrome genes product.In some embodiments, transformation microorganism is to comprise the SCD gene outcome of increase level
Knock out with Glut1, hemoglobin and cytochrome b5 and optional Δ 12 desaturase.In some embodiments, micro-life
Thing is Yarrowia lipolytica.
For producing the engineered microorganism of bio-fuel
Some aspects of the present invention relate to for large-scale production bio-fuel or bio-fuel precursor carried out transformation and/
Or the microorganism optimized.In some embodiments, it is provided that by the method provided by some aspects of the present invention or make
The engineered microorganism operated with the nucleic acid provided by some aspects of the present invention or protein.In some embodiments
In, it is provided that process LAN gives for microorganism needed for producing bio-fuel or bio-fuel precursor according to certain aspects of the invention
And/or the engineered microorganism of the gene outcome of the phenotype of expectation.In some embodiments, it is provided that comprise the SCD of increase
The microorganism of gene product activity.In some embodiments, microorganism shows the fatty acid synthetic ratio of increase, increase
TAG stores and/or other required or anticipant character.
In some embodiments, engineered microorganism is oleaginous yeast, such as Yarrowia lipolytica.Some embodiment party
In case, engineered yeast provided by the present invention shows one or more very good and unexpected phenotypic characteristic, example
As: the conversion (such as with the ratio close to theoretical value) of the carbon of increase to oil, Johnson & Johnson head, lasting oil production, significantly biology
The tolerance that matter produces and strengthens carbon source and related substances.
In some embodiments, some aspects of the present invention engineered microorganism (such as, the engineered ferment provided
Female) show about 0.02g/g (grams of the glucose of the grams of produced oil, lipid or TAG/consumed) to about 0.3g/g
Carbon to oil conversion ratio.In some embodiments, some aspects of the present invention the engineered microorganism provided is (such as through changing
Acrasis) show following carbon to oil conversion ratio: about 0.010g/g (glucose of the grams of produced TAG/consumed gram
Number), about 0.02g/g, about 0.025g/g, about 0.03g/g, about 0.04g/g, about 0.05g/g, about 0.06g/g, about 0.07g/g, about
0.075g/g, about 0.08g/g, about 0.09g/g, about 0.1g/g, about 0.11g/g, about 0.12g/g, about 0.13g/g, about 0.14g/
G, about 0.15g/g, about 0.16g/g, about 0.17g/g, about 0.18g/g, about 0.19g/g, about 0.2g/g, about 0.21g/g, about
0.22g/g, about 0.23g/g, about 0.24g/g, about 0.25g/g, about 0.26g/g, about 0.27g/g, about 0.28g/g, about 0.29g/g
Or about 0.3g/g or close to theoretical value.In some embodiments, some aspects of the present invention the engineered micro-life provided
Thing (the most engineered yeast) shows following carbon to oil conversion ratio: at least about 0.010g/g (produced TAG grams/disappeared
The glucose grams of consumption), at least about 0.02g/g, at least about 0.025g/g, at least about 0.03g/g, at least about 0.04g/g, at least
About 0.05g/g, at least about 0.06g/g, at least about 0.07g/g, at least about 0.075g/g, at least about 0.08g/g, at least about
0.09g/g, at least about 0.1g/g, at least about 0.11g/g, at least about 0.12g/g, at least about 0.13g/g, at least about 0.14g/g,
At least about 0.15g/g, at least about 0.16g/g, at least about 0.17g/g, at least about 0.18g/g, at least about 0.19g/g, at least about
0.2g/g, at least about 0.21g/g, at least about 0.22g/g, at least about 0.23g/g, at least about 0.24g/g, at least about 0.25g/g,
At least about 0.26g/g, at least about 0.27g/g, at least about 0.28g/g, at least about 0.29g/g or at least about 0.3g/g or close reason
Opinion value.
In some embodiments, compared with wild-type yeast, some aspects of the present invention the engineered yeast provided
Show and increase to following biomass and produce: about 2 times, about 2.5 times, about 5 times, about 7.5 times, about 10 times, about 15 times, about 20
Again, about 25 times, about 30 times, about 32 times, about 35 times or about 40 times.In some embodiments, some aspects of the present invention carry
The engineered yeast of confession show carbon source and/or related substances concentration are tolerated the most highly concentrated by tolerated by wild-type yeast
Degree the most about 150%, the most about 175%, the most about 200%, the most about 225%, the most about 250%, the most about 275%,
The most about 300%, the most about 325%, the most about 350%, the most about 375%, the most about 400% or the most about 500%.Carbon source
The non-limitative example of related substances includes the noxious substance polluting carbon source, such as, produce during pretreatment carbon source or use
Material (such as, acidic materials such as acetic acid class or ammonia).
Data shown herein determine a new rate-limiting step of lipid accumulation in oleaginous yeast, transform it and make
The characteristic for producing bio-fuel from carbohydrate source (such as glucose) must be greatly improved through the microorganism of operation.Cause
This, method provided by the present invention and production are to use microorganism (such as yeast) fermentation from renewable carbohydrate source to substitute
Property ground generate bio-fuel major progress.
For producing the culture of microorganism of bio-fuel
Some aspects of the present invention relate to presented herein or that transform according to certain aspects of the invention or
Comprise the nucleic acid of separation presented herein or the culture of microorganism of protein.
In some embodiments, culture comprises presented herein or transforms according to certain aspects of the invention
Or the microorganism that comprises the nucleic acid from the separation listed herein or protein, and culture medium (such as liquid culture
Base).
In some embodiments, culture comprises presented herein or transforms according to certain aspects of the invention
Or the nucleic acid that comprises separation presented herein or the microorganism of protein, and carbohydrate source.
In some embodiments, culture comprises presented herein or transforms according to certain aspects of the invention
Or the nucleic acid that comprises separation presented herein or the microorganism of protein, and set up comply with microorganism survival,
Growth and or microorganism in the carbohydrate salinity, osmotic pressure and the pH condition that convert to bio-fuel or bio-fuel precursor
Salt and/or buffer.
In some embodiments, culture comprises other component, such as additive.The limiting examples of additive is
Nutrient, enzyme, aminoacid, albumin, somatomedin, enzyme inhibitor (such as protease inhibitor), fatty acid, lipid, hormone
(such as dexamethasone and gibberellins), trace element, inorganic compound (such as reducing agent such as manganese), redox modulating agent (example
Such as antioxidant), stabilizer (such as dimethyl sulfoxide), Polyethylene Glycol, polyvinylpyrrolidone (PVP), gelatin, antibiotic (example
Such as brefeldin A), salt (such as NaCl), chelating agen (such as EDTA, EGTA) and enzyme (such as cellulase, Bacillus polymyxa Neutral proteinase
(dispase), hyaluronidase or DNA enzymatic).In some embodiments, culture can comprise induction or suppression from condition
The medicine that property or inducible promoter are transcribed, such as doxycycline, tetracycline, tamoxifen, IPTG, hormone or metal ion.
Although concrete condition of culture (concentration of such as carbon source) depends on engineered microorganism to be cultivated, but is used for producing
Conventional method and the condition of culture of raw culture of microorganism are known to a person skilled in the art, and be described in such as following in:
J.Sambrook and D.Russell, Molecular Cloning:ALaboratory Manual, Cold Spring Harbor
Laboratory Press;3rd edition (January 15,2001);David C.Amberg, Daniel J.Burke and
Jeffrey N.Strathern, Methods in Yeast Genetics:A Cold Spring Harbor Laboratory
Course Manual, Cold Spring Harbor Laboratory Press (April 2005);John N.Abelson,
Melvin I.Simon, Christine Guthrie and Gerald R.Fink, Guide to Yeast Genetics and
Molecular Biology, Part A, volume 194 (Methods in Enzymology Series, 194), Academic
Press (March 11,2004);Christine Guthrie and Gerald R. Fink, Guide to Yeast
Genetics and Molecular and CEll Biology, Part B, the 350th volume (Methods in Enzymology,
Vol 350), Academic Press;1st plate (July 2,2002);And Christine Guthrie and Gerald
R.Fink, Guide to Yeast Genetics and Molecular and Cell Biology Part C, the 351st is apt to,
Academic Press;1st edition (July 9,2002), it is all incorporated herein by.As it is known in the art, for
Oil produces, and cultivates engineered culture of microorganism as herein described under conditions of being suitable to oil accumulation.
In some embodiments, it is provided that display is beyond the wild-type microorganisms of same type and/or beyond other is micro-
Biology (is such as commonly found in carbon source micro-life of contaminating microorganisms culture in bio-fuel or bio-fuel precursor convert
Thing) the engineered microorganism of growth vigor.Such as, in some embodiments, it is provided that micro-with the wild type of same type
Biological or other microbial than show increase multiplication rate and/or to the wild-type microorganisms of identical type and/or
Other microorganism is poisonous or the tolerance of enhancing under conditions of limiting growth or breeding or viability.In some embodiments,
The growth of engineered microorganism provided by some aspects of the present invention and/or proliferative advantage change into use non-sterilizing to cultivate and
Fermentation condition produces bio-fuel or the probability of bio-fuel precursor, because so alleviating or having fully phased out by polluting micro-
The culture undue growth problem that biology causes.In some embodiments, cultivate by the one of the present invention under non-sterilising conditions
The engineered microorganism that a little aspects provide is to produce bio-fuel or bio-fuel precursor.Such as, in some embodiments, make
With non-sterilizing raw material, non-sterilising medium, non-sterilizing additive or non-sterile biological reactor (opening under the most non-sterilising conditions
Put reactor) produce bio-fuel or bio-fuel precursor.
For producing the method/raw material/bioreactor of bio-fuel
Before some aspects of the present invention are directed to use with modified micro-organisms bio-fuel or the bio-fuel of the present invention
The method of body.In some embodiments, it is provided that produce bio-fuel or the method for bio-fuel precursor on an industrial scale.
Use the method provided by some aspects of the present invention that several kinds of carbon source can be converted into bio-fuel or biological combustion
Material precursor.Sugar, starch and fiber apply to the carbohydrate source of the method for transformation by some aspects offer of the present invention
Non-limitative example.According to certain aspects of the invention, carbohydrate source can comprise refine and/or unrefined sugar, shallow lake
Powder and/or fiber or its combination in any.The non-limitative example of sugar is fermentable sugars, such as glucose, fructose, sucrose, xylose
And lactose.The non-limitative example of starch is amylase and amylopectin.The non-limitative example of fiber is Plant fiber, such as fibre
Dimension element, hemicellulose and wood fibre.Some aspects of the present invention are directed to use with industry byproduct, intermediate product or waste product (example
Such as thick plant extract, molasses, straw or sewage) as carbon source.In some embodiments, carbon source is from algae.At some
In embodiment, specially produce algal biomass to use in producing at the bio-fuel of microbe-mediated or bio-fuel precursor
Make carbon source.
In some embodiments, it is provided that for producing bio-fuel or the method for bio-fuel precursor, it includes making
With carbon source raw material that is cheap, abundant and that can be easily obtained as carbon source.In some embodiments, cellulose or half fibre are used
Dimension is as carbon source.In some embodiments, cellulose or hemicellulose are from industry byproduct or waste product.Some embodiment party
In case, cellulose or hemicellulose are directly from plant or algal biomass.Plant or algal biomass are the abundantest former
One of material, and include a large amount of not fermentable sugars and fiber, such as cellulose and hemicellulose.In some embodiments, in advance
Process biomass material so that fermentable sugars or fiber fermentable sugars will do not changed into, so that it can be used for growth of microorganism and micro-
Bio-fuel or the bio-fuel precursor of biological mediation produce.In some embodiments, the pretreatment of biomass material includes
Use well known to a person skilled in the art that cellulose and/or hemi-cellulose components depolymerization are monosaccharide by preprocess method, described pre-
Processing method such as diluted acid or ammonia filament expansion (AFEX) method (see, e.g. Yang B, Wyman CE.Dilute acid and
autohydrolysis pretreatment.Methods Mol Biol.2009;581:103-14;Balan V, Bals B,
Chundawat SP, Marshall D, Dale BE, Lignocellulosic biomasspretreatment using
AFEXMethods Mol Biol.2009;581:61-77).For by other method that biomass polymers depolymerization is monosaccharide being
As well known to those skilled in the art and consideration is used in some embodiments of the present invention.
In some embodiments, use the biomass material that diluted acid method pretreatment comprises not fermentable sugars sending out
Ferment sugar depolymerization is for fermenting monosaccharide.In some embodiments, appropriateness gentleness at a temperature of with dilute sulfuric acid with the time determined
Process biomass.Such as, in some embodiments, with about 0.5%, about 1%, about 2%, about 3%, about 4%, about 5% or about
The sulfuric acid treatment biomass of 6%.In some embodiments, about 30 DEG C, about 37 DEG C, about 40 DEG C, about 50 DEG C, about 60 DEG C, about
70 DEG C, about 80 DEG C, about 90 DEG C, about 100 DEG C, about 110 DEG C, about 120 DEG C, about 130 DEG C, about 140 DEG C, about 150 DEG C, about 175 DEG C, about
200 DEG C or more than processing biomass at about 200 DEG C.
In some embodiments, gained hydrolyzate comprises insoluble lignin and soluble cellulosic polymers and half
Cellulosic polymer.Can be by well known to a person skilled in the art method (such as by with cellulase or other hydrolytic enzyme)
Process the product processed further below to produce hexose and pentose such as glucose and xylose monomer.In some embodiments
In, the by-product including cytotoxic compound is resulted in dilute acid pretreatment not fermentable sugars, according to certain aspects of the invention,
Its suppression is not transformed the growth of microorganism, is reduced its vigor and/or suppress its bio-fuel or the production of bio-fuel precursor.?
In some embodiments, wash pretreated raw material, supplement and support growth of microorganism and bio-fuel or bio-fuel precursor
Produce culture medium and/or add superfluous lime with removing toxic substances.
In some embodiments, use the biomass material that AFEX method pretreatment comprises not fermentable sugars so that can not
Sugar fermentation depolymerization is for fermenting monosaccharide.In some embodiments, at high temperature and pressure with liquefied ammonia with the time-triggered protocol determined
Biomass.In some embodiments, biomass are processed about 10 minutes, about 20 minutes, about 30 minutes, about 40 minutes, about 50 points
Clock, about 60 minutes, about 70 minutes, about 80 minutes, about 90 minutes or longer.In some embodiments, about 30 DEG C, about 37
DEG C, about 40 DEG C, about 50 DEG C, about 60 DEG C, about 70 DEG C, about 80 DEG C, about 90 DEG C, about 100 DEG C, about 110 DEG C, about 120 DEG C, about 130 DEG C,
About 140 DEG C, about 150 DEG C, about 175 DEG C, about 200 DEG C or more than processing biomass at about 200 DEG C.In some embodiments,
AFEX pretreatment cause the crystalline cellulose being contained in raw material be converted into amorphous can fermentation form.In some embodiments
In, before the biomass material of AFEX pretreatment does not comprise a large amount of suppression growth of microorganism and/or bio-fuel or bio-fuel
Without detoxifying for producing bio-fuel or bio-fuel precursor before the harmful by-products that body produces, and use.
In some embodiments, with hydrolysis or the enzyme (such as with cellulase or hemicellulase) of solution chitosan polymer
Process preprocessed or the most pretreated biomass material.In some embodiments, raw material is made to contact in the liquid phase with enzyme,
And make to hatch at a temperature of enzyme catalysis depolymerization or hydrolysis be enough to hydrolyze or significant quantity in depolymerization biomass material not
Fermentable sugars or a period of time of fiber.In some embodiments, hatch after hydrolysis and depolymerization, will by being such as centrifuged
The liquid phase of the raw material contacted with enzyme separates with the solid phase comprising not fermentable sugars and fiber (comprising solubility fermentable sugars fraction).
In some embodiments, the liquid fraction of raw material is made subsequently and for being converted into micro-life of bio-fuel or bio-fuel precursor
Thing (such as being provided by some aspects of the present invention) contact.In some embodiments, not fermentable sugars or the enzymatic of fiber
Conversion betides in united bioprocess, such as with micro-to bio-fuel or bio-fuel precursor of produced fermentable sugars
Bioconversion is in identical time and/or same reactor.In some embodiments, first carry out Enzymatic transformation, then make with
The raw material of enzyme contact contacts with the microorganism producing bio-fuel or bio-fuel precursor.In some embodiments, identical
Time and carry out enzymatic and microorganism in same reactor and convert.
In some embodiments, cultivate engineered microorganism provided herein using acetic acid class as primary carbon source,
Such as process LAN SCD gene and optionally carry as herein described other modify Yarrowia lipolytica.Such as, implement at some
In scheme, about 1%, about 2%, about 3%, about 4%, about 5%, about cultivating microorganism in the acetic acid class solution that concentration is following:
6%, about 7%, about 8%, about 9% or about 10%.In some embodiments, acetic acid class concentration is about 3%~10%.At some
In embodiment, cultivate using the cell comprising engineered microorganism as herein provided that acetic acid class is cultivated as primary carbon source
Thing contacts with glycerol or is impregnated in glycerol.In some embodiments, microorganism is made to contact off and on glycerol.Implement at some
In scheme, microorganism is made continuously or semi-continuously to contact with glycerol.In some embodiments, microorganism is about with concentration
0.5%, the glycerol contact of about 1%, about 2%, about 3%, about 4% or about 5%.Make engineered microorganism provided in this article with
Glycerol contact provides with greater need for metabolite for producing TAG, and produces the reduction part needed for fatty acid from carbohydrate.
In some embodiments, the carbon source (any carbon source the most as herein described) in addition to acetic acid class is being used to carry out bio-fuel
Or bio-fuel precursor production method mixes glycerol.
In some embodiments, the carbohydrate of large scale microbial mediation can to the sweat of lipid Transfer
To carry out in bioreactor.Term " bioreactor " and " fermentor " of replacing use herein refer to wherein give birth to
Thing and/or the closure (enclosure) of chemical reaction (it at least partly relates to the part of living organism or living organism) or portion
Divide closure." Large Scale Biology reactor " or " commercial scale bioreactor " is for business or half commercial mass production
The bioreactor of product (such as bio-fuel or bio-fuel precursor such as fatty acid and/or TAG).Large Scale Biology reacts
The volume range of device is generally at several litres, Shuo Baisheng, thousands of liter or bigger.
Microorganism or culture of microorganism can be comprised according to present invention bioreactor in terms of some.Implement at some
In scheme, bioreactor can comprise the spore of the microorganism arbitrarily separated such as provided by some aspects of the present invention
And/or the rest cell type of any kind, such as in drying regime.In some embodiments, anti-to such biology
Answer and device adds suitable carbohydrate source can cause the sprouting and the most extremely of the activation of rest cell, such as yeast spores
Small part carbohydrate source is converted into bio-fuel or bio-fuel precursor.
Cell culture system, wherein microorganism and shifting can be comprised according to the present invention some bioreactors in terms of some
Hydrodynamic body and/or bubble contact.Microorganism according to certain aspects of the invention or culture of microorganism can in suspension or
Person is attached on solid phase carrier cultivate.The non-limitative example of carrier system includes that microcarrier (can be such as porous or non-
The polymer spheres of porous, microballon and micro-dish), have specified chemical group (such as tertiary amine groups) crosslinking pearl (such as Portugal gather
Sugar), the 2D microcarrier that comprises the cell being trapped in non-porous polymeric fibres, 3D microcarrier is (for example, it is possible to comprise porous fibre
Carrier fibre, hollow fibre, many barrel reactors and semipermeable membrane), there is the microcarrier of the ion-exchange capacity of reduction, encapsulating
Cell, capillary tube and aggregation.Carrier can be made up of material such as glucosan, gelatin, glass and cellulose.
Can carry out according to the present invention plant-scale carbon aquation in terms of some with continuous, semicontinuous or non-continuous mode
Compound is to the conversion process of lipid.The non-limitative example of operations according to the instant invention pattern be in batches, fed-batch, extension divide
Batch (extended batch), repeated batch, take out/fill out, rotate the operation of wall, revolving bottle and/or fill-up mode.
In some embodiments, it is possible to use allow continuously or semi-continuously to feed substrate raw material (example from bioreactor
Such as carbohydrate source) and/or continuously or semi-continuously separate product (such as secrete lipid, the organic facies comprising lipid and/or
Show the cell of required lipid content) bioreactor.
The non-limitative example of bioreactor of the present invention is stirred-tank fermenter, is stirred by rotary blender
Bioreactor, chemostat, by shaking device be stirred bioreactor, airlift fermentation device, packed bed react
Device, fixed bed reactors, fluidized bed aerosol generator, utilize the bioreactor that ripple induction type stirs, centrifugal biological respinse
Device, roller bottle and hollow fibre bioreactor, roller arrangement (the most desk-top, vehicle-mounted and/automatically kind), vertical stacking
Dish, rolling bottle, stir or shake bottle, oscillatory type porous plate, MD bottle, T bottle, Roux bottle, multi-surface tissue culture incubator, improvement
Fermentor and coated pearl (such as, are coated to prevent cell adhesion with serum albumin, nitrocellulose or carboxymethyl cellulose
Pearl).
Can optionally comprise sensor according to present invention bioreactor in terms of some and fermentor and/or control system
Unite to measure and/or regulation response parameter.The non-limitative example of response parameter is: biological parameter such as growth rate, cell
Size, cell number, cell density, cell type or cell state;At the bottom of chemical parameters such as pH, oxidation-reduction potential, reaction
Thing and/or the concentration of product, the concentration such as oxygen concentration and CO of dissolved gas2Concentration, nutrient concentrations, metabolite concentration, Portugal
Grape sugar concentration, glutamine concentration, concentrations of pyruvate, apatite concentration, oligomeric peptide concentration, amino acid concentration, vitamine concentration,
Hormone concentration, additive concentration, serum-concentration, ionic strength, ion concentration, relative humidity, molar concentration, osmotic pressure, other
The concentration of chemicals (such as buffer agent, adjuvant or byproduct of reaction);Physical/chemical parameter, such as density, conductivity, stirring
Degree, pressure and flow velocity, shear stress, shear rate, viscosity, color, turbidity, light absorption, mixing rate, conversion ratio and heat
Kinetic parameter, such as temperature, light intensity/light quality etc..
The sensor that can measure parameters is well known to mechanics and electricity those skilled in the relevant art.Base
It is bioreactor engineering neck in the control system of parameter in bioreactor can be regulated from sensor as herein described input
Well known to the technical staff in territory.
Multiple different microorganisms that some aspects of the present invention are provided can be cultivated with root in suitable bioreactor
Carry out large-scale carbohydrate according to some aspects of the present invention to convert to bio-fuel or bio-fuel precursor, such as from
Many primary yeasts (such as oleaginous yeast), antibacterial, the microorganism in algae and fungi source.
The non-limitative example of yeast cells is from following cell: Yarrowia lipolytica, multiple-shaped nuohan inferior yeast
(Hansenula polymorpha), Pichia sp. (Pichia pastoris), saccharomyces cerevisiae (Saccharomyces
Cerevisiae), saccharomyces bayanus (S.bayanus), Kluyveromyces lactis (S.K.lactis), Waltomyces
Lipofer.Mortierella alpine, Mortierella isabellina, multiple-shaped nuohan inferior yeast (Hansenula
Polymorpha), Zygosaccharomyces rouxii (Mucor rouxii), trichosporon cutaneum (Trichosporon cutaneu), viscous red ferment
Female (Rhodotorula glutinis), amylase yeast (Saccharomyces diastasicus), perhaps prosperous yeast
(Schwanniomyces occidentalis), saccharomyces cerevisiae (S.cerevisiae), pichia stipitis (Pichia
And schizosaccharomyces pombe (Schizosaccharomyces pombe) stipitis).
The non-limitative example of antibacterial be bacillus subtilis (Bacillus subtilis), Salmonella (Salmonella),
Escherichia coli (Escherichia coli), vibrio cholera (Vibrio cholerae), streptomycete (Streptomyces), glimmering
Light pseudomonas (Pseudomonas fluorescens), pseudomonas putida (Pseudomonas putida), pseudomonas
Belong to (Pseudomonas sp), Rhod (Rhodococcus sp), streptomyces (Streptomvces sp) and Alcaligenes
Belong to (Alcaligenes sp.).
Can be from following species cultivation fungal cell: aspergillosis western meat Sa rice (Aspergillus
Shirousamii), Aspergillus niger (Aspergillus niger) and trichoderma reesei (Trichoderma reesei).
The non-limitative example of alga cells is from following cell: rich oil new chlorella (Neochloris
Oleoabundans), scenedesmus obliquus (Scenedesmus obliquus), microalgae are belonged to (Nannochloropsis sp), Du
Family name algae (Dunaliella tertiolecta), chlorella (Chlorella vulgaris), swim chlorella (Chlorella
And spirulina maxim (Spirulina maxima) emersonii).
The type of the carbohydrate source being converted into bio-fuel or bio-fuel precursor according to some aspects of the present invention takes
Certainly in the specified microorganisms used.Some microorganisms provided by some aspects of the present invention may be used for effectively converting spy
Determine carbohydrate source, and different carbohydrate sources may not efficiently be processed by identical microorganism or can not at all
Process.According to certain aspects of the invention, oleaginous yeast Yarrowia lipolytica can effectively by sugar (such as glucose, fructose, sugarcane
Sugar and/or lactose) and the higher carbohydrate source (such as molasses) of sugared content and Plant fiber be converted into fatty acid and spread out
Biological.
In some embodiments, some aspects of the present invention (such as oleaginous yeast is as solved fat in the microorganism provided
Family name's yeast) secrete bio-fuel or the bio-fuel precursor, such as fatty acid or trigalloyl being produced from carbon source raw material at least in part
Glycerol.In some embodiments, make microorganism that some aspects of the present invention provide and carbohydrate source in the reactor
In aqueous solution contact, and secreted bio-fuel or bio-fuel precursor formed can be separated from the water organic facies.
Term as used herein organic facies refers to comprise nonpolar organic compound (such as fatty acid, TAG and/or other is nonpolar
Lipid) liquid phase.The organic facies of the present invention can comprise microorganism, carbohydrate further or see in each bioreactor
Other compound in other phase.Known to those skilled in the art for plant-scale separated method.At some
In embodiment, organic facies is continuously or semi-continuously absorbed.In some embodiments, use and comprise continuously or half
Extract the bioreactor of the separator of organic facies continuously.
In some embodiments, bio-fuel or bio-fuel precursor are according to long-pending in present invention cell in terms of some
Tired.In some embodiments, continuously or semi-continuously separate from bioreactor by being such as centrifuged, settle or filter
Have accumulated bio-fuel or the cell of bio-fuel precursor of desired amount.Can such as based on cell physical characteristic (as cell is big
Little or density) change by well known to a person skilled in the art the cell separation that method is carried out further.It is then possible to use
Standard extraction method as well known to those skilled in the art (such as solvent hexane extraction) extracts the biological combustion accumulated from each cell
Material or bio-fuel precursor.In some embodiments, collect microbial cell and the hexane with cell volume collected by 3 times enters
Row extraction.In some embodiments, further refine is extracted bio-fuel or bio-fuel precursor.Some embodiment party
In case, use and well known to a person skilled in the art that method (such as ester exchange method) is by bio-fuel precursor (such as triacylglycerol)
It is converted into bio-fuel (such as biodiesel).
The function of these and other embodiment of the present invention and advantage will become to be more fully understood from from the following example.
Following example are intended to explain the benefit of the present invention, but do not represent the four corner of the present invention.
Embodiment
Material and method
Gene construct: by each gene (such as, GLUT1, hemoglobin, cytochrome, pyruvate carboxylase, SCD etc.)
It is cloned between site Pm1I and Kpn of plasmid YLEX (Figure 12).The restriction site used is Pm1I and KpnI.To all
CDNA carries out checking order and comparison in genome database (mapped).The cloned cDNA's of comparison is exemplary representational
Sequence database entries includes GLUT1: gene I/D: 6513;Hemoglobin: excrement Vitreoscilla (Vitreoscilla
Stercoraria) Vitreosicilla hemoglobin gene, ACCESSION L77863;Cytochrome: gene I/D: 1528, CYB5A cells
Pigment b5A type;Pyruvate carboxylase: gene I/D: 5091;SCD stearyl-coenzyme A desaturase (SCD): gene I/D: 710155.
The representative series (such as coded sequence) that can be used for producing process LAN microorganism is, such as: hemoglobin is (thin
Bacterium)
ATGTTAGACCAACAAACCGTAGACACCAGCAAAGCCACTGTTCCTGTATTGAAAGAGCATGGCGTGACC
ATTACCACGACGTT
TTACCAAAATTTGTTTGCCAAACATCCTGAAGTACGACCTTTGTTTGACATGGGTCGCCAAGCATCTTT
GGAACAGCCTAAGG
CTTTGGCGATGACGGTTGGGGCGGCGGCACAAAACATTGAAAATTTACCTGCAATTTTGCCTGCAGTAC
AAAAAATTGCCGTC
AAACATTGTCAAGCAGGCGTGGCGGCACGACATTATCCGATTGTGGGTCAAGAATTGTTGGGTGCGATT
AAAGAATTATTGGG
TGATGCGGCGACCGATGATATTTTGGATGCGTGGGGCAAGGCTTATGGCGTGATTGCCGATGTTTTTAT
TCAAGTGGAAGCGG
ATTTGTACGCTCAAGACGCTGAATAA (SEQ ID NO:3)
CYB (Ye Shi yeast)
ATGATCATCAACGGCAAGGTCTACGACATCTCCAGCTTCGTTGACGAGCATCCCGGTGGAGAGGAGGTT
CTTCTTGATGCCGG
TGGAACTGAGGCCACCAACGCTTTCGACGACGTTGGACACTCTGAGGACGCTTACGGCATCCTTAACGA
CCTCTATGTCGGTG
AGGTTGACCCCAGCGAGGACGTTATCCGAAAGACTCACACTGTCAAGACTTCTTACGAGGACGGCGAGT
CTGTTGGTGATGAC
CACGGATCTTCTTCCATGATCTTCCTCATTGTTGCTGCTGCTGTTGCCGCCGCTGCTTTCTTCTACCTCCAGGGTCA
GAAATAA (SEQ ID NO:4)
GLUT (rat)
ATGGAGCCCAGCAGCAAGAAGGTGACGGGCCGCCTTATGTTGGCCGTGGGAGGGGCAGTGCTCGGATCC
CTGCAGTTCGGCTA
TAACACCGGTGTCATCAACGCCCCCCAGAAGGTAATTGAGGAGTTCTACAATCAAACATGGAACCACCG
CTATGGAGAGTCCA
TCCCATCCACCACACTCACCACACTCTGGTCTCTCTCCGTGGCCATCTTCTCTGTCGGGGGCATGATTG
GTTCCTTCTCTGTG
GGCCTCTTTGTTAATCGCTTTGGCAGGCGGAACTCCATGCTGATGATGAACCTGTTGGCCTTTGTGTCT
GCCGTGCTTATGGG
TTTCTCCAAACTGGGCAAGTCCTTTGAGATGCTGATCCTGGGCCGCTTCATCATTGGAGTGTACTGTGG
CCTGACCACCGGCT
TTGTGCCCATGTATGTGGGGGAGGTGTCACCCACAGCTCTTCGTGGAGCCCTGGGCACCCTGCACCAGC
TGGGCATCGTCGTT
GGGATCCTTATTGCCCAGGTGTTCGGCTTAGACTCCATCATGGGCAATGCAGACTTGTGGCCTCTACTG
CTCAGTGTCATCTT
CATCCCAGCCCTGCTACAGTGTATCCTGTTGCCCTTCTGCCCTGAGAGCCCCCGCTTCCTGCTCATCAA
TCGTAACGAGGAGA
ACCGGGCCAAGAGTGTGCTGAAAAAGCTTCGAGGGACAGCCGATGTGACCCGAGACCTGCAGGAGATGA
AAGAAGAGGGTCGG
CAGATGATGCGGGAGAAGAAGGTCACCATCTTGGAGCTGTTCCGCTCACCCGCCTACCGCCAGCCCATC
CTCATCGCCGTGGT
GCTGCAGCTGTCCCAGCAGCTGTCGGGCATCAATGCTGTGTTCTACTACTCAACGAGCATCTTCGAGAA
GGCAGGTGTGCAGC
AGCCTGTGTATGCCACCATCGGCTCGGGTATCGTCAACACGGCCTTCACTGTGGTGTCGCTGTTCGTCG
TGGAGCGAGCTGGC
CGTCGGACCCTGCACCTCATTGGTCTGGCTGGCATGGCGGGCTGTGCTGTGCTCATGACCATCGCCCTG
GCCCTGCTGGAGCA
GCTGCCCTGGATGTCCTATCTGAGTATCGTGGCCATCTTTGGCTTTGTGGCCTTCTTTGAAGTAGGCCC
TGGTCCTATTCCAT
GGTTCATTGTGGCCGAGCTGTTCAGCCAGGGGCCCCGACCTGCTGCTGTTGCTGTGGCTGGCTTCTCTA
ACTGGACCTCAAAC
TTCATCGTGGGCATGTGCTTCCAATATGTGGAGCAACTGTGTGGCCCCTACGTCTTCATCATCTTCACG
GTGCTGCTGGTACT
CTTCTTCATCTTCACCTACTTCAAAGTTCCTGAGACCAAAGGCCGGACCTTCGATGAGATCGCTTCCGG
CTTCCGGCAGGGGG
GTGCCAGCCAGAGCGACAAGACACCTGAGGAGCTCTTCCACCCTCTGGGGGCTGACTCCCAAGTGTGA
(SEQ ID NO:5)
Malate dehydrogenase (Ye Shi yeast)
ATGTTACGACTACGAACCATGCGACCCACACAGACCAGCGTCAGGGCGGCGCTTGGGCCCACCGCCGCG
GCCCGAAACATGTC
CTCCTCCAGCCCCTCCAGCTTCGAATACTCGTCCTACGTCAAGGGCACGCGGGAAATCGGCCACCGAAA
GGCGCCCACAACCC
GTCTGTCGGTTGAGGGCCCCATCTACGTGGGCTTCGACGGCATTCGTCTTCTCAACCTGCCGCATCTCA
ACAAGGGCTCGGGA
TTCCCCCTCAACGAGCGACGGGAATTCAGACTCAGTGGTCTTCTGCCCTCTGCCGAAGCCACCCTGGAG
GAACAGGTCGACCG
AGCATACCAACAATTCAAAAAGTGTGGCACTCCCTTAGCCAAAAACGGGTTCTGCACCTCGCTCAAGTT
CCAAAACGAGGTGC
TCTACTACGCCCTGCTGCTCAAGCACGTTAAGGAGGTCTTCCCCATCATCTATACACCGACTCAGGGAG
AAGCCATTGAACAG
TACTCGCGGCTGTTCCGGCGGCCCGAAGGCTGCTTCCTCGACATCACCAGTCCCTACGACGTGGAGGAG
CGTCTGGGAGCGTT
TGGAGACCATGACGACATTGACTACATTGTCGTGACTGACTCCGAGGGTATTCTCGGAATTGGAGACCA
AGGAGTGGGCGGTA
TTGGTATTTCCATCGCCAAGCTGGCTCTCATGACTCTATGTGCTGGAGTCAACCCCTCACGAGTCATTC
CTGTGGTTCTGGAT
ACGGGAACCAACAACCAGGAGCTGCTGCACGACCCCCTGTATCTCGGCCGACGAATGCCCCGAGTGCGA
GGAAAGCAGTACGA
CGACTTCATCGACAACTTTGTGCAGTCTGCCCGAAGGCTGTATCCCAAGGCGGTGATCCATTTCGAGGA
CTTTGGGCTCGCTA
ACGCACACAAGATCCTCGACAAGTATCGACCGGAGATCCCCTGCTTCAACGACGACATCCAGGGCACTG
GAGCCGTCACTTTG
GCCTCCATCACGGCCGCTCTCAAGGTGCTGGGCAAAAATATCACAGATACTCGAATTCTCGTGTACGGA
GCTGGTTCGGCCGG
CATGGGTATTGCTGAACAGGTCTATGATAACCTGGTTGCCCAGGGTCTCGACGACAAGACTGCGCGACA
AAACATCTTTCTCA
TGGACCGACCGGGTCTACTGACCACCGCACTTACCGACGAGCAGATGAGCGACGTGCAGAAGCCGTTTG
CCAAGGACAAGGCC
AATTACGAGGGAGTGGACACCAAGACTCTGGAGCACGTGGTTGCTGCCGTCAAGCCCCATATTCTCATT
GGATGTTCCACTCA
GCCCGGCGCCTTTAACGAGAAGGTCGTCAAGGAGATGCTCAAACACACCCCTCGACCCATCATTCTCCC
TCTTTCCAACCCCA
CACGTCTTCATGAGGCTGTCCCTGCAGATCTGTACAAGTGGACCGACGGCAAGGCTCTGGTTGCCACCG
GCTCGCCCTTTGAC
CCAGTCAACGGCAAGGAGACGTCTGAGAACAATAACTGCTTTGTTTTCCCCGGAATCGGGCTGGGAGCC
ATTCTGTCTCGATC
AAAGCTCATCACCAACACCATGATTGCTGCTGCCATCGAGTGCCTCGCCGAACAGGCCCCCATTCTCAA
GAACCACGACGAGG
GAGTACTTCCCGACGTAGCTCTCATCCAGATCATTTCGGCCCGGGTGGCCACTGCCGTGGTTCTTCAGG
CCAAGGCTGAGGGC
CTAGCCACTGTCGAGGAAGAGCTCAAGCCCGGCACCAAGGAACATGTGCAGATTCCCGACAACTTTGAC
GAGTGTCTCGCCTG
GGTCGAGACTCAGATGTGGCGGCCCGTCTACCGGCCTCTCATCCATGTGCGGGATTACGACTAG (SEQ
ID NO:6)
Ye Shi yeast Δ (9) desaturase (stearyl-coenzyme A desaturase)
ATGGTGAAAAACGTGGACCAAGTGGATCTCTCGCAGGTCGACACCATTGCCTCCGGCCGAGATGTCAAC
TACAAGGTCAAGTA
CACCTCCGGCGTTAAGATGAGCCAGGGCGCCTACGACGACAAGGGCCGCCACATTTCCGAGCAGCCCTT
CACCTGGGCCAACT
GGCACCAGCACATCAACTGGCTCAACTTCATTCTGGTGATTGCGCTGCCTCTGTCGTCCTTTGCTGCCG
CTCCCTTCGTCTCC
TTCAACTGGAAGACCGCCGCGTTTGCTGTCGGCTATTACATGTGCACCGGTCTCGGTATCACCGCCGGC
TACCACCGAATGTG
GGCCCATCGAGCCTACAAGGCCGCTCTGCCCGTTCGAATCATCCTTGCTCTGTTTGGAGGAGGAGCTGT
CGAGGGCTCCATCC
GATGGTGGGCCTCGTCTCACCGAGTCCACCACCGATGGACCGACTCCAACAAGGACCCTTACGACGCCC
GAAAGGGATTCTGG
TTCTCCCACTTTGGCTGGATGCTGCTTGTGCCCAACCCCAAGAACAAGGGCCGAACTGACATTTCTGAC
CTCAACAACGACTG
GGTTGTCCGACTCCAGCACAAGTACTACGTTTACGTTCTCGTCTTCATGGCCATTGTTCTGCCCACCCT
CGTCTGTGGCTTTG
GCTGGGGCGACTGGAAGGGAGGTCTTGTCTACGCCGGTATCATGCGATACACCTTTGTGCAGCAGGTGA
CTTTCTGTGTCAAC
TCCCTTGCCCACTGGATTGGAGAGCAGCCCTTCGACGACCGACGAACTCCCCGAGACCACGCTCTTACC
GCCCTGGTCACCTT
TGGAGAGGGCTACCACAACTTCCACCACGAGTTCCCCTCGGACTACCGAAACGCCCTCATCTGGTACCA
GTACGACCCCACCA
AGTGGCTCATCTGGACCCTCAAGCAGGTTGGTCTCGCCTGGGACCTCCAGACCTTCTCCCAGAACGCCA
TCGAGCAGGGTCTC
GTGCAGCAGCGACAGAAGAAGCTGGACAAGTGGCGAAACAACCTCAACTGGGGTATCCCCATTGAGCAG
CTGCCTGTCATTGA
GTTTGAGGAGTTCCAAGAGCAGGCCAAGACCCGAGATCTGGTTCTCATTTCTGGCATTGTCCACGACGT
GTCTGCCTTTGTCG
AGCACCACCCTGGTGGAAAGGCCCTCATTATGAGCGCCGTCGGCAAGGACGGTACCGCTGTCTTCAACG
GAGGTGTCTACCGA
CACTCCAACGCTGGCCACAACCTGCTTGCCACCATGCGAGTTTCGGTCATTCGAGGCGGCATGGAGGTT
GAGGTGTGGAAGAC
TGCCCAGAACGAAAAGAAGGACCAGAACATTGTCTCCGATGAGAGTGGAAACCGAATCCACCGAGCTGG
TCTCCAGGCCACCC
GGGTCGAGAACCCCGGTATGTCTGGCATGGCTGCTTAG (SEQ ID NO:7)
Pyruvate carboxylase (people)
ATGCTGAAGTTCCGAACAGTCCATGGGGGCCTGAGGCTCCTGGGAATCCGCCGAACCTCCACCGCCCCC
GCTGCCTCCCCAAA
TGTCCGGCGCCTGGAGTATAAGCCCATCAAGAAAGTCATGGTGGCCAACAGAGGTGAGATTGCCATCCG
TGTGTTCCGGGCCT
GCACGGAGCTGGGCATCCGCACCGTAGCCATCTACTCTGAGCAGGACACGGGCCAGATGCACCGGCAGA
AAGCAGATGAAGCC
TATCTCATCGGCCGCGGCCTGGCCCCCGTGCAGGCCTACCTGCACATCCCAGACATCATCAAGGTGGCC
AAGGAGAACAACGT
AGATGCAGTGCACCCTGGCTACGGGTTCCTCTCTGAGCGAGCGGACTTCGCCCAGGCCTGCCAGGATGC
AGGGGTCCGGTTTA
TTGGGCCAAGCCCAGAAGTGGTCCGCAAGATGGGAGACAAGGTGGAGGCCCGGGCCATCGCCATTGCTG
CGGGTGTTCCCGTT
GTCCCTGGCACAGATGCCCCCATCACGTCCCTGCATGAGGCCCACGAGTTCTCCAACACCTACGGCTTC
CCCATCATCTTCAA
GGCGGCCTATGGGGGTGGAGGGCGTGGCATGAGGGTGGTGCACAGCTACGAGGAGCTGGAGGAGAATTA
CACCCGGGCCTACT
CAGAGGCTCTGGCCGCCTTTGGGAATGGGGCGCTGTTTGTGGAGAAGTTCATCGAGAAGCCACGGCACA
TCGAGGTGCAGATC
TTGGGGGACCAGTATGGGAACATCCTGCACCTGTACGAGCGAGACTGCTCCATCCAGCGGCGGCACCAG
AAGGTGGTCGAGAT
TGCCCCCGCCGCCCACCTGGACCCGCAGCTTCGGACTCGGCTCACCAGCGACTCTGTGAAACTCGCTAA
ACAGGTGGGCTACG
AGAACGCAGGCACCGTGGAGTTCCTGGTGGACAGGCACGGCAAGCACTACTTCATCGAGGTCAACTCCC
GCCTGCAGGTGGAG
CACACGGTCACAGAGGAGATCACCGACGTAGACCTGGTCCATGCTCAGATCCACGTGGCTGAGGGCAGG
AGCCTACCCGACCT
GGGCCTGCGGCAGGAGAACATCCGCATCAACGGGTGTGCCATCCAGTGCCGGGTCACCACCGAGGACCC
CGCGCGCAGCTTCC
AGCCGGACACCGGCCGCATTGAGGTGTTCCGGAGCGGAGAGGGCATGGGCATCCGCCTGGATAATGCTT
CCGCCTTCCAAGGA
GCCGTCATCTCGCCCCACTACGACTCCCTGCTGGTCAAAGTCATTGCCCACGGCAAAGACCACCCCACG
GCCGCCACCAAGAT
GAGCAGGGCCCTTGCGGAGTTCCGCGTCCGAGGTGTGAAGACCAACATCGCCTTCCTGCAGAATGTGCT
CAACAACCAGCAGT
TCCTGGCAGGCACTGTGGACACCCAGTTCATCGACGAGAACCCAGAGCTGTTCCAGCTGCGGCCTGCAC
AGAACCGGGCCCAA
AAGCTGTTGCACTACCTCGGCCATGTCATGGTAAACGGTCCAACCACCCCGATTCCCGTCAAGGCCAGC
CCCAGCCCCACGGA
CCCCGTTGTCCCTGCAGTGCCCATAGGCCCGCCCCCGGCTGGTTTCAGAGACATCCTGCTGCGAGAGGG
GCCTGAGGGCTTTG
CTCGAGCTGTGCGGAACCACCCGGGGCTGCTGCTGATGGACACGACCTTCAGGGACGCCCACCAGTCAC
TGCTGGCCACTCGT
GTGCGCACCCACGATCTCAAAAAGATCGCCCCCTATGTTGCCCACAACTTCAGCAAGCTCTTCAGCATG
GAGAACTGGGGAGG
AGCCACGTTTGACGTCGCCATGCGCTTCCTGTATGAGTGCCCCTGGCGGCGGCTGCAGGAGCTCCGGGA
GCTCATCCCCAACA
TCCCTTTCCAGATGCTGCTGCGGGGGGCCAATGCTGTGGGCTACACCAACTACCCAGACAACGTGGTCT
TCAAGTTCTGTGAA
GTGGCCAAAGAGAATGGCATGGATGTCTTCCGTGTGTTTGACTCCCTCAACTACTTGCCCAACATGCTG
CTGGGCATGGAGGC
GGCAGGAAGTGCCGGAGGCGTGGTGGAGGCTGCCATCTCATACACGGGCGACGTGGCCGACCCCAGCCG
CACCAAGTACTCAC
TGCAGTACTACATGGGCTTGGCCGAAGAGCTGGTGCGAGCTGGCACCCACATCCTGTGCATCAAGGACA
TGGCCGGGCTGCTG
AAGCCCACGGCCTGCACCATGCTGGTCAGCTCCCTCCGGGACCGCTTCCCCGACCTCCCACTGCACATC
CACACCCACGACAC
GTCAGGGGCAGGCGTGGCAGCCATGCTGGCCTGTGCCCAGGCTGGAGCTGATGTGGTGGATGTGGCAGC
TGATTCCATGTCTG
GGATGACTTCACAGCCCAGCATGGGGGCCCTGGTGGCCTGTACCAGAGGGACTCCCCTGGACACAGAGG
TGCCCATGGAGCGC
GTGTTTGACTACAGTGAGTACTGGGAGGGGGCTCGGGGACTGTACGCGGCCTTCGACTGCACGGCCACC
ATGAAGTCTGGCAA
CTCGGACGTGTATGAAAATGAGATCCCAGGGGGCCAGTACACCAACCTGCACTTCCAGGCCCACAGCAT
GGGGCTTGGCTCCA
AGTTCAAGGAGGTCAAGAAGGCCTATGTGGAGGCCAACCAGATGCTGGGCGATCTCATCAAGGTGACGC
CCTCCTCCAAGATC
GTGGGGGACCTGGCCCAGTTTATGGTGCAGAATGGATTGAGCCGGGCAGAGGCCGAAGCTCAGGCGGAA
GAGCTGTCCTTTCC
CCGCTCCGTGGTGGAGTTCCTGCAGGGCTACATCGGTGTCCCCCATGGGGGGTTCCCCGAACCCTTTCG
CTCTAAGGTACTGA
AGGACCTGCCAAGGGTGGAGGGGCGGCCTGGAGCCTCCCTCCCTCCCCTGGATCTGCAGGCACTGGAGA
AGGAGCTGGTAGAC
CGGCATGGGGAGGAGGTGACGCCGGAAGATGTGCTCTCAGCAGCTATGTACCCCGATGTGTTTGCCCAC
TTCAAGGACTTCAC
TGCCACCTTTGGCCCCCTGGATAGCCTGAATACTCGCCTCTTCCTGCAGGGACCCAAGATCGCAGAGGA
GTTTGAGGTGGAGC
TGGAGCGGGGCAAGACGCTGCACATCAAAGCCCTGGCCGTGAGCGACCTGAACCGGGCCGGCCAGAGGC
AGGTCTTCTTTGAG
CTCAATGGGCAGCTGCGGTCCATCTTGGTCAAGGACACCCAGGCCATGAAGGAGATGCACTTCCACCCC
AAGGCCCTAAAGGA
CGTGAAGGGCCAGATCGGGGCGCCCATGCCTGGGAAGGTGATAGACATCAAAGTGGTGGCAGGGGCCAA
GGTGGCCAAGGGCC
AGCCCCTGTGTGTGCTCAGTGCCATGAAGATGGAGACTGTGGTGACCTCACCCATGGAGGGTACTGTCC
GCAAGGTTCATGTG
ACCAAGGACATGACACTGGAAGGTGACGACCTCATCCTGGAGATCGAGTGA (SEQ ID NO:8)
ACC (saccharomyces cerevisiae)
TTATTTCAAAGTCTTCAACAATTTTTCTTTATCATCGGTAGATAACATCTTGATAACTTCAGATAATCC
ATCAATAGCATTGT
CATGGTCGCTTCTGATCTTTTTAGCTAAGTCTTGAGCGAATGACTCTAATTTCAAACCCTTTAGTTTAT
CGTCCAAAGTTTTG
TAGTTTTCTTCAATCCATGTTGCGACTTGCCTATCATCTTCATGGTCCACTGAAGCAGGGTACCACGAT
CTAATTCTTGCGAT
CTTTTCTAATCTTGATGCTTCGCCTACCTGATGGCTCAACCTTTTAATCAAATATTCTTCGTTCAATCT
TCTTCTCAATCTCC
AGAAGAAGAAACGACGTGCCTCGGTCCATTCCAGTTCCTTAGAAATAACACCCTTGGCCACCATACGTG
AAGACCTATCGTGC
AAATCAGCAAATTGAAGACTGATTTGTCCGTAAATTGGCAATAGTTCTCTCTCACGATCAGCTAATTGC
TTGGATATTTGCTG
ATGTACTTCTGGAGCCAAACTCTTGTTGGATAATTGAGATCTCAATTCTCTGTACTTGTCATCCAATCT
GTTCATGGTGTCCA
GCAATTTTTCTCTACGGAACTTGATACCAACCATACCTTGTGGTTCCAAAACACCAGCTCTAGCGTTGA
CGTCGGCATACATT
TCCATTTGGTCAGCGTTGATAGTTGGATCGACAACAACCCATGAACCACCTCTTAGTTCACCGGTAGGT
GGGATATAGATAAT
AATTGGTTGTTTGTAATCCACCAATGCGTCAACAATAAACGAACCATACTTCAAGACTTCGTTGAACAT
ATCACGTTGACCAC
CAGAGAAACCTCTCCAGTTGGCCAAAATCATCATTGGCAATTGTTCACCGTTGTTAAAGTCATTGATAG
CTTGAGCAGTCTTG
AAGGCGGAGTTTGGATGCCAAACTTGACCAGGTTCTTGAATTAATGTTTCAGCACTATTTGGATTAGCT
GGATCAGCAGGAAT
CAAGTTCTCGACAGTTCTTGTTTCAACACCAATAACACCCAGTGGAATACCACCAAGACGGGCTCTACC
AACGACAACACCTT
TGGCCCATCCTGACAAAGTTTCAAAGAAAGACCCTTTATCAAACAAACCATATTCAAATCCACTTTCAG
TCTCACGACCTTCA
ATCATCCATCTTACATCGTAAGTTTCATCATTAGTTGGAGTGAAATCAACTGGTCTATCCCATGTGTCT
TTAGTTTCCAAGAT
AGGAACTGGCATATTACGCTTGGCTGGAACATAAGACATCCATTCAACAATCTTCTCTACACCAGCTAA
ATCGTCAACAGCAG
TCAAATGTGAAACACCGTTGTTATACATGATTTGAGTACCACCCAATTGTAAGTTAGAAGTATAAACTT
CTCTACCCAGCATT
TTGTTGATTGCAGGAGCACCAGTTAAAATAATTGGCTGGCCTTCGACCTGAATAGCTCTTTGACCCAAA
CGAACCAAATAAGC
ACCGATACCGACGGATCTACAAGTGACTAAGGTGATAGTGAAGATATCGTGGTAAGCCCTTGACGTTGC
ACCAGCAATTAAAC
CAGATCCACGTAGACATTCGACACCTAACCCATCTTCAGAACCAATAATTGTCTTGATGACAAATCTTT
CTTCACCGTTTATA
ACAGTACGTTCAGTGAGAACAGAATTTTCTTTGTCAAATTTCTTTAAAGTTTCCATACCTTCACTTGTT
AAGTATAAGTATTG
GAAGCCCTTGTCCGGATTGGCAGCATCATTCCATGCAACTTGAAATAGTGGAACAATCTCTTCAGCCAT
ACCAATTCTGGCAC
CTGAGTTTGCAGCCAAGTAAATTCTTGGGATACCACGCTTTCTAGCATATTCAGTAACCTTATTGAAGA
ATTCGTCTTCTTGT
GGACCAAAGGAACCGATCTTGAATGTGATATCGTTAGCAACAACAACAAATTGACGGCCTCTTGGATAT
TCAGGAGTCTTTAC
AGTAATCTTAAAGGCAACCATACCAATAGCGTTGGCACCAGGTTCTCTTTCCACCTCAGTTAATTCGCC
GTTTTCATCTTCAA
TCAACTCGTTGGAAATAAAGAAATCATCTGTTAACTTAACATCTGCAGAGAAATTTTTCCATTGGGATG
ACGATGCTTGGCGG
AATAATTCTGGGAAGTCATAGACATATGTGGTACCCATCAAGTGTGCCTTATAACGTTTTGGTTGCAAC
CATTCCTTAACAGG
GTAAGGAGTAGCAATAGGTCTTAAATGCATGGATCCAGGTTTACCCAAAGACTTAAATACCCATTCACC
TTTTGCGTTCTTGA
CTTCGGTGTACATTTCTGTTTTGATAACATAACCAGAAACGTTATTGATCAAGGCACGCAATGGTACTG
GGGCACCTGTTTGA
GGATCTTTGATGATGATTCTAATTTCGGCAGAAGAAACACGCAATCTCAACAATCTCTTACCAAATCTT
TCTAAGAAACCACC
GAAGGCGGCTTCGACATCTTCTGGAGAGATATCAAACACCGCAATGAAGTTGATGAAGATATGATTCAA
ATCAGAATTTGAAG
TGTCGGTGACTTCTAAATTATCCAATATATCACTCATCAATCTGTTAGCTTCAGAAGTCAGATATTCTT
GAATAGAAATGTCA
TCACGGATATGACCCGTTCTAATAATACCTCTTGTAAAGAATCTCTTATCCAATGGAGAAGTCTTACTA
ACAGCTTCGTAGAC
ATGGATGTTTCTATTATCAGTGAAAATTGGTTTAATGTTGAAGTTGGACAATCTTCCTAATTCCAGTTG
GAAGGCCAAAGCCG
GCTCAATGTGACGAATTGTTTCATTTTCGTTATAATTTGGACCGTTAAAAGTATAATACTTTGGATAAG
ACCCATCTTTAAAA
CCGAACATAAATGTGATACGACGGATAGAAGCATTGATTAATTCCTGCTTATTCAAATCCAAAATTTCT
CTCAACCTTACCAA
AATTTCCTCTTCAGATTCGAAACCTTCTGTAGAAGCAACACAAACATTAGCAACATTACTCAACGATGC
GGAGCTACCAGAAC
GATCAGGAGCAGGTCCGTTAGAAGAAGATTGGTGACGAGGAATAACTTCCAAACTTTGTGACAAAATTT
CATCAACATCATCT
AAATGATCCACAGCCATCAAAATACCTTCTCTTAACGGAGATGACTGACTGTTTGCAACATATGACAAA
TCTGAAACAGAAAC
AGCCCTGTTCATACCCATTTTAGATTTAACAGTTGGAAAGGTGGAGAACGCAGCTGAAGGTAGTTGGAA
TTTCCATTCAACAA
TTGGAACTGTGACACCTTCGTGAACTCTAATATCTCCTATGGTGTAAGCACGATAAGCACGACGAATAT
AGACTTGAGCAGCT
GCAGCAGTCACAACTGGGTCTTGATGGGTTAGGAATTGAAGTAAAACATCGAACACAACGTAATTAGAA
TCGATCAAGTCCTT
CAAGATATTCAAATCTGGTTCAGAGCGCTTTGGATTGGATGAGCCATAGGCAACCTTCACAACAGAGGA
TTTTAAGATATGTT
CAATTTGTTCAGTTCTTTCCTTGACCGAAGGTAAAGCGCCTTGAATCAAAATTTCTCTTGCTTGTAGAG
CGACCTTAGCGGTA
GCCTTAGATTCTAGTTCAACAATATGTTGTAGAGGAGTAGAGAAAATGGCAGAAACTTTAGAAGATAAC
TTGCACAATGGTTG
ATAATGTTTCAAGATAGCTAGGATCAGGTTATTCTTCGCTGAAACTTTCGAATGAGACAAAACAGTTAG
CGCAACTTTATCTA
GATCTTTAGGGTTTTCATCACGCAATTTCAGAATGATATTTTCCTCACGAACATTTGGACCATTGAATA
ACTTTTCAACTTCG
TAATATTCTTCCAAGAAATGGACAAATATAGAATGTTCATGGGCTTCTAACCCGTTAGAGTACTTATGA
GCAATATCCGCCAA
TGGTTCCACGACGGCGCCCAGCAATTTGTCGGGGTTGTATTCAGGATTCTTCACGGCCATATCAATCAA
TTTACTTAATTGTC
TAGCTGGGAAAACAGCACCACGTCTCAAAGAACGTGCAACTAACTCTTCCATTTGTTCATCTAGCTTAG
CAGGCAATCTTGAA
TGTAAAGCAGAGATGTGTAGTTTCCATTCTGAGTAAGGCAGTTTTGGATTTCTCAAAACCTCTATCAAT
TGTTGCAAGGAAGC
GTTCATAATAACTTGGTTGTCATAACCCTTCAAAATGTTTTCCAAAGTAGACACTAATGACTTGAATTT
ATAGGCAGGTTTGG
TTCCTTCGATAACTGGAGAACCAAAATCTGGCAGCATACCTTCAAATGGTAGAGCGTGCTTGACCTTGG
ATGGATCGTCAAGA
GTCATAATAGCCATGATATCACCTGCAACAATGGTAGAACCAGGTTGCTTTAATAACTGGACGATACCA
TTTTCTTGAGAAAC
CAAAGGCATTTGCATTTTCATAACTTCAATTTCTGCATATGGTTGGCCCTTGATAATGTGTTCACCATT
TTCCACCAAGAATT
TAACCAATTTACCAGGGGATGGAGTACGCAACTGGGTTGGATCGTTTTCAACTTCCAACAAAGTAGTCA
TAGAGTCAACGGAT
AATCTTGTAGCAGCAACTTCTTCTTTCCAATAGATGGTATGCGATTTACCGCCTATGGCAATCAAAAGA
CCACCATCAGATAG
TTGACGCAGTATGATATCACATTTAGAACCATTGATAAATAATGTGTAACGGTCATTACCGGATTTAGC
TACGGTGAACTTGT
ATCTTTTACCCTCATGGATAAAATCTACAGGGAACATAGTTTGCAGTAGGTCTTTAGATAGAACTTGTC
CCTTTTGTAAGGAT
TCGATATACTTGTGGCGGGCTTCTTCAGATGCTAAGAAAGCCTTTGTAGCGGCACCGCAAATGACGGCA
AGAGTTGGATCAGG
CTTTTCAGCGGTCATTTTATGAGTAATCAAATCGTCCAACCAACCGGTGGTAATAGTGTTATCCTCGAA
ATCTTCAGTTTCCA
AAAGTTTGATCAAGTATTCCACAGTAGTTCTGAAATCACCCCTAATGGACAATTCCTTCAGGGCAACAA
CCATGTGTTTCCTG
GAAGCTTGTCTATTTTCACCAAAAGCAAAAATATGGCCGAACTGAGAGTCCGAAAAGGAGTGAATATTA
CCATTGTTACCCAC
GGAGAAGTAACCCCAAACATTAGAGGAAGAACGGAAGTTTAGTTCATGCAAAGTACCACCCGATGGCTT
GAATCCATCGTTTG
GATCTTCTGATGTGATACGACAAGCGGTACAATGACCCTTTGGAATAGGTCTTCTTTGTTTCTTGGTGG
CATCTTGAGTTTTG
AATTCGAAATCGATTTCTGAGGCAGAATGAGGATTCATACCATATAAAGTTCTAATGTCACTTATTCTA
TGCATAGGGATACC
CATAGCGATTTGTAATTGAGCTGCAGGTAAGTTAACACCGGAGACCATTTCCGTTGTTGGATGCTCGAC
TTGTAATCTTGGGT
TCAATTCTAAAAAGTAGAATTTTCCATCATCATGAGAATATAGATACTCCACGGTACCGGCAGAGACAT
AACCGACTAGTTTC
CCCAGTCTGACGGCAGCCTTTTCCATCTCGTGAAATGTTTCAGCCTTGGCAATTGTAACTGGTGCTTCT
TCGATAATTTTTTG
ATGACGTCTCTGAACGGAACAGTCTCTACCGAACAAGGAAATATTTGTACCGTACTGATCTGCTAGCAG
TTGAACTTCCAAGT
GACGCGCTCTACCGGCCAACTTCATGATGAAAATGGGGGAGCCTGGAATTTCGTTGGCTGCCTGGTGGT
ATAAAGCGATGAAA
TCTTCTTCACGTTCAACTTGTCTGATACCTTTACCACCACCACCTTCGGATGCCTTAATCATGACAGGA
AAACCAATACGCTT
GGCCTTTTGTAAACCATCTTCAGGAGAGGTACAACAACCCTTTTGATAGATGTCATCGTCGACAGAGAC
CAGACCGGTTTTCT
CGTCCACGTGAACGGTGTCAACACCGGTACCAGACCATGGAATACATGGGACTTTAGCACTTTGAGCGA
CAATGGTAGAGGAG
ATTTTATCACCTAAAGACCTCATGGCGTTACCTGGAGGCCCAATAAAGATGACTTTCCTCTTAGACTGG
GACAATTTTTCAGG
CAATAGTGGATTCTCGGAGGCGTGACCCCAGCCAGCCCATACGGCGTCTACGTCTGCTCTTTCGGCGAT
GTCTACGATCAAGT
CTACGTTAGCGTAGTTGTTATTATTAGTACCACCTGGCACTTCAATGTATTGATCGGCCATACGGATAT
ATTCTGCGTTGGCC
TCCAGATCTTCTGGGGTGGCCATGGCGACGAATTGGACGGTTCTGTCATCGCCGAACGTCTCGTATGCC
CATTTTCTGACGGA
TCTAATTTCTTTCACGGCGGCAATACCATTATTTGCTATCAGGATCTTGGATATGACCGTGTGACCACC
GTGACTCTTAACAA
AGTCCCTTAACGGGGACTCCTCTAGTTTATCTACTGTATTGAGGCCAATGAAATGACCTGGAAGTTCTG
TATGTCTTTCTGAG
TAGTTTGTAATTTCGTACTCCATCTTCTGTGGAGAAGACTCGAATAAGCTTTCTTCGCTCAT (SEQ
ID NO:9)
FAA (saccharomyces cerevisiae)
ATGGTTGCTCAATATACCGTTCCAGTTGGGAAAGCCGCCAATGAGCATGAAACTGCTCCAAGAAGAAAT
TATCAATGCCGCGA
GAAGCCGCTCGTCAGACCGCCTAACACAAAGTGTTCCACTGTTTATGAGTTTGTTCTAGAGTGCTTTCA
GAAGAACAAAAATT
CAAATGCTATGGGTTGGAGGGATGTTAAGGAAATTCATGAAGAATCCAAATCGGTTATGAAAAAAGTTG
ATGGCAAGGAGACT
TCAGTGGAAAAGAAATGGATGTATTATGAACTATCGCATTATCATTATAATTCATTTGACCAATTGACC
GATATCATGCATGA
AATTGGTCGTGGGTTGGTGAAAATAGGATTAAAGCCTAATGATGATGACAAATTACATCTTTACGCAGC
CACTTCTCACAAGT
GGATGAAGATGTTCTTAGGAGCGCAGTCTCAAGGTATTCCTGTCGTCACTGCCTACGATACTTTGGGAG
AGAAAGGGCTAATT
CATTCTTTGGTGCAAACGGGGTCTAAGGCCATTTTTACCGATAACTCTTTATTACCATCCTTGATCAAA
CCAGTGCAAGCCGC
TCAAGACGTAAAATACATAATTCATTTCGATTCCATCAGTTCTGAGGACAGGAGGCAAAGTGGTAAGAT
CTATCAATCTGCTC
ATGATGCCATCAACAGAATTAAAGAAGTTAGACCTGATATCAAGACCTTTAGCTTTGACGACATCTTGA
AGCTAGGTAAAGAA
TCCTGTAACGAAATCGATGTTCATCCACCTGGCAAGGATGATCTTTGTTGCATCATGTATACGTCTGGT
TCTACAGGTGAGCC
AAAGGGTGTTGTCTTGAAACATTCAAATGTTGTCGCAGGTGTTGGTGGTGCAAGTTTGAATGTTTTGAA
GTTTGTGGGCAATA
CCGACCGTGTTATCTGTTTTTTGCCACTAGCTCATATTTTTGAATTGGTTTTCGAACTATTGTCCTTTT
ATTGGGGGGCCTGC
ATTGGTTATGCCACCGTAAAAACTTTAACTAGCAGCTCTGTGAGAAATTGTCAAGGTGATTTGCAAGAA
TTCAAGCCCACAAT
CATGGTTGGTGTCGCCGCTGTTTGGGAAACAGTGAGAAAAGGGATCTTAAACCAAATTGATAATTTGCC
CTTCCTCACCAAGA
AAATCTTCTGGACCGCGTATAATACCAAGTTGAACATGCAACGTCTCCACATCCCTGGTGGCGGCGCCT
TAGGAAACTTGGTT
TTCAAAAAAATCAGAACTGCCACAGGTGGCCAATTAAGATATTTGTTAAACGGTGGTTCTCCAATCAGT
CGGGATGCTCAGGA
ATTCATCACAAATTTAATCTGCCCTATGCTTATTGGTTACGGTTTAACCGAGACATGCGCTAGTACCAC
CATCTTGGATCCTG
CTAATTTTGAACTCGGCGTCGCTGGTGACCTAACAGGTTGTGTTACCGTCAAACTAGTTGATGTTGAAG
AATTAGGTTATTTT
GCTAAAAACAACCAAGGTGAAGTTTGGATCACAGGTGCCAATGTCACGCCTGAATATTATAAGAATGAG
GAAGAAACTTCTCA
AGCTTTAACAAGCGATGGTTGGTTCAAGACCGGTGACATCGGTGAATGGGAAGCAAATGGCCATTTGAA
AATAATTGACAGGA
AGAAAAACTTGGTCAAAACAATGAACGGTGAATATATCGCACTCGAGAAATTAGAGTCCGTTTACAGAT
CTAACGAATATGTT
GCTAACATTTGTGTTTATGCCGACCAATCTAAGACTAAGCCAGTTGGTATTATTGTACCAAATCATGCT
CCATTAACGAAGCT
TGCTAAAAAGTTGGGAATTATGGAACAAAAAGACAGTTCAATTAATATCGAAAATTATTTGGAGGATGC
AAAATTGATTAAAG
CTGTTTATTCTGATCTTTTGAAGACAGGTAAAGACCAAGGTTTGGTTGGCATTGAATTACTAGCAGGCA
TAGTGTTCTTTGAC
GGCGAATGGACTCCACAAAACGGTTTTGTTACGTCCGCTCAGAAATTGAAAAGAAAAGACATTTTGAAT
GCTGTCAAAGATAA
AGTTGACGCCGTTTATAGTTCGTCTTAA (SEQID NO:10)
Acyl-CoA synthetase
ATGACTGTTACCCCACAGCACCAAGTCGTCCACGAGGCCAACGGTGTCACCCCAAGACCCACTCCTAAG
GAGTTTTTTGACAA
ACAGCCCCGTCCTGGCCATATCACCTCCATCGAACAGTACCAGGAATTATACCAGAAGTCCATCGCCGA
CCCTGAAGGATTCT
TTGGTCCTATGGCCAAGGAGTTGTTGTCGTGGGACAGAGACTTCGACAAGGTCAAGTCCGGTTCTTTGA
AGGACGGTGACGTT
GCCTGGTTCATTGGCGGCCAGTTGAACGCTTCCTACAACTGTGTAGACAGATGGGCCTATGCGACTCCA
GACAAGACTGCCAT
CATCTACGAAGCTGACGAAGAAAAGGACTCGTACAAGTTGACCTACGCCGAGTTGTTGAGAGAAGTCTC
CAAGGTAGCTGGTG
TGTTGAAGAGCTGGGGCATCAAAAAGGGTGATACTGTTGCTATCTACTTGCCAATGACTCCTCAAGCTG
TTATTGCTATGCTC
GCTGTAGCCAGATTAGGTGCCATCCACTCGGTTATCTTTGCAGGTTTCTCTTCTGGTTCCATCAGAGAC
AGAGTCAACGATGC
TTCTTGTAAGGCTCTTATTACCTGTGACGAAGGTAGAAGAGGTGGTAAGACCGTTAACATCAAGAAATT
GTGCGACGAAGCCT
TGAAGAGCTGTCCTACTGTAGAAAAGGTGCTTGTTTTCAAGAGAACCGGAAACGAAAATATTGAATTGG
AAGAGGGTAGAGAT
TTCTGGTGGGATGAAGAAACCGCCAAGTTCTCGGGTTACTTGCCACCTGTTCCAGTCAATTCTGAAGAC
CCATTGTTCTTGTT
GTATACATCTGGTTCCACTGGTACTCCTAAGGGTGTTGTCCACACCACTGGGGGCTACCTCTTAGGTGC
TGCCATGACCACCA
AGTACATTTTCGACGTCCACCCAGAAGACATCTTGTTCACTGCCGGTGATGTCGGTTGGATTACTGGTC
ACACCTATGCTTTG
TACGGACCTTTGGCTCTCGGTATCCCAACAATCGTTTTTGAAGGTACTCCAGCCTACCCAGACTTTGGT
AGATTCTGGCAAAT
TGTCGAAAAGCACAAGGCTACCCACTTCTACGTAGCTCCTACTGCCCTCAGATTGTTGAGAAAGAGTGG
CGAGCAAGAGATTC
CAAAGTACGACTTGTCTTCTTTGAGAACATTGGGCTCTGTTGGTGAACCTATCTCCCCTGATATCTGGG
AATGGTACAACGAG
CACGTTGGACAAGGCAGATGCCACATCTCCGACACCTACTGGCAAACTGAGTCTGGTTCTCACTTCATT
GCTCCAATTGCCGG
TGTCACTCCAAACAAACCTGGTTCAGCCTCTTTGCCATTCTTTGGTATCGAGACCGCTCTTATTGATCC
AGTTTCCGGCCACG
AACTCGAAGGTAACGACATCGAAGGTGTTCTTGCCATCAAGAGCACCTGGCCATCTATGGCTAGATCTG
TCTGGAACAACCAC
ACCAAGTACATGGACACATACTTGAACCCATACCCAGGCTACTACTTTACCGGCGACGGTGCTGCCAGA
GATCACGACGGCTA
CTACTGGATTAGAGGTAGAGTCGATGATGTCGTCAATGTGTCTGGTCACAGATTGTCTACTGCTGAAAT
AGAAGCTGCCCTCA
TCGAACACAACGGTGTTTCTGAAGCTGCTGTGGTTGGTATTACCGACGACTTAACTGGTCAAGCCGTAG
TTGCCTACGTTGCT
CTCAAGAACGAATACGTCGACAAGATCGCCGGCAAGGAAACCAGCGACGAAGCCTTTGCCTTGAGAAAG
GAATTGATCATGAC
CGTCAGAAAGGAAATCGGACCTTTCGCAGCTCCAAAGAGCGTCATCATTGTCGCCGACTTGCCAAAGAC
CAGATCTGGTAAGA
TCATGAGAAGAATCTTGAGAAAGATCTCTGCCAACGAAGCAGACCAATTGGGTGACATCACCACTTTGT
CCAACCCTCAGTCT
GTCGTTGGTATAATCGACTCCTTTGCTGCTCAATTTGCTAAGAAATAA (SEQ ID NO:11)
FAT
ATGGGGAGACACTTGGCCTTGCTTCTGCTTCTGCTCTTCTTCCTCCAGCATTTTGGAGATGGTGATGGA
AGCCAAAGACTTGA
ACCGACCCCTTCCCTCCAGTTTACACACGTCCAGTACAATGTCACTGTGCACGAAAACTCGGCCGCAAA
GACCTATGTCGGCC
ACCCTAGAAAAATGGGCATCTACATCTTAGACCCCTCGTGGGAAATAAGGTACAAAATCATCTCAGGAG
ACAACGAAAACCTA
TTCAAAGCGGAAGAGTATGTTCTCGGAGACTTTTGCTTTCTAAGGATAAGAACCAAGGGAGGGAATACT
GCCATCCTGAACCG
AGAAGTGAGAGACCATTACACACTGGTAATCAAAGCAGTTGAAAAAGTCACAGATGCCGAGGCCCGAGC
CAAGGTCAGGGTGC
AAGTGCTGGATACAAACGACTTACGGCCGTTGTTCTCACCCACGTCCTACAGCGTTTCTCTGCCGGAAA
ACACAGCCATAAGG
ACCAGTATCGCAAGAGTCAGTGCCACGGATGCGGACATTGGAACCAACGGCGAATTTTACTACAGCTTT
AAAGACAGAACGGA
CATGTTTGCCATCCACCCAACCAGTGGTGTGGTTGTTTTGACTGGCAGGCTTGATGTCCTGGAGACCCA
GCGCTATGAGCTGG
AGATCTTGGCTGTGGACCGGGGAATGAAGCTGTACGGTAGCAGTGGGGTCAGCAGTCTGGCCAAGCTGA
CGGTTCACGTGGAG
CAGGCTAACGAGTGTGCACCCGGGATAACCGCCGTGACGTTATCACCATCTGAGCTGGACAAGGACCCA
ACGTACGCCATTAT
CACTGTGGAGGACTGCGATCAGGGTGCCAACGGGGAGATAGCATCTTTGAGCATTGTGGCTGGCGACCT
CCTTCAGCAGTTTA
AAACGGTGAGGTCTTTCCCAGGGAGTAAAGCATTCAAAGTGAAAGCCGTCGGGGGCGTCGACTGGGACA
GCCATCCTTATGGC
TACAACCTGACAGTGCAGGCTAAAGACAAAGGAACTCCTCCGCAGTTTTCCCCTGTGAAAGTCATTCAC
GTCATTTCTCCTCA
GTTCAGAGCTGGCCCGGTCAAGTTTGAAATGGATGTTTACAGAGCTGAGATCAGTGAGTTTGCCCCTCC
ACATACACCCGTGG
TCCTGGTCAAGGCTATTCCTAGTTATTCCCATTTGAGGTACGTTTTTAAAAGCACTCCTGGAAAACCCA
AATTCGGTTTAAAT
CACAACACGGGTCTCATTTCCATTTTAGAACCAATTAAAAGGCAGCACACATCCCATTTTGAGCTTGAG
GTGACAACAAGTGA
CAGACGAGCCTCCACCAAAGTCGTGGTCAAAGTTGTAGGTACAAACAGCAACCCCCCGGAGTTTACACA
GACCTCGTACAAAG
CATCCTTTGATGAGAATGCACCCGTCGGTACCCCGGTCATGAGGGTGAGCGCGGTTGACCCTGACGAGG
GGGAGAATGGCTAC
GTGACTTACAGTATTGCAAACTTAAATCACGTGCCATTTGTCATCGACCACTTTACGGGTGCTGTGAGT
ACCTCTGAGAATCT
GGACTATGAACTGATGCCTCGAGTCTACACGCTGAGGATTCGTGCTTCCGACTGGGGCTTACCGTACCG
CCGGGAAGTTGAAG
TCCTTGCCACAATTACTCTGAATAACCTGAATGACAACACCCCCCTGTTTGAGAAGACAAACTGTGAAG
GGACAATTCCCCGA
GACCTGGGTGTAGGGGAGCAGATAACCACGGTTTCTGCCATTGACGCTGATGAGCTGCAGTTGGTCCGG
TACCAGATTGAAGC
TGGAAATGAGTTGGATTTGTTTGGCTTAAACCCCAGCTCTGGTGTGCTGTCATTGAAGCACTCGCTCAT
GGACGGCTTGGGTG
CAAAGGTTTCCTTTCACAGCTTGAGAATCACAGCTACAGACGGAGAAAATTTTGCCACACCATTATATA
TCAACCTAACGGTG
GCTGCCAGTCGCAAGCCAGTAAACTTGCGGTGTGAGGAGACCGGTGTTGCCAAAATGCTGGCAGAGAAA
CTCCTGCAGGCGAA
TAAATTACACCATCAGGGGGACGCGGAGGATATTTTCTTTGATTCTCACTCCGTCAACGCCCATGCCCC
ACAGTTTAGGGGTT
CTCTTCCAACAGGAATTGAGGTAAAGGAGGACCTCCCAGTGGGCGCCAGTATACTATTCATGAATGCTA
CTGACCTTGACTCT
GGCTTCAATGGGAAACTGGTCTATGCTATCTCTGGAGGGAATGATGACAGTTGCTTTACTGTTGACATG
GAAACAGGAATGCT
GAAAGTCCTCTCTCCACTTGACCGAGAAGTAACGGACAAATACACACTGAACATTACCGTGTATGACCT
TGGTATACCCCAGA
GGGCTGCCTGGCGCCTTCTGGATGTCACCGTCCTGGATGCCAATGACAACGCGCCCGAGTTTTTACAGG
AGAGCTATTTTGTC
GAAGTGAGCGAAGACAAGGAGATAAACAGTGAAATCATCCAGGTAGAGGCCACCGATAAAGACCTGGGC
CCCAGCGGACACGT
GACATACGCCATCCTCACGGACACAGAGAAGTTTGCGATCGACAGGGTGACCGGTGTGGTGAAAATTAT
CCAGCCTTTGGATC
GTGAAGTGCAGCGTGTACATTACCTGAAGATCGAGGCCAGGGACCAAGCCACAGAGGAACCCTGGCTGT
CCTCCACTGTGCTT
CTGAAAGTGTCACTCGATGATGTTAATGACAACCCACCTAGGTTCATTCCACCCAGTTACTCCGTGAAG
GTTCGAGAAGACCT
ACCGGAAGGAACCATCATCATGTGGTTAGAAGCCCATGACCCTGATGTAGGTCAGTCCAGTCAGGTGAG
ATACAGCCTCCTGG
ACCACGGAGAAGGCCACTTCGATGTGGATAAACTCAGCGGGGCAGTGAGAATTGTCCAGCAGCTGGACT
TTGAGAAGAAGCAA
CTGTATAATCTCACCGTGAGGGCCAAAGACAAAGGGAAGCCGGCGTCTCTGTCTTCCACTGGCTACGTG
GAAGTGGAGGTCGT
GGACGTGAATGAGAACTTACACGCGCCAGTGTTCTCCAGCTTCGTGGAGAAGGGCACAGTGAAAGAAGA
CGTCCCTATGGGCT
CATCAGTAATGACCGTGTCAGCTCACGATGAGGACACCGGGAGAGATGGAGAGATCCGGTATTCCATCA
GAGATGGCTCTGGT
GTTGGTGTTTTCAGGATAGATGAAGAAACAGGTGTCATAGAGACCTCAGATCGACTGGACCGAGAGTCG
ACTTCCCACTACTG
GCTCACCGTCTACGCCACAGATCAGGGTGTGGTGCCTCTGTCATCCTTCATAGAGGTCTACATAGAGGT
TGAGGATGTCAATG
ACAACGCACCACAGACATCAGAGCCTGTGTATTATCCTGAAATAATGGAGAATTCACCCAAGGATGTAT
CTGTGGTCCAGATT
GAGGCATTTGACCCGGATTCCAGCTCCAGTGACAAGCTGACGTACAGAATTACAAGTGGAAATCCCCAA
GGGTTCTTCTCAAT
ACACCCTAAAACAGGTCTCATCACAACCACATCGAGGAAGCTGGACCGAGAGCAGCAGGATGAACACAT
TCTGGAAGTTACTG
TGACAGACAATGGTGTACCTCCCAGATCCACCATTGCCAGGGTCATTGTGAAAATCCTGGATGAGAACG
ACAACAGGCCTCAG
TTCCTTCAGAAGTTTTATAAAATCAGGCTCCCGGAGCGAGAAAAAGCTGATGGAGACCGGAGCGCGAAG
CGCGAGCCTCTCTA
CCGAGTCATAGCCGCAGATAAGGATGAAGGGCCCAATGCCGAGCTCTCCTACAGCATCGAGGAAGGGAA
CGAGCACGGCCGGT
TTTCCATTGAACCCAAGACAGGAGTGGTCTCATCCAAAAAGTTCTCTGCGGCTGGAGAATACGACATTC
TTTCTATTAAGGCA
ATTGACAATGGGCGCCCCCAGAAGTCATCGACCACCAGACTCCATATTGAATGGATCTCCAAACCCAAG
CCGTCCTTGGAGCC
GATTTCGTTTGAGGAATCGGTTTTCTCGTTTACTGTAATGGAGAGTGATCCGGTGGCTCACATGATCGG
CGTGATCTCCGTTG
AGCCTCCTGGCATGCCTCTGTGGTTTGACATCATCGGGGGCAACTATGACAGTCACTTTGATGTGGACA
AGGGCACTGGAACC
ATCATTGTGGCCAAGCCCCTTGACGCAGAGCAGAAGTCCAGCTATAACCTCACAGTGGAGGCGACAGAC
GGGACCTCCACTAT
CCTCACCCAGGTACTCATCAAAGTAATAGATACCAATGACCACCGCCCTCAGTTTTCTACCTCGAAATA
CGAAGTCTCTGTTC
CCGAAGACACAGAGCCAGAAACAGAGATTCTGCAAATCAGCGCCGTAGACAGGGACGAGAAAAACAAAC
TGATCTACACCCTC
CAGAGCAGCATAGATCCAGCAAGTCTCAAGAAATTCCGCCTCGATCCTGCAACAGGCGCTCTCTACACA
TCTGAGAAGCTCGA
TCACGAAGCCATTCACCAGCACGTCCTCACAGTCATGGTCCGGGATCAGGATGTCCCTGTGAAACGCAA
CTTTGCCAGAATCA
TTGTGAATGTCAGTGACATGAATGACCACTCTCCGTGGTTCACCAGTTCGTCCTATGAAGGGCGGGTTT
ATGAGTCGGCAGCC
GTGGGCTCGGTCGTGCTACAGGTTACAGCTCTGGACAGAGACAAAGGGAGAAATGCTGAAGTGCTCTAC
TCCATCGAGTCAGG
AAACATTGGAAATTCCTTTACAATCGACCCCATCTTGGGCTCTATAAAAACTGCCAGAGAATTGGATCG
AAGTCACCAAGTAG
ACTATGATTTAATGGTAAAAGCTACAGACAAAGGGGAGCCACCAATGAGCGAAATGACCTCCGTGCGGA
TCTCTGTCACCGTC
GCCGACAATGCCTCTCCTAAGTTCACATCCAAGGAGTACTCGGCTGAGATTAGTGAAGCCATCAGGATT
GGGAGTTTTGTTGG
AATGGTCTCTGCTCACAGTCAGTCATCAGTGATGTATGAAGTAAAAGATGGAAATATAGGCGATGCATT
TAATATCAATCCAC
ATTCAGGAAGCATCGTCACTCAGAGAGCCTTGGATTTTGAGACACTGCCCATTTATACATTGACAGTAC
AAGGGACCAACATG
GCCGGCTTGTCCACCAATACAACGGTGGTAGTGCACATACAGGATGAGAATGACAACCCTCCAGCTTTC
ACACGGGCGGAATA
TTCAGGATTCATTAGTGAATCAGCCTCAGTCAACAGCGTGGTGCTAACGGATAAGAATGTTCCGCTCGT
GATCCGAGCCACCG
ACGCTGATCGGGAATCCAATGCTCTGCTCGTCTATCAAATTGTCGAGCCATCTGTGCACAACTATTTTG
CCATTGATCCCACC
ACCGGTGCCATCCATACCGTACTGAGTCTGGACTATGAAGAGACACGTGTCTTTCACTTCACCGTCCAA
GTGCATGACATGGG
GACGCCTCGTCTGTTTGCTGAGTATGCAGCAAATGTGACCGTGCATGTGATTGACATCAATGACTGCCC
CCCTGTCTTCTCTA
AGTCACTGTACGAAGCATCCCTCCTATTGCCGACGTACAAAGGCGTGAACGTCATCACAGTGAATGCCA
CAGATGCCGACTCC
AGGGCGTTCTCCCAGTTAATATACTCCATCACCAAAGGCAACATTGGGGAGAAGTTCTCCATGGACCAC
AAGACTGGCACCAT
AGCAATTCAGAACACAACCCAGTTACGGAGCCGCTATGAGCTGACCGTCCGCGCCTCCGATGGCCGGTT
TACAAGCGTGGCCT
CCGTGAGAATCAACGTGAAGGAAAGCAGAGAGAGTCCTCTCAAGTTTACCCAAGATGCCTACTCTGCGG
TGGTGAAGGAGAAC
TCCACCGAAGCCAAAACCTTAGCTGTCATTACCGCGATAGGGAACCCGATTAACGAGCCTTTGTTTTAC
CGTATCCTCAACCC
AGACCGCAGATTTAAAATCAGCCACACCTCAGGCGTGTTGTCAACCACTGGGATACCATTTGATCGGGA
GCAACAGGAGACGT
TTGTTGTGGTGGTAGAGGTGACTAAAGAACGGGAGCCGTCGGCCGTGGCCCACGTTGTGGTGAAGGTCA
CCGTGGAAGACCAG
AATGATAATGCACCCGTGTTTGTCAACCTTCCCTACTATGCTGTGGTGAAGGTGGATGCTGAGGTGGGC
CATGTCATCCGCCA
CGTCACTGCCATTGACAGAGACAGTGGCAGAAACGGTGACGTTCACTACTACCTTAAGGAGCATCATGA
CCACTTTGAGATTG
GACCCTCTGGTGACATTTCTCTGAAAAAGCAATTTGAGCACGACACCTTGAATAAAGAATACCTTGTCA
CAGTGGTTGCGAAG
GACGGGGGGAACCCAGCTTTCTCCGCAGAAGTTCTAGTTCCCATCACCGTCATGAACAAAGCCATGCCC
GTGTTTGAAAAGGC
TTTCTACAGTGCAGAGATTCCCGAGAACGTCCAGACGCACAGCCCAGTGGTCCACGTCCAAGCCAACAG
CCCAGAAGGGTTGA
AAGTGTTCTACAGTATCACAGACGGGGACCCTTTTAGTCAGTTTACTATCAACTTCAACACTGGGGTGA
TAAACGTCATCGCA
CCGCTGGACTTTGAGTCCCACCCAGCCTATAAGCTAAGCATACGGGCCACTGACTCCCTGACTGGCGCC
CACGCTGAAGTGTT
TGTTGACATCGTAGTAGAAGACATCAATGACAACCCTCCCGTGTTTGTGCAACAGTCTTACTCGACAAC
CCTGTCTGAAGCAT
CTGTCATCGGAGCGCCTATCCTTCAAGTTAGAGCCACCGACTCTGACTCGGAACCAAATAGAGGGATTT
CCTACCAGCTGATT
GGAAATCACAGCAAAAGCCACGATCACTTTCACATAGATAGTCACACTGGGCTGATTTCACTGGTGAGG
GCTTTGGATTACGA
ACAGTTCCAGCAGCACAAGCTGCTCGTAAGGGCTGTTGATGGAGGAATGCCGCCACTGAGCAGCGATGT
GGTCGTCACTGTGG
ATGTCACCGACCTCAACGATAACCCGCCTCTGTTTGAACAACAGGTTTACGAAGCTAGGATCAGTGAGC
ACGCTGCCCACGGG
CATTTTGTGATGTGCGTAAAGGCCTGTGATGCAGATCGCTCAGACCTAGACAGGCTGGAGTACTCCATT
CTGTCCGGCAATGA
TCACAAGAGCTTTGTCATTGACGGGGAGACAGGAATCATCACGCTCTCCAACCCGCGCCGCCACACCTT
GAAGCCGTTCTATA
GTCTCAACGTTTCTGTGTCTGATGGGGTTTTCCGAAGCTCGGCTCGGGTGAATGTCACCGTGATGGGAG
GGAATTTGCACAGC
CCTGTCTTTCACCAGAATGAGTATGAGGTAGAGCTGGCTGAAAACGCCCCCTTGCACACCCTGGTGGTC
CAAGTGAAGGCTAC
TGACAGAGATTCCGGTATCTACGGCCACCTGACTTACCACCTTGTAAATGACTTTGCCAAAGACAGGTT
TTACGTGAACGACG
GAGGGCAGGTCTTCACTCTGGAGAGACTTGATCGAGAGGCTCCAGCAGAGAAAGTGATCTCAGTCCGTT
TAATGGCTAAGGAT
GCTGGGGGGAAGGTCGCCTTCTGCACTGTCAACGTCATCCTCACGGACGACAATGACAACGCACCACAG
TTTCGCTCAACCAA
GTACGAGGTGAACGTGGGGTCCAGCGCCGCCAAAGGGACGTCGGTCGTCAAGGTCTTCGCGAGTGATGC
CGATGAGGGGTCGA
ATGCTGACGTCACCTACGCCATCGAGGCAGATTCGGAAAGTGTCGAGGAGAACTTGGAAATCAACCAAC
TGACCGGCCTCATT
ACTACAAAGGAAAGCTTAATAGGTTTAGAGAATGAATTCTTCACTTTCTTCGTTAGAGCTGTGGATAAC
GGGTCTCCGCCCAA
AGAGTCTGTTGTTCCTGTCTATGTTAAAATACTTCCCCCGGAAGTGCAGCTTCCTAGGTTCTCAGAGCC
CTTTTATACCTATT
CCATTTCAGAAGACATGCCTATTGGCACAGAGATTGACCTCATCCGGGTAGAGCATAGCGGGACTGTTC
TCTACACCCTGGTC
AAAGGCAATACTCCCGAGAGTAACAGGGACGAGTTCTTTGTGATTGACCGGCAGAGTGGGAGACTGAAG
CTGGAGAAGAGCCT
TGACCACGAGACCACTAAGTGGTATCAGTTTTCCATCCTGGCCAGGTGTACTCTGGATGACTACGAGGT
GGTGGCTTCTATAG
ATGTCAGTATCCAGGTGAAAGACGCTAATGATAACAGCCCAGTTTTGGAGTCCAATCCATACGAGGCAT
TTATTGTCGAAAAC
CTGCCAGCAGGGAGTAGGGTCATCCAGGTCAGAGCATCTGACCTAGACTCAGGAGTCAACGGCCAAGTC
ATGTACAGTCTAGA
TCAGTCCCAAGATGCAGACATCATCGAGTCTTTTGCCATTAACATGGAAACAGGCTGGATTACAACCCT
CAAGGAGCTTGACC
ATGAAGAGAGAGCCAGTTACCAGATTAAAGTGGTTGCCTCAGACCATGGTGAAAAGGTGCAGCTGTCTT
CCACCGCCATTGTG
GATGTCACCGTCACTGACGTCAACGACAGCCCGCCTCGATTCACAGCTGAGATTTATAAAGGGACAGTG
AGTGAGGATGACCC
CCCAGGGGGTGTGATCGCCATCTTGAGCACCACTGACGCCGACTCTGAAGAGATTAACCGACAAGTGTC
GTACTTCATAACAG
GAGGGGATGCATTGGGACAGTTTGCTGTGGAAAATATGCAGAATGACTGGAGGGTGTACGTGAAGAAAC
CTCTCGACAGGGAA
CAAAAGGACAGTTACCTTCTGACCGTCACTGCAACAGATGGGACCTTCTCTTCCAAAGCTAGAGTTGAA
GTCAAGGTTCTCGA
TGCCAATGATAACAGTCCAGTGTGTGAGAGGACCGCATATTCTGATGCCATTCCCGAAGACGCTCTTCC
GGGGAAGCTGGTCA
TGCAGGTCTCTGCCACAGATGCAGATATCCGGTCCAACGCGGAGATCACTTACACTTTATTTGGCTCAG
GTGCAGAAAAGTTT
AAACTGAATCCAGACACAGGTGAACTGAGAACATTAGCCCTCCTTGATCGTGAGGAGCAAGCAGTTTAT
CATCTTCTGGTCAA
GGCCACAGACGGAGGGGGCAGATCCTGTCAGGCAACTATTGTGCTCACGTTAGAAGATGTAAATGACAA
CACCCCCGAGTTCA
CCGCGGATCCATACGCCATCACGGTATTTGAAAACACAGAGCCTGGGACACCGTTGACCAGAGTGCAGG
CCACCGATGCAGAC
GCAGGGTTGAATCGGAAGATTTCCTACTCACTGCTTGACTCTGCTGACGGGCAGTTCTCCATTAACGAG
CAGTCCGGAATTCT
TCAGTTGGAAAAGCATTTGGACAGGGAACTACAGGCAGTCTATACTCTCACTTTGAAAGCAGCGGACCA
AGGATTGCCAAGGA
AATTGACAGCCACTGGCACGGTGGTTGTGTCTGTTTTGGATATAAATGACAACCCACCTGTGTTTGAGT
ACCGTGAATATGGT
GCCACCGTGTCAGAGGACATTGTCATCGGGACCGAAGTTCTCCAGGTGTACGCAGCCAGTCGGGATATC
GAGGCGAATGCAGA
AATCACATACGCAATCATAAGTGGGAACGAACACGGAAAATTCAGCATCGATTCTAAGACAGGGGCCAT
ATTTATCATTGAGA
ACCTGGATTATGAAAGCTCCCATGGCTATTACCTGACTGTGGAAGCCACTGATGGAGGCACGCCCTCGT
TGAGTGACGTGGCG
ACCGTGAACATCAACATCACAGATATTAACGATAACAGCCCAGTGTTCAGCCAGGACAGCTACACCACA
GTGGTCAGCGAAGA
CGCGGCCCTGGAGCAGCCCGTCATTACAATTATGGCTGATGATGCTGATGGCCCTTCAAACAGCCACAT
CCTCTACTCCATTA
TAGAGGGTAACCAAGGAAGTCCATTCACAATCGACCCTGTCAGAGGAGAAATCAAAGTAACGAAGCCCC
TAGACCGCGAAACG
ATCTCAGGTTATACGCTCACGGTGCAGGCTGCCGACAACGGCAATCCACCCAGAGTCAACACCACCACA
GTGAACATCGATGT
CTCCGATGTCAACGACAATGCTCCCCTCTTCTCCAGAGACAACTACAGTGTCATCATCCAGGAAAACAA
GCCCGTGGGTTTCA
GCGTCCTGAAGCTAGTAGTGACAGACAAGGACTCGTCCCACAACGGCCCCCCTTTCTCCTTTGCTATTG
TGAGTGGAAATGAT
GACAACATGTTTGAGGTGAACCAGCACGGGGTCCTCCTGACAGCGGCAACAGTCAAGAGGAAAGTGAAG
GACCATTACCTTCT
GCACGTTAAGGTGGCTGACAATGGAAAGCCTCAGCTGTCTTCGTTGACACACATTGACATCAGGGTTAT
TGAGGAGAGCATCC
ACCCTCCTGCCATTTTGCCACTGGAGATTTTCATCACTGCTTCTGGAGAGGAATACTCAGGCGGGGTCA
TAGGAAAGATCCAT
GCCACAGACCAGGATGTGTATGACACCTTGACGTACAGTCTGGATCCCCACATGGATGGCCTGTTCTCT
GTTTCCAGCACGGG
GGGTAAACTGATTGCACACAGAAAGCTGGATATAGGCCAGTACCTTCTTAATGTCAGCGTGACAGACGG
GAAGTTTACAACGG
TGGCTGACATCACCGTGCACATCCAGCAAGTGACCCAGGAGATGCTGAACCACACCATCGCTATCCGAT
TTGCAAATCTCACC
CCGGAAGAGTTTGTCGGCGACTACTGGCGCAACTTCCAGCGAGCTTTACGCAACATCCTGGGCATCCGG
AAGAACGACATACA
GATTGTCAGCTTGCAGCCCTCCGAACCCCACTCCCACCTTGACGTCTTACTCTTTGTAGAGAAATCAGG
GGGCACCCAGATCT
CAACGAAACAACTTCTGCACAAGATCAATTCTTCCGTCACGGACATCGAGGAAATCATTGGCGTGAGGA
TACTGGATGTGTTC
CAGAAACTCTGTGCAGGGCTGGATTGCCCGTGGAAATTCTGTGATGAGAAGGTTTCTGTGGATGAAAAC
ATTATGTCAACTCA
TAGCACAGCCAGACTGAGTTTTGTGACTCCCCGGCACCATAGAACAGCCGTGTGTCTCTGCAAAGATGG
GACATGCCCGCCTG
TCCACCAAGGGTGCGAAGATAACCCCTGTCCTGCAGGATCCGAATGTGTCGCTGATCCCCGAGAAGAGA
AGTACAGCTGTGTG
TGTCCTGGTGGCGGGTTCGCCAAATGTCCAGGGAGTTCATCCATAACTTTTACCGGCAGCAGCTTTGTG
AAATATCGTCTGAT
GGAAAATGAAAACCGACTGGAGATGAAGTTGACCATGCGCCTGAGAACCTACTCTTCCCACGCGGTTGT
GATGTACGCTCGAG
GAACTGACTACAGTATCCTGGAGATTCATACTGGGAGACTGCAGTACAAATTTGACTGTGGAAGTGGCC
CTGGGATCGTCTCT
GTTCAGAGCATTCAAGTCAACGATGGGCAGTGGCATGCAGTGTCCCTGGAAGTGGAGGGGAATTATGCA
AAATTGGTTCTAGA
TGAAGTCCACACTGCCTCGGGCACAGCCCCAGGAGCTCTGAAAACCCTCAACCTGGATAACTACGTAAT
TTTTGGTGGCCACC
TCCGCCAGCAAGGGACAAAACATGGACGAAACACCCAGGTGGCCAATGGTTTCAGGGGCTGCATGGACT
CTATTTATTTGAAT
GGGCAGGAGCTACCTTTGAACAACAAACCAAGAGCCTATGCACACATCGAAGAATGGGTGGACCTAGCT
CATGGGTGCTTGTT
AACTGCCACCGAAGACTGTTCCAGCAACCCTTGTCAGAATGGAGGCGTCTGCAATCCCTCGCCCACTGG
AGGTTATTACTGCA
AGTGCAGTGCATTGCACGCAGGGACGTACTGTGAGGTGAGCGTCAACCCGTGCTCCTCCAACCCCTGCC
TCTACGGAGGAACG
TGCATGGTAGACAACGGAGGTTTTGTTTGCCAGTGCAGGGGGCTGTACACTGGCCAGAGATGTCAGCTT
AGTCCGTACTGCAA
AGATGAACCCTGTAAAAATGGTGGAACGTGTTTTGACAGTTTGGATGGTGCTGTCTGTCAGTGTGACTC
AGGCTTTAGGGGAG
AAAGATGTCAGAGTGACATTGACGAGTGTGCTGGGAACCCCTGTCGGAACGGGGCCCTTTGCGAGAACA
CGCATGGCTCCTAT
CACTGTAACTGCAGCCAGGAGTACAGAGGGAAGCACTGTGAGGATGCCACTCCCAACCACTACGTGTCC
ACCCCGTGGAACAT
CGGACTGGCCGAAGGAATCGGAATTATTGTGTTTATAGCCGGGATATTCTTACTGGTGGTGGTGTTTGT
CCTCTGCCGAAAGA
TGATCAGTCGGAAGAAGAAACACCAGGCGGAACCTGAAGACAAGCGTTTGGGGCCAACCACGGCTTTCT
TACAGAGACCTTAC
TTTGATTCCAAGCCGAGCAAGAACATTTACTCTGACATCCCGCCCCAGGTGCCCGTGCGTCCCATTTCC
TACACTCCGAGCAT
TCCCAGTGACTCTAGAAACAATCTGGACCGGAACTCGTTTGAAGGCTCGGCAATCCCAGAGCACCCAGA
ATTCAGCACTTTTA
ACCCCGAGTCTATGCACGGACATCGGAAAGCCGTGGCTGTGTGCAGCGTGGCTCCAAACTTGCCTCCCC
CACCCCCTTCCAAC
TCTCCCTCAGACAGCGACTCCATTCAGAAGCCCAGCTGGGACTTCGACTACGACGCTAAAGTGGTGGAT
CTTGACCCTTGTCT
TTCCAAGAAGCCCCTGGAGGAAAAACCCTCTCAGCCATACAGTGCCCGGGAGAGCCTGTCCGAGGTGCA
GTCCCTTAGCTCCT
TCCAGTCAGAGTCCTGTGATGACAATGGGTACCACTGGGATACATCAGACTGGATGCCCAGTGTTCCTC
TGCCAGACATACAA
GAGTTCCCCAATTACGAGGTTATCGATGAGCACACGCCCCTCTACTCAGCTGATCCAAATGCCATCGAC
ACTGACTATTACCC
TGGGGGTTATGACATTGAAAGTGACTTTCCACCCCCACCAGAGGACTTCCCTGCACCCGATGAACTGCC
ACCATTGCCTCCAG
AATTCAGCGACCAGTTCGAGTCCATACACCCACCCAGAGACATGCCCGCAGCAGGTAGCTTGGGGTCTT
CCTCCAGGAATCGT
CAGAGGTTCAACCTGAATCAGTACCTGCCCAATTTCTACCCCGTCGATATGTCTGAACCTCAGAAACAA
GGCGCTGGTGAGAA
CAGTACCTGTAGAGAACCCTACACTCCCTACCCTCCAGGGTATCAAAGAAACTTCGAGGCGCCCACCAT
AGAAAACATGCCCA
TGTCTGTGTACACCTCTACGGCTTCCTGCTCCGATGTGTCAGCGTGCTGCGAAGTGGAGTCTGAGGTCA
TGATGAGTGACTAC
GAGAGCGGGGACGACGGCCACTTTGAAGAGGTGACCATTCCCCCGCTAGATTCCCAGCAGCATACGGAAGTGTGA
(SEQ IDNO:12)
FAT
ATGAAGATTAAAAAATATGTAACTCCTGTAAAAAGAAAAGCTTTCACCATACTCCAATGGATTTCACTA
CTGTGTAGTCTATG
GTTGATCCCCACTGTACAAAGCAAGGCCGATGAGAAGCACACGGCGACCCTGGAGTATAGACTAGAGAA
CCAACTGCAAGATC
TATATAGGTTTAGCCATAGTGTATATAATGTTACCATACCAGAAAATAGTCTGGGCAAGACTTACGCCA
AGGGAGTATTGCAT
GAAAGACTGGCCGGCCTGAGAGTTGGCTTGAACGCAGAGGTTAAGTATAGGATAATTAGTGGCGATAAG
GAGAAGCTATTTAA
GGCCGAGGAGAAACTGGTCGGAGATTTTGCCTTCTTAGCGATTCGAACGCGGACAAATAACGTTGTGCT
AAACAGAGAAAAAA
CTGAGGAATACGTTATAAGAGTGAAGGCACATGTACATTTGCACGACCGAAATGTATCAAGCTATGAAA
CGGAGGCGAATATC
CACATCAAAGTACTGGATCGCAATGACCTGAGTCCGCTGTTTTATCCGACCCAGTACACCGTTGTTATT
CCGGAGGACACGCC
CAAATATCAAAGTATTTTAAAGGTCACAGCTGACGATGCTGACCTCGGCATCAATGGGGAAATCTACTA
CAGCCTCCTGATGG
ATAGTGAATACTTTGCTATCCATCCAACAACTGGCGAAATTACTCTCCTGCAGCAGCTTCAGTATGCGG
AGAACTCGCACTTC
GAGCTCACGGTGGTGGCCTACGATCGGGGATCATGGGTGAACCATCAGAACCACCAGGCCAGCAAGACG
AAGGTTAGTATTTC
GGTGAAACAGGTTAACTTTTACGCTCCAGAGATTTTCACGAAAACCTTCTCGAGCGTGACGCCAACATC
AAACCCTTTGATTT
ATGGAATTGTACGAGTAAACGACAAAGACACTGGGATAAATGGCAACATAGGGCGATTGGAAATCGTCG
ATGGAAATCCGGAT
GGCACGTTTCTTCTGAAGGCGGCGGAGACCAAAGACGAGTACTACATCGAATTGAATCAGTTTGCCCAT
CTTAACCAGCAACA
TTTCATTTACAACTTAACCCTACTGGCGGAGGACCTCGGAACTCCCCGTCGATTCGCCTACAAATCCGT
TCCGATTCAAATCA
AGCCCGAGAGCAAAAATATACCCATATTCACACAGGAGATTTACGAAGTATCCATTCCAGAAACGGCAC
CCATTAACATGCCT
GTGATAAGGCTCAAAGTAAGCGATCCAGATTTGGGCAAAAATGCATTGGTCTACTTGGAAATCGTGGGT
GGAAATGAGGGCGA
CGAGTTCCGAATTAATCCCGATTCGGGAATGTTGTACACAGCAAAGCAACTGGATGCCGAAAAGAAGTC
AAGTTATACCTTAA
CAGTCTCCGCCATTGATCAGGCAAATGTTGGGTCGCGGAAACAATCTTCAGCCAAGGTGAAAATCAGCG
TACAGGATATGAAC
GACAATGATCCCATTTTTGAGAATGTCAATAAGGTCATTAGTATCAATGAGAACAACTTGGCTGGCTCG
TTTGTTGTGAAGCT
TACTGCCAAGGACAGGGATTCTGGTGAAAATTCATACATATCGTATAGTATTGCCAATCTAAATGCGGT
TCCATTTGAAATCG
ATCACTTTAGCGGTATAGTTAAGACCACATCACTGCTTGACTTTGAAACAATGAAGCGTAACTATGAGC
TGATAATCCGTGCA
TCCGATTGGGGATTGCCGTACAGAAGACAGACGGAAATCAAACTGTCCATCGTCGTCAAGGATATCAAC
GATAATCGGCCGCA
GTTTGAACGTGTGAACTGCTATGGCAAAGTGACCAAATCGGCGCCGATGGGCACCGAGGTATTCGTTAC
CTCAGCCATTGACT
TTGATGCAGGCGATATAATATCCTATAGGTTGAGCGACGGCAACGAGGATGGCTGCTTTAACTTGGACC
CCACATCGGGTTCC
CTGTCTATTTCCTGCGACCTGAAGAAAACAACCTTAACAAACCGTATTCTCAAAGTTTCCGCCACGGAC
GGCACCCACTTTTC
CGATGACTTGATCATCAATGTACACCTAATGCCCGAAGATTTGGGTGGAGATTCCAGTATTCTACATGG
TTTTGGATCCTTTG
AGTGCCGGGAAACCGGCGTGGCCAGGAGATTGGCGGAAACATTATCGTTGGCCGAAAAAAACAATGTAA
AGAGTGCATCGCCA
TCCGTTTTCAGTGACTTGTCTCTAACACCCAGTCGATATGGCCAAAATGTGCATAGACCAGAGTTCGTG
AACTTCCCTCAGGA
GCTGTCCATTAACGAAAGTGTCCAATTGGGCGAAACAGTTGCTTGGATAGAGGCCAAAGATCGCGATTT
GGGCTACAATGGAA
AGCTGGTATTTGCAATTTCAGACGGGGACTACGATTCGGTTTTTCGTATTGATCCAGACCGCGGTGAAC
TGCAGATTATTGGA
TATTTGGATAGAGAGCGTCAAAATGAATATGTTCTCAACATCACCGTCTACGATCTGGGTAACCCGACC
AAATCGACGTCAAA
AATGTTGCCAATAACGATCCTCGACGTGAACGATAATCGCCCGGTTATTCAGAAGACGTTGGCCACCTT
CCGGCTGACTGAGA
GCGCCAGGATAGGAACTGTGGTACACTGCCTTCATGCCACGGATGCGGATTCTGGAATCAATGCTCAGG
TGACATATGCCCTG
TCGGTTGAGTGCAGCGATTTCACAGTAAATGCTACTACGGGATGTCTTCGTCTGAACAAACCACTGGAT
CGCGAGAAGCAGGA
TAACTACGCTCTTCACATAACTGCCAAGGATGGTGGCAGTCCCGTGCTATCCTCGGAGGCATTGGTTTA
CGTCCTGGTCGACG
ATGTCAACGACAACGCGCCCGTTTTCGGAGTGCAAGAGTACATATTTAAGGTGCGCGAAGATCTGCCCC
GTGGAACAGTGTTG
GCCGTAATCGAGGCGGTGGACGAAGATATTGGACCCAATGCCGAGATCCAATTCTCTTTGAAAGAGGAG
ACCCAGGATGAGGA
ACTATTCAGAATCGATAAGCACACGGGTGCAATTAGGACTCAAGGATATCTGGACTATGAGAACAAACA
AGTGCACAACCTTA
TTGTCAGTGCCATCGATGGCGGAGATCCCTCTCTAACTTCGGACATGTCCATCGTAATAATGATCATCG
ACGTCAACGAGAAC
CGATTTGCGCCCGAATTCGACGACTTTGTGTACGAGGGAAAGGTAAAGGAGAACAAGCCGAAGGGAACG
TTCGTAATGAATGT
CACAGCACGGGATATGGACACGGTGGACCTGAACTCCAAGATCACGTACTCAATAACAGGTGGCGATGG
ACTGGGAATTTTTG
CGGTTAACGACCAAGGTTCAATAACTTCCTTGTCGCAACTCGATGCGGAGACGAAAAACTTTTACTGGC
TGACGCTCTGTGCA
CAGGATTGCGCAATAGTTCCCCTCAGCAATTGTGTGGAAGTTTACATACAAGTCGAAAACGAAAACGAT
AACATTCCTCTTAC
GGACAAACCAGTGTACTACGTTAATGTCACGGAAGCCAGTGTGGAAAATGTGGAGATCATTACCCTAAA
GGCTTTCGATCCCG
ATATAGATCCCACTCAGACTATAACATATAACATAGTTTCCGGAAATCTTGTCGGGTACTTTGAAATTG
ATTCGAAAACAGGA
GTGATTAAGACGACAGAACGCAAATTGGATAGAGAAAATCAAGCGGAACATATTTTGGAGGTGGCTATA
TCAGATAACGGATC
TCCAGTACTATCTTCTACATCGCGAATCGTTGTGTCAGTACTGGATATTAACGATAACAGCCCCGAGTT
TGACCAAAGGGTCT
ACAAGGTGCAAGTTCCGTCTTCAGCCACAGTCAATCAATCTATTTTTCAGGTTCACGCTATCGACAGCG
ACAGTGGCGAAAAT
GGTCGAATTACCTACTCAATTAAGTCCGGAAAGGGTAAGAATAAATTTCGCATCGATAGCCAAAGGGGC
CATATACATATAGC
AAAACCATTGGACTCCGACAATGAGTTTGAGATTCACATCAAGGCTGAGGACAACGGAATTCCTAAAAA
GAGTCAAACTGCTA
GAGTTAATATTGTTGTAGTTCCTGTAAATCCTAATTCCCAAAATGCACCGTTGATAGTCAGAAAGACAT
CCGAAAATGTCGTT
GATCTTACGGAAAATGACAAGCCTGGATTTTTGGTCACTCAAATTTTAGCTGTCGATGATGACAACGAC
CAGCTGTGGTACAA
CATTTCCAATGGCAATGACGACAATACCTTTTACATTGGCCAAGACAACGGAAACATACTGCTTTCAAA
ATATTTGGACTACG
AGACCCAACAGTCCTATAATCTGACTATCAGCGTCACTGATGGCACATTCACAGCGTTTACTAATCTTT
TGGTTCAAGTGATC
GATATTAATGACAACCCCCCTCAGTTCGCTAAAGATGTGTATCATGTCAATATATCCGAAAATATTGAA
GAGGAATCAGTTAT
AATGCAACTCCACGCCACTGACAGAGATGAGGACAAGAAGCTATTCTATCACCTGCACGCAACTCAGGA
TCCGTCGTCGCTGG
CATTGTTCCGAATCGATTCCATAAGTGGAAATGTCATTGTCACTCAGAGATTGGATTTTGAAAAGACTG
CGCAGCATATACTC
ATCGTTTTTGTTAAGGATCAAGGAGCGCCTGGAAAAAGAAACTATGCCAAGATAATTGTAAACGTGCAT
GACCACAACGACCA
TCATCCAGAATTTACTGCTAAAATAATTCAAAGTAAGGTTCCCGAAAGCGCAGCTATTGGCTCTAAGTT
AGCCGAAGTGAGGG
CCATAGATAGAGATAGTGGTCACAATGCCGAGATCCAGTACTCGATTATCACGGGTAACGTGGGTAGTG
TGTTTGAGATTGAT
CCGACTTTCGGTATAATCACATTGGCTGGCAACTTGAATATCAACAAGATCCAGGAGTACATGCTTCAA
GTGAAGGCCGTAGA
TCTGGGAAATCCACCGCTGTCATCGCAGATTCCGGTACACATCATTGTCACCATGTCCGAGAACGATCC
TCCGAAGTTCCCAA
CCAACAACATTGCCATTGAAATATTCGAAAACCTGCCCATCGGAACATTTGTTACTCAAGTCACCGCTC
GGTCGTCGTCATCC
ATATTCTTCAATATTATTTCCGGCAACATCAACGAAAGCTTCCGCATTAACCCATCTACTGGAGTTATT
GTTATCAATGGAAA
TATCGACTATGAATCCATCAAAGTATTCAACCTTACGGTTAAAGGAACCAATATGGCAGCCGAGTCATC
CTGCCAAAATATAA
TTATACATATCCTAGATGCTAACGATAATATTCCGTATTTCGTTCAAAATGAATATGTTGGAGCATTAC
CCGAATCCGCCGCT
ATTGGATCTTACGTACTGAAAGTACACGACTCATCAAAAGATCATTTAACATTACAAGTTAAGGATGCG
GATGTCGGAGTAAA
CGGAATGGTTGAATACCACATAGTTGACGATCTGGCAAAAAACTTTTTTAAAATAGATTCGACAACTGG
CGCTATTGAACTGT
TACGACAATTGGACTATGAAACAAACGCTGGTTATACCTTTGACGTTACGGTTAGTGATATGGGAAAGC
CCAAACTACATTCC
ACTACAACTGCACATGTGACGATTCGTGTCATAAATGTTAACGATTGTCCTCCAGTATTTAATGAGCGT
GAACTCAATGTAAC
TTTGTTCCTTCCAACTTTTGAGAATGTGTTTGTAAGACAAGTTAGCGCAAAGGATGCTGATAACGATAC
CTTAAGGTTTGATA
TTGTGGATGGAAACACCAACGAATGTTTCCAGATCGAAAAATACACCGGAATAATTACAACACGAAATT
TTGAAATACTAAAT
AACGAAAATGATCGGGACTATGCCTTGCACGTCCGTGCCTCCGACGGAATTTTCTCTGCAATTTTAATA
GTTAAAATTAAGGT
TTTGTCCGCCATCGATTCGAATTTCGCATTCCAACGTGAATCGTACAGATTTTCTGCATTTGAAAATAA
CACAAAGGTAGCTA
CCATTGGATTGGTGAACGTAATAGGAAACACACTGGACGAAAACGTTGAGTATCGCATCCTGAACCCAA
CACAATTGTTTGAT
ATTGGAATCAGTTCGGGAGCCCTAAAAACCACTGGAGTTATTTTCGATCGCGAAGTAAAGGATTTGTAC
AGACTCTTCGTGGA
AGCAAAGTCAATGCTATACGACGGCATGAATTCAAATGTTCGCAGAGCAGTAACGTCCATAGATATATC
CGTCTTGGATGTGA
ACGACAATTGCCCCTTGTTTGTCAATATGCCCTATTATGCCACAGTCTCTATTGACGATCCAAAAGGAA
CGATTATTATGCAG
GTCAAGGCCATTGACTTGGACAGTGCAGAAAACGGCGAAGTTCGGTACGAACTTAAGAAGGGCAATGGG
GAGTTGTTCAAACT
GGACCGCAAATCTGGGGAGTTATCCATAAAGCAGCATGTCGAAGGTCATAACCGAAACTATGAATTGAC
AGTGGCTGCCTATG
ATGGCGCCATAACACCATGCTCCTCGGAAGCTCCTCTGCAGGTTAAGGTTATAGATCGTTCGATGCCCG
TTTTTGAAAAGCAG
TTTTATACTGTTAGCGTCAAGGAAGACGTGGAAATGTACTCAGCCCTTTCCGTATCCATTGAAGCAGAA
AGTCCCCTGGGAAG
GAGTTTAATTTACACAATATCTTCCGAGAGTCAATCGTTTGAAATTGATTACAACACGGGATCAATTTT
TGTCGTAAATGAAT
TGGATTACGAGAAAATAAGCTCACACGATGTTTCCATTCGAGCGACTGACAGTCTTTCTGGTGTTTATG
CTGAAGTCGTTTTA
TCTGTTTCCATTATGGATGTCAATGACTGCTATCCAGAAATTGAGAGTGATATATACAACCTAACCATT
CCGGAAAATGCATC
GTTTGGAACACAAATTCTGAAGATTAATGCAACTGATAACGACTCGGGAGCAAATGCAAAACTTTCCTA
TTACATTGAGTCCA
TTAATGGGCAAAATAATTCAGAACTGTTTTACATTGACGTCACAGACGGAAATCTGTATTTAAAGACTC
CATTGGACTATGAA
CAAATCAAGTATCATCATATAGTCGTTAACGTAAAGGACCATGGATCGCCATCATTAAGTTCCCGATCA
AACGTATTTATAAC
AGGTAGAATTCTATGTCGCTTTATCTCTTACAAACTAATTTATGATTCTATTATTCCAGTTAAAGACTT
AAACGACAACGCTC
CATGTTTCGTTGAGCCGTCGTACTTCACCAAAGTGTCAGTGGCAGCTGTTCGTGGACAATTTGTTGCTT
TACCTAAAGCATAC
GATAAGGATATTTCCGATACCGATTCTCTGGAATACAAAATTGTTTACGGAAATGAATTGCAAACCTAT
AGTATTGATAAGCT
AACAGGAGTGATTTCCCTTCAAAATATGTTAAATTTCACTGATAAAAGTAGCACAGTCTTGAATATTTC
CGTCTCCGATGGAG
TTCATACGGCATATGCCCGGCTCAAAATATCCTTATTGCCAGAAAACGTTTACAGTCCACTGTTTGATC
AAAGTACTTATGAG
GCTCAAGTACCTGAAAACTTGCTACACGGTCATAATATAATCACGGTAAAAGCATCGGATGGAGACTTT
GGCACCTACGCCAA
TCTTTACTACGAAATAGTTTCGGAGGAAATGAAAAAAATCTTTCTCATCGACCAAACGACGGGTGTAAT
AACCTCAAAAGTAA
CTTTCGACCGTGAAAAAAAGGATGAGTACGTGGTGCTACTGAAGGTGTCCGACGGTGGCGGAAAATTCG
GATTTGCCTCTCTC
AAGGTCATAGTCGTCGACGTGAACGATAACGTTCCTTACTTCCTATTGAAGGAATACAAAATGGTTGTT
AGCACAACAGTGGA
AGCAAACCAAACTATCCTGACGGTCAAAGCCAAAGACGACGATATTGTTGATAATGGATCGGTGCATTT
CCAAATTGTTCAAA
AATCCAACGATAAGGCAGTAAAGGATGTAATCGAAATCAACGAGAAAACTGGGGATATTGTGTTTAAAA
GCAAGGCGGAATCT
TACGGAGTGAACTCATATCAGTTTTTCGTTCGCGCTTCCGATCGCGGTGAACCTCAATTTCATTCGGAA
GTTCCAGTGTCAAT
CGAAATAATCGAGACTGATGCCAATATTCCCACTTTTGAGAAATCGTCAGTTCTACTAAAGATCATAGA
GTCAACGCCACCAG
GAACCGTGCTAACGAAGCTACATATGATTGGAAACTATACGTTCAAATTCTCAATAGCAGCGGATCAGG
ATCACTTCATGATA
TCCGATAGTGGTGAACTGATCCTTCAGCAGACATTGGACAGGGAGCAGCAAGAGTCGCACAATTTGATT
GTAGTGGCGGAAAC
TTCCACGGTTCCCGTTTTTTTCGCCTACGCTGATGTTTTGATTGACGTTAGGGACGAAAATGATAACTA
TCCCAAGTTTGACA
ACACATTCTACAGTGCCAGTGTTGCGGAAAACAGTGAAAAGGTGATATCCTTGGTGAAAGTATCGGCCA
CAGATGCGGACACT
GGGCCAAATGGCGACATTCGCTACTACTTGGAAAGTGATACTGAAAACATTCAAAATATTTTTGACATT
GACATTTACTCTGG
CTGGATCACCTTGCTAACCTCCTTGGACAGAGAAGTTCAGTCCGAGTACAATTTCAAAGTAATTGCTGC
CGATAATGGCCACC
CAAAGCATGATGCAAAAGTACCTGTAACTATCAAAATCGTAGACTATAATGATAACGCACCAGTATTTA
AGTTGCCTATCGAA
GGGCTTTCTGTTTTCGAAAACGCGCTGCCTGGCACGGTTTTAATCAACTTACTCCTAATTGATCCCGAT
ATCGAGAAACAGGA
AATGGATTTCTTTATCGTTTCTGGGGACAAGCAAGCCCAGTTTCAGATCGGTAAGAGCGGAGAGTTATT
TATTGCCAAACCAT
TAGATCGCGAACAACTCATGTTCTACAACTTAAGCATAATAGCCACTGATGGAAAATTCACTGCCAAAG
CCAATGTGGAAATA
GATGTAAAAGACATAAACGACAATACGCCTTACTGCCTAAAACCCCGCTATCATATCTCCACTAATGAA
TCAATCTCGATTGG
AACTACACTCGTTGAGGTCAAGGCGATTGACTTTGATTTTCAAAGCAAACTGCGCTTCTATCTTTCGGG
CAAAGGTGCGGACG
ACTTCAGTATAGGAAAGGAAAGTGGCATCCTGAAGGTGGCAAGCGCACTGGATCGGGAGACAACCCCCA
AGTACAAATTGGTC
GCACATGTACAGGATGGCAAGGACTTTACGCAAGAGTGTTTCTCGGAAATAATCATCACGGTCAATGAC
ATAAATGACAATAT
GCCCATTTTCTCAATGGCTCAATATAGAGTGAGTGTACCCGAGGATGCACAACTGAACACATTGATCAC
GAAAGTGCACGCGA
TGGATAAGGATTTCGGGGTAAATAGACAAATCAAATACTCGCTAATGGGTGAAAACCATGATTATTTCA
AAATATCAAAATCG
ACTGGTATCATAAGGCTGCACAAAAGTCTCGATCGTGAAACAATTTCATTGTTTAATCTCACTGTGAAG
GCGGAGGACTGTGG
CGTTCCAAAACTACACTCCATTGCAACAGTTGCTGTGAACATATTGGACATTAATGACAATCCACCCGA
GTTCAGTATGCGTC
AGTATTCGTGCAAAATTCTGGAAAACGCCACACACGGCACAGAAGTGTGCAAAGTTTATGCCACTTCGA
TAGATATTGGGGTA
AATGCGGATATTCACTACTTCATAATGAGTGGCAACGAGCAGGGGAAGTTCAAAATGGATTCCACGACG
GGCGACTTGGTGCT
AAATGCAACCTTGGACTATGAAATGTCCAAGTTTTACTTCTTGACCATTCAAGCAATCGATGGCGGCAC
TCCACCGCTTAGCA
ACAATGCATATGTGAACATCTCTATTCTGGACATTAATGACAACAGTCCCACGTTTCTGCAAAACCTGT
ACCGCATTAATGTC
AATGAAGATATTTTCGTGGGCTCCAAGATTCTGGACGTCAAAGCCACGGACGAAGATTCAGATGTAAAT
GGTCTTGTAACTTA
CAACATTGAAAGAGGCGACAATATAGGCCAGTTTTCAATAGATCCGAAAAACGGAACAATTAGCGTTTC
GAGGCCATTAGATC
GTGAGACTATTTCGCACTACACTCTTGAAATTCAAGCCTGTGATCAGGGAGATCCTCAGAGATGCAACA
GTGTTCCAATCAAT
ATAAACATTTTGGACACTAACGATAATGCACCCATATTTTCCAGCTCTAACTACAGTGTAGTACTTCAA
GAAAACCGACTTCT
GGGCTATGTATTCCTTACCTTCAAGATATCAGACGCAGACGAAACACCCAATACCACGCCATACACCTT
CGATATTAGGTCTG
GAAATGAGGGTGGGCTTTTCCGGCTGGAGCAAGATGGTTCCTTGAGAACGGCCTCGCGATTTAATCACA
ATCTGCAGGACGAA
TTCGTGATTCAAGTTCGAGTTTTCGACAACGGCACACCTCCATTATATTCCGATGCCTGGGTGGTTGTG
AAAATAATTGAAGA
AAGCCAATACCCGCCCATTGTCACACCCCTAGAAGTAACCATAAATTCATTCGAGGACGATTTTTCGGG
CGCATTCATTGGCA
AAGTTCATGCCTCGGATCAGGACAAGTATGATGAATTGAACTTTAGTTTGGTGTCCGGTCCCGATGACA
TGTATCAGAGCTCG
AAGCTGTTCAACATTTCCAACAACACGGGAAAGATCTATGCCATATCCAACCTGGATATTGGTCTGTAC
AAGCTAAATGTGTC
CGTTTCGGATGGTAAATTTCATGTGTTCTCCATTGTCAAAATCAACGTGGAACTGGTAACCAATGATAT
GCTAAAAGAGTCGG
TTGTCATTCGATTCAGAAGGATTTCAGCATCTGAGTTTCTGCTGAGTCACAGGAAAACCTTTATGCGCT
CCATTCGCAATATA
ATGCGATGTCGCCAAAAGGATGTAATTCTCATCACCCTTCAATCGGATTATCAAAAAGCATCACAACAT
GCTGTGGGTAATCG
ACGAGCCAGGTCCATTGACTCCGATTTGAACGTGGTGTTTGCAGTGCGAAAGCAGCAAATAATACCCGA
TTCCGATGAATTCT
TCACAAGTGATGAAATTCGGCAGACACTGATAGACAAGAAGAACGAGATTGAAAACGAAACCAACCTGG
TGGTGGAGGATGTA
CTACCATCCACCTGTCAAAGCAACAAAAACGACTGCGTTCACGGGGAATGCAAACAGATATTACAGATC
CTGAAGAACAACGT
TACCACCACCTTTACGGATGTGATTAGTTTTGCTGCTCCATCTTACATTCCGGTGAATACGTGTGTCTG
TCGACCAGGATTCG
ATGGAAAGCACTGCAAAGAGACTGTGAATGCCTGCTCCACGGATCCATGTTCCCCGCAGAGGATCTGCA
TGCCGTCTGGCTCG
GCTTTGGGTTACCAATGTGTGTGTCCCAAGGGATTTTCAGGAACCTACTGCGAGCGGAAGTCTTCGAAG
TGCAGCAATGAGTC
CTGTGACATGGGTCTATTCACTGCGGTGTCCTTTGGCGGAAAGAGCTATGCCCACTACAAGATCAACAA
GGTGAAGGCGAAGT
TCACGCTGGAAAACGGGTTTTCCTACTCCCTGCAGATAAGAACTGTGCAACAAACTGGGACTCTGCTGT
ATGCCAGCGGCAAG
GTGGACTACAACATCCTGGAGATCATAAACGGAGCTGTTCAGTACAGATTCGATTTGGGCTCGGGCGAG
GGAGTCATCAGTGT
GTCCAGCATTAACATCTCTGACGGCGAGTGGCATCAAATCAGCCTAGAGCGGTCCCTCAATAGTGCCAA
AGTGATGGTGGACA
ACAAGCACGTCTCCCATGGCAGTGCTCCGGGTGTGAATGGCATCCTGAACATCCAGTCGAACGATATCT
TTGTAGGCGCCGAG
GTTCGTCCGCATCCATCGATAATTGGCTACGAGGATATTCAGCGTGGCTTCATCGGTTGCATGGCAAAC
ATCAAAATAGCCAA
AGAGTCGCTGCCATTGTACATTTCCGGTGGGAGTACCATTGCTGCCTTGAAACGTTTTACGAATGTCGA
GTTCAAGTGCGATC
CGTCGAATGTTCTGGTGCGCCTGGGCATTTGCGCATCTCAGCCGTGTGCCAATAGTGGAATCTGCAAGG
AACTCGATACGGAC
GTGTTTGAATGCGCCTGTCAGCCCCGATATTCCGGCAAGCATTGCGAGATTGATTTGGACCCTTGCTCA
TCGGGACCCTGCTT
GTTTGGCGGCAGGTGCGACTACCACGGACCGAACAACTACAGCTGCACGTGTCCCATCCACTTATCCGG
AAAGAGGTGTGAGT
ACGGCAAGTTCTGCACGCCGAACCCGTGCAAAAACGGTGGCATTTGCGAGGAAGGCGATGGAATATCGC
ACTGCATGTGCCGC
GGCTACACGGGACCCACTTGTGAGATCGATGTGGATGAGTGCGAGAACCAGCCGTGCGGCAATGGAGCG
ACCTGCATCAATGA
ACCCGGAAGTTTCCGTTGCATTTGTCCATCTTATCTCACAGGAeCCAGCTGCGGCGATCCCCTGTATTCGAACTCTA
TTTCTA
CAAAGCTGAAGAACTTTTCTATAGAGCACATTAGCGGGATCATTTCCGGCGTGGCCGTGGTACTGGTCA
TCATCAGTTGTGTC
CTGTGTTGeGTGGTGTTGAAGAGGAGTTCCTCTTCAAAGCGAAGGAACCGACTAGAAAAGGACAAGAACAAGTCGTC
GTACAA
GGAGGCGAACTTGAACTCACTGGTGGACAAGGACAATTACTGCAAACCAAACGTAAAGTTGAGTAACTT
GGAGGTTAACCAGC
GTCCAATTAGCTACACAGCAGTTCCAAATGACAACCTAGTCCTGAGCAATAGGAATTTTGTAAATAACT
TAGACATCTTGCGT
AGCTACGGTTCGGCCGGCGATGAACTGGAAAATGTGCCATTCGAGTACCAGAAGGTTAATCGAAACAAA
CAGCATGTGAACAT
AAACTCCTGCCATTCAACCGATGCAGATAATGCCTACAAACAAGAATGGTGCGAGCAAATGCATTTAAG
AACCTTCAGTGAAA
ATAAACTGAACAATGAACTTAAACGGGATTTCGGACCATCTGTGAGTCGCTTTTCAACTGGGAAACTAA
TCCAAGTTGAAATG
CCCAACGTGTGCCACTCTTCCAGTGCGAATTTCGTTGATTATTCAGCTCTTGCCAATGGTCAGTATCAT
TGGGACTGTTCCGA
CTGGGTTCGCAAAAGCCATAATCCCTTGCCAGATATAACCGAAGTTCCTGGAGCAGAAATAGCTGATTC
GTCGAGCTTACACA
GCAACGATAGCAACGAGTCCAAGTCGAAGAAAGCCTTTTTCGTGCACAGGGAAGACGGAGATGTTGATC
CGACGAGGGATATA
GCCGCGTTGAATGAGGATATCGGATCGGAGTATTTGGACTCGGAGGCAGAGAGCTGCTTGGAGCCGTTT
ATGTTGCCAAGATC
AAGTAATCAGCCACTTTCAAGACTGAGTTCTTTTAATAATATCGAGAATGAAGACTATAAATCAAATAC
AGGCAAAGTATATT
TAAGACATCeTGATTCGTATTTACCGACGATGCATTTTCCAAGTGAGACCGATGGGGAAAGCTCTATGACCGAGGGG
CCGATT
TCTAGGATGGAAATAAAAACCAGGAGGACGATAAGTGAAAATTCAGAGGAGGCATACCTATTTCCATGeACTGTCGG
AGAAAT
TGGATCCAACAGCAACATTTCGGTTCGACTGTGTGAAATTGAAGATTCTGAGTTGGAGGAGTTTTTACC
ACAACAACAAACAA
ACAATTAA (SEQID NO:13)
PCS (saccharomyces cerevisiae)
CTACAACTTACTCTTATTTCTGCTGCTCTTAGCAAAAGTTTCTGCGATAACTCTTCTCTGGATTTTACC
TGTAGCGGTTTTTG
GTAGCTTATCAACAAAGTACACCTTGGTTGGAATTTTGAAAGAGGCTAGGTGCTTCTTTAAGAAGTTCA
CCAGTTCTTCGTAG
GTCATTTTTTCTCCCTTCTTCAAAACAATGGCGGCTTGAACTACTTGGCCGTACATATCGTCGGGAACA
CCAAATGCAACGGC
TTCATCGATCTTTGGATGCGATAGCATAATGCCGTeGAGCTCAATGGGTGAAATCTTTTCACCACCCCTGTTGATAA
GCTCTT
TGATTCTGCCTGTAAGGACCAAAAACCCCTCAGGGTCGAAATAACCTTGGTCACCGGTTCTGAAATAGT
TCTCTCTCTTGGTG
AAGTTCTCCTTGTTAGCTTTTGGATTATTAGCATACCCCAAAGTGACGTTTTCGCCTCTGATGGAAACT
TCGCCGACTTTGCC
CGGGGGCAAGACATTGTCATTGTCATCTAGAATGACGACGGTGACTCCTTGTGGCTGGCCCACAGTACC
AGGCTTTCTCTTTC
CTGGAGGCAGATTGTTTGAGGTCATTTGATGTGATGCTTCGGTCATCGCATAGGCCTCCAAGACAGGTG
CATTGAATTCCTTC
TCCAGCTTATGGAACGTTGCTGGAGCCAAAGCAGAAGAACACGATCTGATGAATCTAATGTGTGGGAAA
GGGTTTGGTTTGGG
CATGTTCAGCATAATCATGCTTATTGTGGGAACGCAACTGAACCAATTACAGTTGTACTTAAeAAATTGGTCCCAGA
ATAACT
TTGGATGGAATCCATCGGGAACCACAACAGAACCCTGAGTTCTAAAAGTGGAAAGTAAAACACCAATTA
ACCCATGGACGTGG
AAAAGAGGCATCACGACATAAGATCTGTCCAAGGGCGTTAGCTTGTAAGTGTTAGCAATGTTCAACGTG
CTTCTCACAATGTT
eAAATGTAACAAAGGCACCGTTTTTGGAGTGGAGGTGGTACCACTGGTATGCAAAATCAGGGCAACGTCACTGGAAC
GGGCAA
ACCCAGGGAATTTAACGGGATTTGTGTTGACAAATTTGGCGTTGTTCAAAGACCGGTAAATAACCCTTT
TGTAGTTGTCCTCT
GGAGAGTATATATCATACTCTACCCTAAACCTGGTCGCATCGAAGGCCAGCTCTACGATAAAACATCCA
AACGTGGAGGCAGA
TTTTAGAATTTCAGAACTCTGTAACTTTGTGGTACCCTTTGGGACGCAAATCGCCTTAGATTTCAGGTC
ATTCAAATAAAAAT
TGAACTCCTTTTCCTTATAATTGGGATTCAAGGGCGCGCCAATTTTAGCGTCCATAGTAGCACCGAGGA
AAGCGACGATAAAT
TCCAGCCCATTACGCATGGATATCGCCACTGTATCTTGTCTGAAAACAGCTCCGTACAATGGAGAATTA
GGATTTGTGAACAT
GGTCTGGAAGTGACCCACCATGTGGGATAGATCCCTGTAGGTCACCTGAGTGTCCGTTTCAGGAACAAT
AACGGCGACATTAT
CGGATACGCTAAAAGTATCGTTGAACGAAGCAGTAACAGTAGCGGCACTTGTCAT (SEQ ID NO:
14)
ACLY (people (Homo sapiens))
GCGAGCCGATGGGGGCGGGGAAAAGTCCGGCTGGGCCGGGACAAAAGCCGGATCCCGGGAAGCTACCGG
CTGCTGGGGTGCTC
CGGATTTTGCGGGGTTCGTCGGGCCTGTGGAAGAAGCTGCCGCGCACGGACTTCGGCAGAGGTAGAGCA
GGTCTCTCTGCAGC
CATGTCGGCCAAGGCAATTTCAGAGCAGACGGGCAAAGAACTCCTTTACAAGTTCATCTGTACCACCTC
AGCCATCCAGAATC
GGTTCAAGTATGCTCGGGTCACTCCTGACACAGACTGGGCCCGCTTGCTGCAGGACCACCCCTGGCTGC
TCAGCCAGAACTTG
GTAGTCAAGCCAGACCAGCTGATCAAACGTCGTGGAAAACTTGGTCTCGTTGGGGTCAACeTCACTCTGGATGGGGT
CAAGTC
CTGGCTGAAGCCACGGCTGGGACAGGAAGCCACAGTTGGCAAGGCCACAGGCTTCCTCAAGAACTTTCT
GATCGAGCCCTTCG
TCCCCCACAGTCAGGCTGAGGAGTTCTATGTCTGCATCTATGCCACCCGAGAAGGGGACTACGTCCTGT
TCCACCACGAGGGG
GGTGTGGACGTGGGTGATGTGGACGCCAAGGCCCAGAAGCTGCTTGTTGGCGTGGATGAGAAACTGAAT
CCTGAGGACATCAA
AAAACACCTGTTGGTCCACGCCCCTGAAGACAAGAAAGAAATTCTGGCCAGTTTTATCTCCGGCCTCTT
CAATTTCTACGAGG
ACTTGTACTTCACCTACCTCGAGATCAATCCCCTTGTAGTGACCAAAGATGGAGTCTATGTCCTTGACT
TGGCGGCCAAGGTG
GACGCCACTGCCGACTACATCTGCAAAGTCAAGTGGGGTGACATCGAGTTCCCTCCCCCCTTCGGGCGG
GAGGCATATCCAGA
GGAAGCCTACATTGCAGACCTCGATGCCAAAAGTGGGGCAAGCCTGAAGCTGACCTTGCTGAACCCCAA
AGGGAGGATCTGGA
CCATGGTGGCCGGGGGTGGCGCCTCTGTCGTGTACAGCGATACCATCTGTGATCTAGGGGGTGTCAACG
AGCTGGCAAACTAT
GGGGAGTACTCAGGCGCCCCCAGCGAGCAGCAGACCTATGACTATGCCAAGACTATCCTCTCCCTCATG
ACCCGAGAGAAGCA
CCCAGATGGCAAGATCCTCATCATTGGAGGCAGCATCGCAAACTTCACCAACGTGGCTGCCACGTTCAA
GGGCATCGTGAGAG
CAATTCGAGATTACCAGGGCCCCCTGAAGGAGCACGAAGTCACAATCTTTGTCCGAAGAGGTGGCCCCA
ACTATCAGGAGGGC
TTACGGGTGATGGGAGAAGTCGGGAAGACCACTGGGATCCCCATCCATGTCTTTGGCACAGAGACTCAC
ATGACGGCCATTGT
GGGCATGGCCCTGGGCCACCGGCCCATCCCCAACCAGCCACCCACAGCGGCCCACACTGCAAACTTCCT
CCTCAACGCCAGCG
GGAGCACATCGACGCCAGCCCCCAGCAGGACAGCATCTTTTTCTGAGTCCAGGGCCGATGAGGTGGCGC
CTGCAAAGAAGGCC
AAGCCTGCCATGCCACAAGATTCAGTCCCAAGTCCAAGATCCCTGCAAGGAAAGAGCACCACCCTCTTC
AGCCGCCACACCAA
GGCCATTGTGTGGGGCATGCAGACCCGGGCCGTGCAAGGCATGCTGGACTTTGACTATGTCTGCTCCCG
AGACGAGCCCTCAG
TGGCTGCCATGGTCTACCCTTTCACTGGGGACCACAAGCAGAAGTTTTACTGGGGGCACAAAGAGATCC
TGATCCCTGTCTTC
AAGAACATGGCTGATGCCATGAGGAAGCACCCGGAGGTAGATGTGCTCATCAACTTTGCCTeTCTeCGCTCTGCCTA
TGACAG
CACCATGGAGACCATGAACTATGCCCAGATCCGGACCATCGCCATCATAGCTGAAGGCATCCCTGAGGC
CCTCACGAGAAAGC
TGATCAAGAAGGCGGACCAGAAGGGAGTGACCATCATCGGACCTGCCACTGTTGGAGGCATCAAGCCTG
GGTGCTTTAAGATT
GGCAACACAGGTGGGATGCTGGACAACATCCTGGCCTCCAAACTGTACCGCCCAGGCAGCGTGGCCTAT
GTCTCACGTTCCGG
AGGCATGTeCAACGAGCTCAACAATATCATCTCTCGGACCACGGATGGCGTCTATGAGGGCGTGGCCATTGGTGGGG
ACAGGT
ACCCGGGCTCCACATTCATGGATCATGTGTTACGCTATCAGGACACTCCAGGAGTCAAAATGATTGTGG
TTCTTGGAGAGATT
GGGGGCACTGAGGAATATAAGATTTGCCGGGGCATCAAGGAGGGCCGCCTCACTAAGCCCATCGTCTGC
TGGTGCATCGGGAC
GTGTGCCACCATGTTCTCCTCTGAGGTCCAGTTTGGCCATGCTGGAGCTTGTGCCAACCAGGCTTCTGA
AACTGCAGTAGCCA
AGAACCAGGCTTTGAAGGAAGCAGGAGTGTTTGTGeCCCGGAGCTTTGATGAGCTTGGAGAGATCATCCAGTCTGTA
TACGAA
GATCTCGTGGCCAATGGAGTCATTGTACCTGCCCAGGAGGTGCCGCCCCCAACCGTGCCCATGGACTAC
TCCTGGGCCAGGGA
GCTTGGTTTGATCCGCAAACCTGCCTCGTTCATGACCAGCATCTGCGATGAGCGAGGACAGGAGCTCAT
CTACGCGGGCATGC
CCATCACTGAGGTCTTCAAGGAAGAGATGGGCATTGGCGGGGTCCTCGGCCTCCTCTGGTTCCAGAAAA
GGTTGCCTAAGTAC
TCTTGCCAGTTCATTGAGATGTGTCTGATGGTGACAGCTGATCACGGGCCAGCCGTCTCTGGAGCCCAC
AACACCATCATTTG
TGCGCGAGCTGGGAAAGACCTGGTCTCCAGCCTCACCTCGGGGCTGCTCACCATCGGGGATeGGTTTGGGGGTGCCT
TGGATG
CAGCAGCCAAGATGTTCAGTAAAGCCTTTGACAGTGGCATTATCCCCATGGAGTTTGTGAAeAAGATGAAGAAGGAA
GGGAAG
CTGATCATGGGCATTGGTCACCGAGTGAAGTCGATAAACAACCCAGACATGCGAGTGCAGATCCTCAAA
GATTACGTCAGGCA
GCACTTCCCTGCCACTCCTCTGCTCGATTATGCACTGGAAGTAGAGAAGATTACCACCTCGAAGAAGCC
AAATCTTATCCTGA
ATGTAGATGGTCTCATCGGAGTCGCATTTGTAGACATGCTTAGAAACTGTGGGTCCTTTACTCGGGAGG
AAGCTGATGAATAT
ATTGACATTGGAGCCCTCAATGGCATCTTTGTGCTGGGAAGGAGTATGGGGTTCATTGGACACTATCTT
GATCAGAAGAGGCT
GAAGCAGGGGCTGTATCGTCATCCGTGGGATGATATTTCATATGTTCTTCCGGAACACATGAGeATGTAA (SEQ
ID NO:15)
FAS (cow mycobacteria subspecies, Mycobacterium bovid subsp.bovis):
ATGAGTCAGACGGTGCGCGGTGTGATCGCACGACAAAAGGGCGAACCCGTTGAGCTGGTGAACATTGTC
GTCCCGGATCCCGG
ACCCGGCGAGGCCGTGGTCGACGTCACeGCCTGCGGGGTATGCCATACCGACCTGACCTACCGCGAGGGCGGCATCA
ACGACG
AATACCCTTTTCTGCTCGGACACGAGGCCGCGGGCATCATCGAGGCCGTCGGGCCGGGTGTAACCGCAG
TCGAGCCCGGCGAC
TTCGTGATCCTGAACTGGCGTGCCGTGTGCGGCCAGTGCCGGGCCTGCAAACGCGGACGGCCCCGCTAC
TGCTTCGACACCTT
TAACGCCGAACAGAAGATGACGCTGACCGACGGCACCGAGCTCACTGCGGCGTTGGGCATCGGGGCCTT
TGCCGATAAGACGC
TGGTGCACTCTGGCCAGTGCACGAAGGTCGATCCGGCTGCCGATCCCGCGGTGGCCGGCCTGCTGGGTT
GCGGGGTCATGGCC
GGCCTGGGCGCCGCGATCAACACCGGCGGGGTAACCCGCGACGACACCGTCGCGGTGATCGGCTGCGGC
GGCGTTGGCGATGC
CGCGATCGCCGGTGCCGCGCTGGTCGGCGCeAAACGGATCATCGCGGTCGACACCGATGACACGAAGCTTGACTGGG
CCCGeA
CeTTCGGCGCCACCCACACCGTCAACGCCCGCGAAGTCGACGTCGTCCAGGCCATCGGCGGCCTCACGGATGGATTC
GGCGCG
GACGTGGTGATCGACGCCGTCGGCCGACCGGAAACCTACCAGCAGGCCTTCTACGCCCGCGATCTCGCC
GGAACCGTTGTGCT
GGTGGGTGTTCCGACGCCCGACATGCGCCTGGACATGCCGCTGGTCGACTTCTTCTCTCACGGCGGTGC
GCTGAAGTCGTCGT
GGTACGGCGATTGCCTGCCCGAAAGCGACTTCCCCACGCTGATCGACCTTTACCTGCAGGGCCGGCTGC
CGCTGCAGCGGTTC
GTTTCCGAACGCATCGGGCTCGAAGACGTCGAGGAGGCGTTCCACAAGATGCATGGCGGCAAGGTATTG
CGTTCGGTGGTGAT
GTTGTGA (SEQ ID NO:1G)
AMPK (people)
AGTTCCTGGAGAAAGATGGCGACAGCCGAGAAGCAGAAACACGACGGGCGGGTGAAGATCGGCCACTAC
ATTCTGGGTGACAC
GCTGGGGGTCGGCACCTTCGGCAAAGTGAAGGTTGGCAAACATGAATTGACTGGGCATAAAGTAGCTGT
GAAGATACTCAATC
GACAGAAGATTCGGAGCCTTGATGTGGTAGGAAAAATCCGCAGAGAAATTCAGAACCTCAAGCTTTTCA
GGCATCCTCATATA
ATTAAACTGCACCAGGTCATCAGTACACCATCTGATATTTTCATGGTGATGGAATATGTCTCAGGAGGA
GAGCTATTTGATTA
TATCTGTAAGAATGGAAGGAAATCTGATGTACCTGGAGTAGTAAAAACAGGCTCCACGAAGGAGCTGGA
TGAAAAAGAAAGTC
GGCGTeTGTTCCAACAGATCCTTTCTGGTGTGGATTATTGTCACAGGCATATGGTGGTCCATAGAGATTTGAAACCT
GAAAAT
GTCCTGCTTGATGCACACATGAATGCAAAGATAGCTGATTTTGGTCTTTCAAACATGATGTCAGATGGT
GAATTTTTAAGAAC
AAGTTGTGGCTCACCCAACTATGCTGCACeAGAAGTAATTTCAGGAAGATTGTATGCAGGCCCAGAGGTAGATATAT
GGAGCA
GTGGGGTTATTCTCTATGCTTTATTATGTGGAACCCTTCCATTTGATGATGACCATGTGCCAACTCTTT
TTAAGAAGATATGT
GATGGGATCTTCTATACCCCTCAATATTTAAATCCTTCTGTGATTAGCCTTTTGAAACATATGCTGCAG
GTGGATCCCATGAA
GAGGGCCACAATCAAAGATATCAGGGAACATGAATGGTTTAAACAGGACCTTCCAAAATATCTCTTTCC
TGAGGATCCATCAT
ATAGTTCAACCATGATTGATGATGAAGCCTTAAAAGAAGTATGTGAAAAGTTTGAGTGCTCAGAAGAGG
AAGTTCTCAGCTGT
CTTTACAACAGAAATCACCAGGATCCTTTGGCAGTTGCCTACCATCTCATAATAGATAACAGGAGAATA
ATGAATGAAGCCAA
AGATTTCTATTTGGCGACAAGCCCACCTGATTCTTTTCTTGATGATCATCACCTGACTCGGCCCCATCC
TGAAAGAGTACCAT
TCTTGGTTGCTGAAACACCAAGGGCACGCCATAeCCTTGATGAATTAAATCCACAGAAATCCAAACACCAAGGTGTA
AGGAAA
GCAAAATGGCATTTAGGAATTAGAAGTCAAAGTCGACCAAATGATATTATGGCAGAAGTATGTAGAGCA
ATCAAACAATTGGA
TTATGAATGGAAGGTTGTAAACCCATATTATTTGCGTGTACGAAGGAAGAATCCTGTGACAAGCACTTA
CTCCAAAATGAGTC
TACAGTTATACCAAGTGGATAGTAGAACTTATCTACTGGATTTCCGTAGTATTGATGATGAAATTACAG
AAGCCAAATCAGGG
ACTGCTACTCCACAGAGATCGGGATCAGTTAGCAACTATCGATCTTGCCAAAGGAGTGATTCAGATGCT
GAGGCTCAAGGAAA
ATCCTCAGAAGTTTCTCTTACCTCATCTGTGACCTCAeTTGACTCTTCTCCTGTTGACCTAACTCCAAGACCTGGAA
GTCACA
CAATAGAATTTTTTGAGATGTGTGCAAATCTAATTAAAATTeTTGCACAATAA (SEQ ID NO:17)
Conversion carrier selection on leucine auxotrophy type agar plate in Po 1g Yarrowia lipolytica strain.Use PCR
The bacterium colony that screening is correctly inserted in genome.
Δ 9-FW AATGGTGAAAAACGTGGACCAAGTGGA (SEQ ID NO:18)
Δ 9-REV ATGGATCCCTAAGCAGCCATGCCAGACATAC (SEQ ID NO:19)
GLUT1-FW AATGGAGCCCAGCAGCAAGAAGGTGA (SEQ ID NO:20)
GLUT1-REV AATGGGTACCTCACACTTGGGAGTCAGeC (SEQ ID NO:21)
Hemoglobin F W AGAGACCGGGTTGGCGGCGCA (SEQ ID NO:22)
Hemoglobin REV CAGCGTCTTGAGCGTACAAA (SEQ ID NO:23)
Cytochrome FW AATGATCATCAACGGCAAGGTCT (SEQ ID NO:24)
Cytochrome REV TTATTTCTGACCCTGGAGGTAGAAG (SEQ ID NO:25)
AATGCTGAAGTT DEG C of CGAACAGT of pyruvate carboxylase FW (SEQ ID NO:26)
Pyruvate carboxylase CGATGGTACCTCACTCGATCTCCAGGATG (SEQ ID NO:27)
(substantially cultivate in YPD culture medium (complete medium: yeast extract, peptone, glucose) and YNB culture medium
Base, comprises all nutrients, but without aminoacid, and the most nitrogenous source or carbon source) in cultivate gained bacterium colony.When using YNB training
When foster base is cultivated, providing nitrogen with ammonium sulfate and provide carbon with glucose, carbon-nitrogen ratio is 150.It is long-pending that this C/N is compared to start oil
Tired is necessary.After consuming nitrogen in yeast, excessive glucocorticoid is converted into oil accumulation.
Results oil: cultivate cell in the constrained culture medium of nitrogen.Harvesting be dried 2 at 60 DEG C after 72 hours
My god.At 90 DEG C, directly process cell 24 hours with 1% sulphuric acid and methanol.Oil is converted into FAME (fatty acid methyl ester) and passes through
Hexane extracts.Hexane extraction is repeated twice to reclaim the FAME of 95%.Evaporation of hexane fraction is the most resuspended in 5ml hexane.Will
10 μ l fraction inject GC-MS to quantify FAME.
(Voelker and Davies, 1994) as described by early stage, gathers in the crops and prepares cell culture and divide for fatty acid
Analysis.The quadrupole MS of list with electron bombardment ionization source is used to be quantified the content of fatty acid of each sample by GC-MS.GC post is ID
For 0.25mm and HP-5MS (5% the phenyl)-methyl polysiloxane of 30m length that film thickness is 25 μm.GC elution requirement is as follows:
100 DEG C as initial temperature (5 minutes), within 15 minutes, rise to 250 DEG C, at 250 DEG C keep 10 minutes.
Embodiment 1
GC-MS detection is used to be grown on logarithm and stablize total free fatty in trophophase Yarrowia lipolytica culture
(FFA) the qualitative spectrum (Figure 1A-C) stored up.Main FFA stores up and comprises saturated Palmic acid and stearic acid and unsaturated oleic acid.
The FFA spectrum of relatively two trophophases demonstrates that stable phase does not has oleic acid, and observes the class of stearic acid and oleic acid in logarithmic (log) phase
As peak density (Figure 1A, B).The analysis of the oleic acid that the TL (FFA+ lipid) in stable phase has reclaimed partial amount shows, oil
Acid enters TAG forming feature (Fig. 1 C).The residue of oleic acid is stored up for downstream polyunsaturated fatty acids and therefore can not be helped
Rescue.Therefore, oleic acid imports TAG with instantaneous versions during stable trophophase and is formed, its store with intracellular TAG pathway activation time
Between meet.This shows that can there is monitoring point mechanism carrys out monitor and detection oleic levels with regulation oil accumulation.
Embodiment 2
Because in mice, SCD is necessary (to see, e.g. Regulation of stearoyl for lipogenesis
Coenzyme A desaturases and role in metabolism.Prog Lipid Res.2004Mar;43 (2): 91-
104), and be in the news in most of biologies synthesize unsaturated fatty acid be important, so we test understanding fat
Family name yeast SCD in TAG accumulates as the role of rate-limiting step.The saccharomyces cerevisiae OLE1 gene of coding SCD and solution fat Ye Shi ferment
The protein sequence analysis display protein of parent protein sequence has the homogeneity of 51%.Yarrowia lipolytica desaturase bag
Containing typical 3 histidine boxes and cytochrome b5 domain for other stearic acid coa desaturase.Because going to satisfy
(see for example, Regulation of stearovl coenzyme A desaturase by gene transcription level with enzyme
polyunsaturated fatty acids and cholesterol. James M.Ntambi.Journal of Lipid
Research, volume 40,1549-1558, September 1999) and (see Mol at logarithm and the stable phase of cell growth
Cell Biol Res Commun.1999Apr;1 (1): 36-43) by altitude mixture control, so we use half constitutive promoter
Express to natural Yarrowia lipolytica delta 8 desaturase genes.The modified stable gene of single copy is integrated into base
Because of in group.The GC-MS spectrum of saltant type and wild-type strain shows in terms of unsaturation with satisfied fatty acid ratio and dramatically increases
(Fig. 2 A, B).Show unsaturated fatty acid with the confocal microscopy of the intracellular lipid of Nile red dyeing to increase and TAG
Mutual relation (Fig. 2 C: wild type, Fig. 2 D:SCD process LAN type) between excess accumulation.In most of the cases, SCD process LAN
The whole cell volume of cell is completely filled with TAG (Fig. 2 D).These evidences finding to provide key regulatory genes, described gene
Be enough to the process LAN by changing unsaturated fatty acid and ratio induction intracellular TAG of satisfied fatty acid unexpectedly.
The Confocal Images of trophophase and stable phase cell demonstrates dramatically different in oil accumulation pattern.We test
Intracellular TAG entering back into the stable phase rich oil mutant cell after cell division cycle moves.We are with containing high concentration sugar
(300g/l) minimal medium feeds stable phase cell in batches.Cell enters back into logarithmic (log) phase effectively, and then fast-growth is also
The biomass carrying out consuming all sugar in 96 hours produce.Even if it is interesting that graphical analysis illustrates during logarithmic (log) phase also
The mutant strain of the intracellular oil of accumulation excess, this is atypical for oleaginous yeast.Although wild-type cell can not be at height
Sugar concentration grows, but even if under the sugared concentration of favourable growth, logarithmic (log) phase does not the most exist lasting oil and produces and yeast
Sample sign.
In a word, these results use the sugar of high concentration to establish continuous print fed batch process, show the yeast of transformation
Strain can accumulate oil at exponential phase during stablizing trophophase continuously.
Embodiment 3
Create two kinds of mutant yeast, the following gene of its process LAN: mutant 1:SCD, hemoglobin, Glut1,
Cytochrome;Mutant 2: hemoglobin, Glut1, cytochrome.Each gene is cloned into the site PmlI of plasmid YLEX with
Between Kpn.Select with vector Po 1g Yarrowia lipolytica strain and on leucine auxotrophy agar plate.Use PCR screening
The bacterium colony being correctly inserted in genome.Gained bacterium is cultivated in the YPD culture medium that carbon-nitrogen ratio (C/N) is 150 and YNB culture medium
Fall.This C/N comparison causes oil accumulation to be necessary.After consuming nitrogen, the sugar of excess enters the oil accumulation in yeast.
In order to measure maximum oil accumulation, nitrogen restricted type culture medium is cultivated cell.After 72 hours, harvesting and
It is dried 2 days at 60 DEG C.At 90 DEG C, cell is directly processed 24 hours with 1% sulphuric acid and methanol.Oil is converted into FAME (fat
Acid methyl ester) and extracted by hexane.Hexane extraction is repeated twice to reclaim the FAME of 95%.Evaporation of hexane fraction at 5ml
In hexane resuspended.10 μ l fraction are injected GC-MS to quantify FAME.Maximum oil accumulation in mutant strain is 80g/l.
Compare mutant 1 (" D9 ") and the glucose uptake kinetics of wild-type yeast (" LS ").Fig. 3 illustrates 72 hours
Rear mutant 1 consumes the whole sugar provided, and wild-type yeast only consumes about the 70% of provided sugar.It was additionally observed that
Even if in a period of time extended, wild-type strain does not consumes all sugar yet.
It is then determined that whether mutant strain can use biomass hydrolysate as carbon source.2L bioreactor is arranged
For comprising corn straw hydrolyzate (Hz) in the presence of 1% yeast extract.Hz comprises 20g glucose.We add (benefit
Material is in batches) 180g glucose extremely final concentration of 200g/l.We determined that wild type can not grow in hazard biological matter Hz.Shaking
Cultivating mutant 1 and mutant 2 cell in Ping to the final OD in 50ml is 3.Overnight culture is added each bioreactor
And carry out fermenting 72 hours at 30 DEG C.Running two reactors under the same conditions, one of them has mutant 1, another
Individual have mutant 2.Stirring is set to 5.5 for 800rpm, pH.
Due to the restriction of some nutrient factors in culture medium, so in 72 hours, two kinds of bacterial strains all consume and carried
About 50% (Fig. 4 A, it is shown that mutant 1 bacterial strain) for glucose.The reason of 50% sugar consumption of two kinds of bacterial strains is to there is Glut1,
Glucose transport is entered cell by known Glut1.Mutant 1 consumes 123 grams of glucoses and mutant 2 consumes 105 grams of sugar.Should
Result shows compared with wild type, mutant cell can consumption sugar almost 50% and toxicity robust against Hz, in early days
In test, wild type growth is bad and consumes less than 10g sugar.Mutant strain illustrates Johnson & Johnson head consumption sugar well.Due to battalion
Support some consumption of the factor, so not consuming remaining sugar (seeing Fig. 5 and 6).
Compared with mutant 2, mutant 1 (having the combination of process LAN gene) illustrates the oil synthesis of increase.Every liter of sudden change
Body 1 produces 26g oil (Fig. 4 B), and every liter of mutant 2 produces 14g oil.This shows that the combination of process LAN gene not only causes is provided
The consuming of sugar increases and produce the bio-fuel precursor of more oil-useful with causing increase.
Embodiment 4
Then, we measure transformation bacterial strain and the growth vigor of wild-type strain, TL life in 2 liters of rounds
Produce, carbohydrate substrates tolerates to transformation efficiency and the substrate of lipid Transfer.
GC-MS is used to measure the total amount (Fig. 7) of lipid.Transformation bacterial strain is observed than wild-type strain 10 times
Lipid production (80g/l), is represented as other people (S.Papanikolaou I.Chevalot, M.Komaitis, I.Marc
G.Aggelis, Single cell oil production by Yarrowia lipolytica growing on an
industrial derivative of animal fat in batch cultures Appl Microbiol
Biotechnol.2002Mar;58 (3): 308-12) increase of the Yarrowia lipolytica strain described in 20 times.Monounsaturated fatty acid
The main species of acid is oleic acid, and it increases to 8.5 times (g/l) (Fig. 8) compared with control strain.Total unsaturated fatty acid is with saturated
The ratio of fatty acid significantly increases, and total unsaturated fatty acid does not increases to exceed satisfied fatty acid, but wherein minority is c18.1
Situation (seeing Fig. 7 and 8).The sugar of mutant strain-oil conversion ratio is defined as 0.28g/g, when in view of being used for producing biomass
Sugared time, it is close to theoretical value.
Notable and unexpected 32 times of growth vigors (figure is observed between engineered bacterial strain and wild-type strain
9).The growth characteristics of mutant strain keep identical (Figure 10) under the sugared concentration lethal to wild-type strain permeability.Higher
Sugar tolerance is particularly important for the high gravity being generally used for industrial bio fuel production ferments.Before, fat Ye Shi ferment is being solved
Female culture is observed negative correlation that higher biomass produce between lipid accumulation (Papanikolaou S,
Chevalot I, Komaitis M, Marc I, Aggelis G.Single cell oil production by Yarrowia
lipolytica growing on an industrial derivative of animal fat in batch
cultures.Appl Microbiol Biotechnol.2002Mar;58 (3): 308-12.).Therefore, the bacterium of our transformation
The contact that biomass higher in strain produce between the lipid accumulation of excess is unexpected.Owing to fat stores is mainly used
In synthesis film and activity (the FEBS J.2008 Nov that sprouts;275 (22): 5552-63), a probability of logarithmic (log) phase cell is
Guide excess lipid again to flow to film by activating cell division approach to synthesize and/or by Lipid Secretion to extracellular matrix.This
The excessive lipid production after lipid within endothelial cells accumulation in early days will be entered after stable phase cell cycle in, equilibrium.It is true that it is higher
Biomass produce relevant to growth Lipid Secretion in early days.
Figure 11 illustrates sudden change and the growth of wildtyp Y. lipolytica and lipid production kinetics.With wild type (comparison)
Bacterial strain is compared, and mutant strain not only shows strong growth vigor, and it also produces the fatty acid of significantly higher amount.
In a word, these results show on the basis of glucose is as single carbon source, effective Metabolically engineered oleaginous yeast table
Reveal very good multiple phenotypes.
Embodiment 5
Detect the SCD regulatory mechanism causing the multiple phenotypic characteristic of mutant strain.In view of Yarrowia lipolytica desaturation
The low sequence of the similar functions gene in enzyme gene and nematode C. elegans (Caenorhabditis elegans) and mice
Row homogeneity, tests the fatty acid specificity across species SCD cloned in Yarrowia lipolytica.Ye Shi natural with process LAN
The mutant of yeast genes is similar to, and Caenorhabditis elegans has similar specificity with the SCD in mice to stearic acid, shows
Higher yield of biomass.During co-focusing imaging confirms stable trophophase, the oily of excess accumulates.These results show oil
The desaturase activity of acid is relevant to the excess accumulation of TAG.Owing to the SCD in known bakery yeast (baker ' s yeast) exists
Transcribe regulated with post-transcriptional level (see Tabor DE, Kim JB, Spiegelman BM, Edwards PA,
Identification of conserved cis-elements and transcription factors required
For sterol-regulated transcription of stearovl coenzyme A desaturase.J Biol
Chem.1999 Jul 16;274 (29): 20603-10;Shimano H, Sterol regulatoryelement-binding
protein family as global regulators of lipid synthetic genes in energy
metabolism.Vitam Horm.2002;65:167-94), have studied the oleic acid feedback suppression conduct to delta 8 desaturase genes
Possible regulation mechanism.We stably incorporate the natural delta 8 desaturase genes of single copy and the 1kb upstream comprising promoter region
Sequence.Mutant strain have accumulated excessive oil and has growth vigor and sugar tolerance as mutant before.This shows and bread
Yeast is different, and oil accumulation is not driven the promoter sequence regulation and control that desaturase is expressed.This means desaturation in Ye Shi yeast
The negative regulator of enzyme gene is to be non-dependent on transcribing and is likely to occur in metaboilic level.These data provide for the first time
In oleaginous yeast, the inhibitory action by overcoming oleic acid carries out the mechanism that oil regulates.
Embodiment 6
The engineered microorganism that the present invention provides can be cultivated in multiple substrate.Figure 13 illustrates using algae bio as carbon
The Johnson & Johnson head of sudden change Yarrowia lipolytica strain during hydrate source.Figure 14 illustrates be incubated in algal biomass engineered micro-
Oil accumulation in biological cell.Figure 15 illustrates the oil accumulation in the engineered cell being incubated in crude glycerine.
Embodiment 7
It is senior chain lipid that Δ-12 desaturase is responsible for the lipid Transfer comprising oleic acid.In order to produce bio-fuel, examine
Consider the cold flow characteristic to diesel fuel, preferably C18 chain fatty acid such as stearic acid and oleic acid.Therefore, in some embodiments, the phase
Hope that blocking or suppress C18 convert fatty acids is longer chain fatty acid.
It can complete (example by the expression of wild type Δ-12 delta 8 desaturase genes in suppression or blocking-up host microorganism
Microorganism such as process LAN Δ 9 desaturase (SCD)).To this end, create nucleic acid construct to knock out in Yarrowia lipolytica
Wild type Δ-12 desaturase.The schematic structure knocking out construct is shown in Figure 16.It is phleomycin that this carrier comprises flank
(such as, ZeocinTM) genome sequence of Δ-12 delta 8 desaturase genes of resistant gene.The sequence of this construct is shown in following.
Δ-12 desaturase knockout carrier sequence
CCAACAGACCGACCATAGAAATGGATTCGACCACGCAGACCAACACCGGCACCGGCAAGGTGGCCGTGC
AGCCCCCCACGGCC
TTCATTAAGCCCATTGAGAAGGTGTCCGAGCCCGTCTACGACACCTTTGGCAACGAGTTCACTCCTCCA
GACTACTCTATCAA
GGATATTCTGGATGCCATTCCCCAGGAGTGCTACAAGCGGTCCTACGTTAAGTCCTACTCGTACGTGGC
CCGAGACTGCTTCT
TTATCGCCGTTTTTGCCTACATGGCCTACGCGTACCTGCCTCTTATTCCCTCGGCTTCCGGCCGAGCTG
TGGCCTGGGCCATG
TACTCCATTGTCCAGGGTCTGTTTGGCACCGGTCTGTGGGTTCTTGCCCACGAGTGTGGCCACTCTGCT
TTCTCCGACTCTAA
CACCGAGAGACCGGGTTGGCGGCGCATTTGTGTCCCAAAAAACAGCCCCAATTGCCCCAATTGACCCCA
AATTGACCCAGTAG
CGGGCCCAACCCCGGCGAGAGCCCCCTTCACCCCACATATCAAACCTCCCCCGGTTCCCACACTTGCCG
TTAAGGGCGTAGGG
TACTGCAGTCTGGAATCTACGCTTGTTCAGACTTTGTACTAGTTTCTTTGTCTGGCCATCCGGGTAACC
CATGCCGGACGCAA
AATAGACTACTGAAAATTTTTTTGCTTTGTGGTTGGGACTTTAGCCAAGGGTATAAAAGACCACCGTCC
CCGAATTACCTTTC
CTCTTCTTTTCTCTCTCTCCTTGTCAACTCACACCCGAAATCGTTAAGCATTTCCTTCTGAGTATAAGA
ATCATTCAAAATGG
CCAAGTTGACCAGTGCCGTTCCGGTGCTCACCGCGCGCGACGTCGCCGGAGCGGTCGAGTTCTGGACCG
ACCGGCTCGGGTTC
TCCCGGGACTTCGTGGAGGACGACTTCGCCGGTGTGGTCCGGGACGACGTGACCCTGTTCATCAGCGCG
GTCCAGGACCAGGT
GGTGCCGGACAACACCCTGGCCTGGGTGTGGGTGCGCGGCCTGGACGAGCTGTACGCCGAGTGGTCGGA
GGTCGTGTCCACGA
ACTTCCGGGACGCCTCCGGGCCGGCCATGACCGAGATCGGCGAGCAGCCGTGGGGGCGGGAGTTCGCCC
TGCGCGACCCGGCC
GGCAACTGCGTGCACTTCGTGGCCGAGGAGCAGGACTGATCCATGGCCTGTCCCCACGTTGCCGGTCTT
GCCTCCTACTACCT
GTCCATCAATGACGAGGTTCTCACCCCTGCCCAGGTCGAGGCTCTTATTACTGAGTCCAACACCGGTGT
TCTTCCCACCACCA
ACCTCAAGGGCTCTCCCAACGCTGTTGCCTACAACGGTGTTGGCATTTAGGCAATTAACAGATAGTTTG
CCGGTGATAATTCT
CTTAACCTCCCACACTCCTTTGACATAACGATTTATGTAACGAAACTGAAATTTGACCAGATATTGTTG
TAAATAGAAAATCT
GGCTTGTAGGTGGCAAAATGCGGCGTCTTTGTTCATCAATTCCCTCTGTGACTACTCGTCATCCCTTTA
TGTTCGACTGTCGT
ATTTCTTATTTTCCATACATATGCAAGTGAGATGCCCGTGTCCTGGCCATCACCTACCTGCAGCACACC
GACCCCACTCTGCC
CCACTACCACGCCGACCAGTGGAACTTCACCCGAGGAGCCGCCGCCACCATCGACCGAGAGTTTGGCTT
CATCGGCTCCTTCT
GCTTCCATGACATCATCGAGACCCACGTTCTGCACCACTACGTGTCTCGAATTCCCTTCTACAACGCCC
GAATCGCCACTGAG
AAGATCAAGAAGGTCATGGGCAAGCACTACCGACACGACGACACCAACTTCATCAAGTCTCTTTACACT
GTCGCCCGAACCTG
CCAGTTTGTTGAAGGTAAGGAAGGCATTCAGATGTTTAGAAACGTCAATGGAGTCGGAGTTGCTCCTGA
CGGCCTGCCTTCTA
AAAAGTAGAGCTAGAAATGTTATTTGATTGTGTTTTAACTGAACAGCA (SEQ ID NO:28)
A-12 desaturase at Yarrowia lipolytica knocks out process LAN series of genes in cell and (includes A9 desaturation
Enzyme, Glut1, hemoglobin and cytochrome b5) flow into the sugar of cell with further increasing and increase oil content.Observe cell
Dramatically increasing of size, wherein the cell the most up to 95% is filled with oil.
Embodiment 8
The Yarrowia lipolytica 148 hours (Figure 17) of process LAN SCD is cultivated in 3% acetic acid class solution.At about 84 hours
Time to cell culture add 2% glycerol with provide glycerol to drive fatty acid to produce.The latter is to use acetic acid class as raw material
Produce the bottleneck of oil.Observed by confocal laser microscope and use the acetic acid class culture medium mixing glycerol to dramatically increase
Oil produces, and is the more economical new method effectively producing oil.
Although being described herein as and illustrated several embodiments of the present invention, but those skilled in the art being readily able to
Envision other method multiple and/or structure is used for realizing function as herein described and/or obtaining result as herein described and/or
Individual or more advantages, and think that these each changing and/or changing are also within the scope of the invention.More generally,
Those skilled in the art will be apparent from all parameters as herein described, yardstick, material and structure and are intended to exemplary, and
Actual parameter, yardstick, material and/or structure will depend upon which the concrete application that present invention teach that used.People in the art
Member is it will be appreciated that maybe can use not more than routine experiment to determine many equivalents of invention as described herein specific embodiments
Variant.It is therefore understood that previous embodiment scheme is only meant as exemplary, and in appended claims and its equivalent
In the range of variant, can implement with the differently present invention being specifically described and claim.Present invention is generally directed to institute herein
Each feature, system, goods, material, test kit and/or the method stated.As long as additionally, these features, system, goods, material,
Test kit and/or method are the most conflicting, then two or more these features, system, goods, material, test kit and/or
The combination in any of method is also contained in the scope of the present invention.
Defined and used herein being defined should be understood to control dictionary definition, in the file that is incorporated by reference into
Definition and/or the conventional sense of defined term.
Contradiction unless clearly indicated, the indefinite article used the most in the specification and claims is to be understood that
For meaning " at least one ".
The phrase "and/or" used in the specification and claims should be understood to united element " or
Or the two ", i.e. in some cases, element exists with being combined, and in other cases, element is separately present.Unless it is clear
Show and contradict, otherwise relevant or uncorrelated to those elements specifically determined, except concrete by phrase "and/or"
Other element beyond element that ground determines can be optionally present.Accordingly, as non-limitative example, with reference to " A and/or B ",
When being used in combination with open language such as " comprise/include ", in one embodiment, can refer to that A does not has B (optionally
Element including in addition to B);In another embodiment, can refer to that B does not has A (optionally comprising the element in addition to A);
In yet another embodiment, A and B both (optionally comprising other element) etc. can be referred to.
The "or" used in the specification and claims should be understood to have with "and/or" as defined above
Identical implication.Such as, when the project in list being separated, "or" or "and/or" should be understood to include, i.e. include
At least one in some elements or element list, also includes more than one, and optionally other unlisted project.The most clear
Point out to Chu the term of contradiction, such as " only one " or " one exactly ", or when in claims,
" consist of " refers to the element accurately comprising in some elements or element list.Typically, when being above exclusiveness art
When language such as "or", " one in ... " " only one in ... " or " one accurately in ... ", it should will be made herein
Term "or" be only understood to mean that exclusive alternative (that is, " and one or another but not the two ").When for right
Time in claim, " substantially by ... composition " should have as in Patent Law field use its conventional sense.
The phrase " at least one " referring to one or more kinds of element list used in the specification and claims
Should be understood at least one element of any one in element list or more element, but unnecessarily include tool
At least one of each element being listed in element list body, and it is not excluded for the combination in any of element in element list.Nothing
Opinion is relevant or uncorrelated to specifically defined those elements, this definition also allow for being optionally present except in element list specifically
The element beyond element limited.Accordingly, as a non-limitative example, " at least one of A and B " (or, equally,
" at least one of A or B, " or equally " at least one of A and/or B ") at least one can be referred in one embodiment
Individual, optionally include more than one, A and there is not B (optionally including the element in addition to B);In another embodiment, may be used
To refer at least one, optionally include more than one, B and there is not A (optionally including the element in addition to A);In another reality
Execute in scheme, can be referred at least one, optionally include more than one, A and at least one, optionally include more than one, B
(with optionally including other element);Deng.
It is also understood that contradiction unless clearly indicated, otherwise include required by this paper of more than one step including
Any means in, the order of the step of method is unnecessarily limited by the order of cited method step.
REFERENCES
1.J.Sambrook and D, Russell, Molecular Cloning:A Laboratory Manual, Cold
Spring Harbor Laboratory Press;3rd edition (January 15,2001), 978-0879695774
2.David C.Amberg, Daniel J.Burke;And Jeffrey N.Strathern, Methods in
Yeast Genetics:A Cold Spring Harbor Laboratory Course Manual, Cold Spring
Harbor Laboratory Press (April 2005), 978-0879697280
3.John N.Abelson, Melvin I.Simon, Christine Guthrie, and Gerald R.Fink,
Guide to Yeast Genetics and Molecular Biology, Part A, Volume 194 (Methods in
Enzymology Series, 194), Academic Press (March 11,2004), 978-0121827786
4.Christine Guthrie and Gerald R.Fink, Guide to Yeast Geneties and
Molecular and Cell Biology, Part B, Volume 350 (Methods in Enzymology, Vol 350),
Academic Press;1st edition (July 2,2002), 978-0123106711
5.Christine Guthrie and Gerald R.Fink, Guide to Yeast Geneties and
Molecular and Cell Biology, PartC, Volume 351, Academic Press;1st edition(July
9,2002), 978-0123106728
6.Gregory N.Stephanopoulos, Aristos A.Aristidou and Jens Nielset,
Metabolic Engineering:Principles and Methodologies, Academic Press;1edition
(October 16,1998), 978-0126662603
7, Christina Smolke, The Metabolic Pathway Engineering Handbook:
Fundamentals, CRC Press;1edition (July 28,2009), 978-1439802960
All publications, patent and sequence library entrance (including being listed in those above entries) mentioned herein
Full content be incorporated herein by, be equal to represent that each single application or patent are specifically and individually by drawing
With being expressly incorporated herein.In the case of conflicting, it is as the criterion with the application (including the most arbitrarily defining).
Claims (41)
1. the oil-producing fungal cell separated, it comprises restructuring stearyl-coenzyme A desaturase (SCD) gene improving SCD expression
And/or improve what SCD expressed, and relative to same type unmodified cell, at least one extra SCD gene copy, and
Reduce the genetic modification that Δ-12 desaturase is expressed.
2. the oil-producing fungal cell of the separation described in claim 1, wherein reduces the something lost of Δ-12 delta 8 desaturase genes Product Expression
Biography is modified to convert with nucleic acid construct, and described nucleic acid construct comprises:
A () comprises the expression cassette of suitable homology or allogeneic promoter,
B () comprises the expression cassette of the nucleic acid of the RNA interfering of coding targeting Δ-12 delta 8 desaturase genes product, and/or
C () reduces the nucleotide sequence of the expression of Δ-12 delta 8 desaturase genes product when inserting the genome of described cell.
3. the oil-producing fungal cell of the separation described in claim 1, wherein:
Described cell comprises restructuring stearyl-coenzyme A desaturase (SCD) gene;
Described restructuring SCD gene comprises the endogenous nucleotide sequences in described cellular genome;
Described endogenous nucleotide sequences encodes the SCD albumen of described cellular endogenous;
Described restructuring SCD gene is that the described endogenous nucleotide sequences that is because of restructuring has passed through mutation or passed through recombination event
It is changed;And
Described mutation or recombination event improve the expression of natural SCD albumen.
4. the oil-producing fungal cell of the separation described in claim 2, wherein said nucleic acid construct suppresses or eliminates described Δ-12
The expression of delta 8 desaturase genes product.
5. the oil-producing fungal cell of the separation described in claim 4,
Wherein by lacking, destroy, suddenly change and/or replace the coded sequence of natural Δ-12 delta 8 desaturase genes or regulating natural
Regulatory region or a part for regulatory region that Δ-12 delta 8 desaturase genes is expressed mediate Δ-12 delta 8 desaturase genes product table
The suppression reached or elimination.
6. the oil-producing fungal cell of the separation described in claim 2,4 or 5, wherein said nucleic acid construct inserts described cell
In genome.
7. the oil-producing fungal cell of the separation according to any one of claim 1 to 6, the raising that wherein SCD expresses gives described
Carbohydrate source is converted into fatty acid, derivative of fatty acid and/or the advantageous phenotypes of triacylglycerol (TAG) by cell.
8. the oil-producing fungal cell of the separation according to any one of claim 1 to 7, wherein said cell is that oleaginous yeast is thin
Born of the same parents.
9. the oil-producing fungal cell of the separation described in claim 8, wherein said cell is Yarrowia lipolytica
(Y.lipolytica) cell.
10. culture, it comprises the oil-producing fungal cell according to any one of claim 1 to 9.
The culture of 11. claim 10, it also comprises carbohydrate source.
Culture described in 12. claim 11, wherein said carbohydrate source is fermentable sugars.
Culture described in 13. claim 11 or 12, wherein said carbohydrate source is monosaccharide.
Culture described in 14. claim 11 or 12, wherein said carbohydrate source is glucose and/or glycerol.
Culture according to any one of 15. claim 11 to 14, the non-sterilizing of wherein said carbohydrate source.
Culture according to any one of 16. claim 11 to 15, wherein said culture is maintained under non-sterilising conditions.
Culture according to any one of 17. claim 11 to 16, wherein said culture does not comprise described oil-producing fungus
Cell selectively antibiotic or antiproliferative.
Culture according to any one of 18. claim 11 to 17, wherein said carbohydrate source is from plant or algae
Biomass.
Culture according to any one of 19. claim 11 to 18, wherein said carbohydrate source is from cellulose, half fibre
Dimension element, starch or glycerol.
Culture described in 20. claim 18 or 19, it also comprises cellulolytic enzyme or hydrolysis of hemicellulose enzyme.
Culture according to any one of 21. claim 18 to 20, wherein said biomass or described cellulose or half fiber
Element pretreatment in hot water or diluted acid or the process of ammonia filament expansion, uses hydrolytic enzyme pretreatment, by steam pre-treatment and/or Calx
Pretreatment.
22. 1 kinds are used for the method producing fatty acid or triacylglycerol, and it includes
Carbohydrate source is made to contact with the oil-producing fungal cell of the separation any one of claim 1-9;With
Be suitable to be converted into by described carbohydrate source at least in part the condition of fatty acid or triacylglycerol by described cell
Under hatch the described carbohydrate source with described cells contacting.
Method described in 23. claim 22, wherein said carbohydrate source is fermentable sugars or raw from plant or algae
The carbohydrate starch of material.
Method described in 24. claim 22 or 23, wherein said carbohydrate source is from cellulose or hemicellulose.
Method according to any one of 25. claim 22 to 24, wherein at cellulolytic enzyme or hydrolysis of hemicellulose enzyme
In the presence of, make described carbohydrate source and described cells contacting.
Method according to any one of 26. claim 22 to 25, wherein at every gram of biomass 15IU cellulolytic enzyme or half
In the presence of fiber hydrolase, described carbohydrate source is made to contact 48 hours with described cell in 55 DEG C.
Method according to any one of 27. claim 22 to 26, wherein process at hot water or diluted acid or ammonia filament expansion neutralize/
Or with biomass described in hydrolytic enzyme pretreatment or described cellulose or hemicellulose.
28. 1 kinds are used for the method producing restructuring oil-producing fungal cell, and it includes with the first nucleic acid and the second nuclear transformation fungus
Cell, wherein:
Described first nucleic acid is arranged to natural stearyl-coenzyme A desaturase (SCD) gene recombinaton with described cell, or institute
State the first nucleic acid and comprise the SCD gene of at least one copy;
Described first nucleic acid improves the expression of SCD;With
Described second nucleic acid reduces the expression of Δ-12 desaturase.
Method described in 29. claim 28, wherein said fungal cell is yeast cells.
Method described in 30. claim 29, wherein said yeast cells is Yarrowia lipolytica.
The oil-producing fungal cell of the separation of 31. claim 1, wherein said SCD gene is
The nucleotide sequence of coding SEQ ID NO:1.
The oil-producing fungal cell of the separation described in 32. claim 31, wherein said nucleotide sequence is SEQ ID NO:2.
The oil-producing fungal cell of the separation according to any one of 33. claim 31 to 32, it also comprises the promoter of allos.
The oil-producing fungal cell of the separation described in 34. claim 33, wherein said allogeneic promoter be constitutive promoter or
Inducible promoter.
The oil-producing fungal cell of the separation described in 35. claim 33, wherein said allogeneic promoter is translation elongation factor
(TEF) promoter.
The oil-producing fungal cell of the separation described in 36. claim 33, wherein said allogeneic promoter is drug induced startup
Son.
The oil-producing fungal cell of the separation described in 37. claim 33, it also comprises modified SCD promoter.
The oil-producing fungal cell of the separation described in 38. claim 1, the restructuring that wherein said cell comprises raising SCD expression is hard
Acyl coenzyme A desaturase (SCD) gene.
The oil-producing fungal cell of the separation described in 39. claim 1, wherein said cell comprises what raising SCD expressed, relative to
Same type unmodified cell, at least one extra SCD gene copy.
The oil-producing fungal cell of the separation described in 40. claim 8, wherein said cell is selected from: Yarrowia lipolytica, the multiform Chinese
Inferior yeast (Hansenula polymorpha), Pichia sp. (Pichia pastoris), saccharomyces bayanus (S.bayanus), Crewe
Family name's saccharomyces lactis (K.lactis), Waltomyces lipofer, Mortierella alpine, Mortierella
Isabellina, Zygosaccharomyces rouxii (Mucor rouxii), trichosporon cutaneum (Trichosporon cutaneu), rhodotorula glutinis
(Rhodotorula glutinis), amylase yeast (Saccharomyces diastasicus), perhaps prosperous yeast
(Schwanniomyces occidentalis), pichia stipitis (Pichia stipitis) and schizosaccharomyces pombe
(Schizosaccharomyces pombe)。
The oil-producing fungal cell of the separation described in 41. any one of claim 1 to 7, wherein said cell is selected from: the western meat of aspergillosis
Sa rice (Aspergillus shirousamii), Aspergillus niger (Aspergillus niger) and trichoderma reesei
(Trichoderma reesei)。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US30978210P | 2010-03-02 | 2010-03-02 | |
US61/309,782 | 2010-03-02 | ||
PCT/US2011/026903 WO2011109548A2 (en) | 2010-03-02 | 2011-03-02 | Microbial engineering for the production of fatty acids and fatty acid derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102869768A CN102869768A (en) | 2013-01-09 |
CN102869768B true CN102869768B (en) | 2016-11-30 |
Family
ID=
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1653174A (en) * | 2002-05-08 | 2005-08-10 | 巴斯福植物科学有限公司 | Methods for increasing oil content in plants |
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1653174A (en) * | 2002-05-08 | 2005-08-10 | 巴斯福植物科学有限公司 | Methods for increasing oil content in plants |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2011223619B2 (en) | Microbial engineering for the production of fatty acids and fatty acid derivatives | |
Mhlongo et al. | The potential of single-cell oils derived from filamentous fungi as alternative feedstock sources for biodiesel production | |
Sreeharsha et al. | Obscure yet promising oleaginous yeasts for fuel and chemical production | |
Beopoulos et al. | Yeast: A new oil producer? | |
US9862977B2 (en) | Engineered microbes and methods for microbial oil production | |
US20180201943A1 (en) | Compositions and methods for lipid production | |
CN103080305B (en) | Production of biodiesel by yeast from lignocellulose and glycerol | |
US9879248B2 (en) | Engineered microbes and methods for microbial oil overproduction from cellulosic materials | |
Qian et al. | Valorization of crude glycerol into citric acid and malic acid by Yarrowia lipolytica | |
US8999683B2 (en) | Production of biodiesel by yeast from lignocellulose and glycerol | |
Zhu et al. | Oleaginous fungi in biorefineries | |
CN102869768B (en) | Produce fatty acid and the microbial project of derivative of fatty acid | |
Mattila | Phlebia radiata as an ethanol producing fungus: conversion of lignocelluloses and metabolic regulation under hypoxia | |
Showkat et al. | Biotechnological Intercession in Biofuel Production | |
WO2022232444A1 (en) | Genetically modified yeast cells and methods of use for increased lipid yield | |
Gu | Metabolic carbon partitioning and nitrogen utilization in photosynthetic microorganisms | |
Liu et al. | Biomanufacturing of value‐added products from oils or fats: A case study on cellular and fermentation engineering of |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant |